Processing 00000000.tx.1: Increased Apoptosis Arising from Increased Expression of the Alzheimer's Disease-associated Presenilin-2 Mutation (N141I) Susan Janicki, and Mervyn J. 

Phrase: "Increased Apoptosis Arising from Increased Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332284:arising [Qualitative Concept]

Phrase: "of the Alzheimer's Disease-associated Presenilin-2 Mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0026882:Mutation [Genetic Function]
   799   C1705285:Mutation [Cell or Molecular Dysfunction]
   719   C1863051:ALZHEIMER DISEASE 2 [Disease or Syndrome]

Phrase: "(N141I"

Phrase: ")"

Phrase: "Susan Janicki,"

Phrase: "and"

Phrase: "Mervyn J."
Processing 00000000.tx.2: Monteiro Medical Biotechnology Center of the University of Maryland Biotechnology Institute and Departments of Molecular Biology and Biophysics, Neurology, and Human Genetics, Baltimore, Maryland 21201 Abstract Materials and Methods Results Discussion Footnotes Acknowledgements Abbreviations used in this paper References Abstract Mutations in the genes for presenilin 1and 2(PS-1 and PS-2) have been linked to development of early-onset Alzheimer's disease (AD). 

Phrase: "Monteiro Medical Biotechnology Center of the University of Maryland Biotechnology Institute"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   754   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   754   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   738   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Departments of Molecular Biology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Biophysics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005553:Biophysics [Biomedical Occupation or Discipline]

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "and"

Phrase: "Human Genetics,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020124:Human Genetics [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C0086418:Human [Human]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "Maryland 21201 Abstract Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Footnotes Acknowledgements Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "used in this paper"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C1273517:used [Finding]
   770   C1547566:Paper [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Abstract Mutations in the genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "for presenilin 1and 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1418986:PRESENILIN 2 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "linked to development of early-onset Alzheimer's disease"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   833   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   789   C0814120:early disease onset [Disease or Syndrome]
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C1833334:Early-onset [Finding]
   767   C0277793:disease onset [Temporal Concept]
   767   C0679245:early disease [Temporal Concept]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0243107:development [Physiologic Function]
   744   C0332162:Onset [Qualitative Concept]
   744   C0678723:Development [Organism Function]
   744   C1279919:Early [Temporal Concept]
   744   C1527148:Development [Functional Concept]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "(AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0002395:Alzheimer's Disease [Disease or Syndrome]
   913   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.3: As neither the normal function of either presenilin is known nor why mutations cause disease, we examined the properties of wild-type, truncated, and mutant PS-2 upon expression in HeLa cells. 

Phrase: "As"

Phrase: "neither the normal function of either presenilin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "nor"

Phrase: "why mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the properties of wild-type,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "truncated"

Phrase: ","

Phrase: "and"

Phrase: "mutant PS-2 upon expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "in HeLa cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.4: Although HeLa cells are strongly predisposed to continued mitosis, expression of PS-2 induced programmed cell death (apoptosis). 

Phrase: "Although"

Phrase: "HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "strongly"

Phrase: "predisposed to continued mitosis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026255:Mitosis [Cell Function]
   770   C0231203:Predisposed [Functional Concept]
   770   C0549178:Continued [Idea or Concept]

Phrase: "expression of PS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "programmed cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:Programmed Cell Death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.5: Direct evidence for apoptosis was obtained by double staining for terminal deoxynucleotide transferase nick end labeling (TUNEL) and PS-2 expression and by following green fluorescent protein-tagged PS-2 over time. 

Phrase: "Direct evidence for apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "was"

Phrase: "obtained by double staining"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0205173:Double [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1301820:Obtained [Functional Concept]
   770   C1704680:Staining [Finding]
   770   C1705764:Double [Activity]
   770   C1705765:Double [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   737 E C1706701:Obtain [Activity]

Phrase: "for terminal deoxynucleotide transferase nick end labeling (TUNEL)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   919   C0600528:terminal nick end labeling [Molecular Biology Research Technique]
   799   C1167624:Labeling [Mental Process]
   799   C1947902:Labeling [Manufactured Object]
   799   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "PS-2 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "green fluorescent protein-tagged PS-2 over time."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   800   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   770   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0808270:Time 2 [Finding]
   754   C1818826:protein tag [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040223:Time [Temporal Concept]
   744   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0332583:Green [Qualitative Concept]
   744   C1418867:Ps [Gene or Genome]
   744   C1518860:PS [Geographic Area]
   744   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   744   C1552158:Ps [Body Part, Organ, or Organ Component]
   744   C1708632:Tagged [Qualitative Concept]
   744   C3541383:Time [Temporal Concept]
   711 E C0037293:Tag [Neoplastic Process]
   711 E C0181496:Tag [Manufactured Object]
   711 E C1710492:TAG [Gene or Genome]
Processing 00000000.tx.6: Deletion analysis indicates that as little as 166NH2-terminal residues of PS-2 are sufficient for endoplasmic reticulum (ER) localization and apoptosis. 

Phrase: "Deletion analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "as"

Phrase: "little as 166NH2-terminal residues of PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   744   C0700321:Little [Quantitative Concept]
   744   C2700395:Little [Quantitative Concept]

Phrase: "are"

Phrase: "sufficient for endoplasmic reticulum (ER) localization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205410:Sufficient [Qualitative Concept]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.7: Moreover, the AD- associated PS-2 missense mutation (N141I) more efficiently induced cell death compared to wild-type PS-2 despite lower mutant protein accumulation. 

Phrase: "Moreover,"

Phrase: "the AD- associated PS-2 missense mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0599155:Missense Mutation [Genetic Function]
   793   C0026882:Mutation [Genetic Function]
   793   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(N141I"

Phrase: ")"

Phrase: "more efficiently induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "compared to wild-type PS-2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1883559:Wild Type [Organism Attribute]
   783   C0441730:Type 2 [Classification]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1547052:*Type [Quantitative Concept]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   753   C1707455:Compared [Activity]

Phrase: "despite lower mutant protein accumulation."
Processing 00000000.tx.8: Expression of the presenilins in several other cell lines and transgenic mice has been accompanied by rapid protein cleavage without the induction of cell death. 

Phrase: "Expression of the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "has"

Phrase: "been"

Phrase: "accompanied by rapid protein cleavage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0597304:Protein Cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439831:Rapid [Qualitative Concept]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "without the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.9: In contrast, PS-2 expressed in HeLa cells was not cleaved, and cell death occurred. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "expressed in HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0018873:HeLa Cells [Cell]
           HeLa
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: ","

Phrase: "and"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "occurred."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.10: We hypothesize that full-length but not cleaved PS-2 may be important in the regulation or induction of apoptosis. 

Phrase: "We"

Phrase: "hypothesize"

Phrase: "that full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "but"

Phrase: "not cleaved PS-2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0205242:Cleaved [Spatial Concept]
   812   C0333853:Cleaved [Cell]
   812   C1418867:Ps [Gene or Genome]
   812   C1518422:Not [Functional Concept]
   812   C1518860:PS [Geographic Area]
   812   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "be"

Phrase: "important in the regulation"

Phrase: "or"

Phrase: "induction of apoptosis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   790   C0205263:Induction [Functional Concept]
   790   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.11: ALZHEIMER'S disease (AD)1 is a neurodegenerative disorder manifesting with increasing incidence in the aging population. 

Phrase: "ALZHEIMER'S disease (AD)1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   923   C2931257:Alzheimer disease 1 [Disease or Syndrome]
   875   C0002395:Alzheimer's Disease [Disease or Syndrome]
   875   C1521724:Alzheimer's Disease [Pathologic Function]
   833   C1425075:MALS-1 [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "a neurodegenerative disorder manifesting with increasing incidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205319:manifesting [Functional Concept]

Phrase: "in the aging population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.12: Clinically, it is characterized by memory loss and declining cognitive functions. 

Phrase: "Clinically,"

Phrase: "it"

Phrase: "is"

Phrase: "characterized by memory loss"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0002622:Memory loss [Mental or Behavioral Dysfunction]
   833   C0751295:Memory Loss [Sign or Symptom]
   770   C0025260:Memory [Mental Process]
   770   C0700327:memory [Finding]
   770   C1517945:Loss [Quantitative Concept]
   770   C1706377:Memory [Manufactured Object]
   770   C1880022:Characterized [Activity]
   715 E C0679055:mnemonic [Mental Process]

Phrase: "and"

Phrase: "declining cognitive functions."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   901   C0392335:Cognitive functions [Mental Process]
   827   C0542341:Functions [Functional Concept]
   827   C1516691:Cognitive [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.13: Familial studies, especially in early-onset cases, indicate molecular heterogeneity and have linked AD to mutations in at least three genes: the -amyloid precursor protein gene (APP) located on chromosome 21(for review see Mullan and Crawford, 1993) and the presenilin 1and 2(PS-1 and PS-2, respectively) genes located on chromosome 14and 1,respectively (Alzheimer's Disease Collaborative Group, 1995; Campion et al., 1995; Chapman et al., 1995; Cruts et al., 1995; Levy-Lahad et al., 1995a,b; Perez-Tur et al., 1995; Rogaev et al., 1995; Sherrington et al., 1995; Wasco et al., 1995; Boteva et al., 1996). 

Phrase: "Familial studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0199236:Familial Study [Diagnostic Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "especially in early-onset cases,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C1833334:Early-onset [Finding]
   760   C0332162:Onset [Qualitative Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1279919:Early [Temporal Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "indicate"

Phrase: "molecular heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "and"

Phrase: "have"

Phrase: "linked AD to mutations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0002395:Alzheimer's Disease [Disease or Syndrome]
   783   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]

Phrase: "in"

Phrase: "at least three genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: ":"

Phrase: "the -amyloid precursor protein gene (APP)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "located on chromosome 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008664:Chromosome 21 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Mullan"

Phrase: "and"

Phrase: "Crawford,"

Phrase: "1993"

Phrase: ")"

Phrase: "and"

Phrase: "the presenilin 1and 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1418986:PRESENILIN 2 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "PS-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "respectively"

Phrase: ")"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "located on chromosome 14and 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0008651:Chromosome 1 [Cell Component]
   760   C0008633:Chromosome [Cell Component]

Phrase: "respectively"

Phrase: "(Alzheimer's Disease Collaborative Group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "1995"

Phrase: "; Campion et al.,"

Phrase: "1995"

Phrase: "; Chapman et al.,"

Phrase: "1995"

Phrase: "; Cruts et al.,"

Phrase: "1995"

Phrase: "; Levy-Lahad et al.,"

Phrase: "1995a,"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "; Perez-Tur et al.,"

Phrase: "1995"

Phrase: "; Rogaev et al.,"

Phrase: "1995"

Phrase: "; Sherrington et al.,"

Phrase: "1995"

Phrase: "; Wasco et al.,"

Phrase: "1995"

Phrase: "; Boteva et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.14: In addition, there is evidence that the acquisition of the apolipoprotein E type 4(APOE-E4) allele on chromosome 19predisposes individuals to early onset of AD (Corder et al., 1993; Strittmatter and Roses, 1995). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "there"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the acquisition of the apolipoprotein E type 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1706701:Acquisition [Activity]

Phrase: "(APOE-E4"

Phrase: ")"

Phrase: "allele on chromosome 19predisposes individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]

Phrase: "to early onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1833334:Early-onset [Finding]
   861   C0332162:Onset [Qualitative Concept]
   861   C1279919:Early [Temporal Concept]

Phrase: "of AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0002395:Alzheimer's Disease [Disease or Syndrome]
   913   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(Corder et al.,"

Phrase: "1993"

Phrase: "; Strittmatter"

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.15: Mutations in APP account for ~5% of familial cases (~19 families) with six different single or double missense mutations described so far (for review see Haass et al., 1995; Van Broeckhoven, 1995). 

Phrase: "Mutations in APP account"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "for ~5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "of familial cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(~19 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: ")"

Phrase: "with six different single"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]

Phrase: "or"

Phrase: "double missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0599155:Mutations, Missense [Genetic Function]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "so"

Phrase: "far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Haass et al.,"

Phrase: "1995"

Phrase: "; Van Broeckhoven,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.16: The larger proportion of familial AD patients (50-70% of all cases >50 families) have mutations within the PS-1 gene, which has been shown to be a hot spot for missense mutations, as greater than 35different mutations have been identified so far (for review see Cruts et al., 1996; Haass, 1997). 

Phrase: "The larger proportion of familial AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709707:Proportion [Quantitative Concept]

Phrase: "(50-70% of all cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: ">50 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: ")"

Phrase: "have"

Phrase: "mutations within the PS-1 gene,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a hot spot for missense mutations,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0263214:hot spot [Disease or Syndrome]
   790   C1521990:Hot Spot [Spatial Concept]
   790   C2947985:Hot Spot [Pharmacologic Substance]
   790   C2986491:Hotspot [Nucleotide Sequence]
   753   C0329155:Spot [Fish]
   753   C0444519:Hot [Qualitative Concept]
   753   C1427618:SPOT [Gene or Genome]
   753   C1705203:Spot [Conceptual Entity]
   753   C2350229:Hot [Natural Phenomenon or Process]

Phrase: "as"

Phrase: "greater than 35different mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "so"

Phrase: "far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Cruts et al.,"

Phrase: "1996"

Phrase: "; Haass,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.17: Interestingly, the age of onset of AD correlates somewhat with the location of mutations within the coding regions of PS-1 (for review see Cruts et al., 1996). 

Phrase: "Interestingly,"

Phrase: "the age of onset of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   744   C0001779:Age [Organism Attribute]

Phrase: "correlates"

Phrase: "somewhat with the location of mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0026882:Mutations [Genetic Function]
   753   C0450429:Location [Spatial Concept]
   753   C1515974:Location [Body Location or Region]
   753   C2984079:Somewhat [Intellectual Product]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "within the coding regions"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   966   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "for review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Cruts et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.18: Fewer AD cases are associated with mutations in PS-2 as only two missense mutations have been described in eight families, mainly of Volga-German descent (Levy-Lahad et al., 1995a,b; Rogaev et al., 1995), and recent evidence indicates at least one of these mutations is variably penetrant (Sherrington et al., 1996). 

Phrase: "Fewer AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]

Phrase: "are"

Phrase: "associated with mutations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026882:Mutations [Genetic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "only two missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0599155:Mutations, Missense [Genetic Function]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "described in eight families,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015576:Families [Family Group]
   770   C0205454:Eight [Quantitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C1704727:Family [Conceptual Entity]

Phrase: "mainly of Volga-German descent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0680043:descent [Family Group]
   760   C1556085:German [Population Group]

Phrase: "(Levy-Lahad et al.,"

Phrase: "1995a,"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "; Rogaev et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "recent evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates at least one of these mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0026882:Mutations [Genetic Function]
   748   C0205447:One [Quantitative Concept]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "variably penetrant"

Phrase: "(Sherrington et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.19: PS-1 and PS-2 are highly homologous by sequence comparison with the highest degrees of variability occurring in the amino- and carboxyl-terminal regions. 

Phrase: "PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "highly homologous by sequence comparison"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0162774:Sequence, Homologous [Molecular Sequence]
   760   C1334043:Homologous [Gene or Genome]

Phrase: "with the highest degrees"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0449286:degrees [Quantitative Concept]
   861   C0542560:degrees [Intellectual Product]
   827 E C0441889:Degree [Qualitative Concept]
   827 E C1561545:degree [Quantitative Concept]
   827 E C2348088:Degree [Quantitative Concept]

Phrase: "of variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2827666:Variability [Conceptual Entity]
   928 E C0439828:Variable [Qualitative Concept]

Phrase: "occurring in the amino-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1709305:Occur [Activity]
   737   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "carboxyl-terminal regions."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0205088:Terminal [Temporal Concept]
   827   C0596260:Carboxyl [Organic Chemical]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.20: Although the function of these proteins is not known, they share homology with two Caenorhabditis elegans proteins. 

Phrase: "Although"

Phrase: "the function of these proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0815043:function proteins [Amino Acid, Peptide, or Protein]
   781 E C1527118:Protein Function [Molecular Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "they"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "homology with two Caenorhabditis elegans proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1334043:Homology [Gene or Genome]
   753   C2697616:Homology [Qualitative Concept]
   717   C1512488:Protein Homolog [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.21: The presenilins are ~50% homologous to Sel-12, which is involved in cell signaling by Notch-based receptors, and they exhibit limited homology to SPE-4, which functions in spermatogenesis (Levitan and Greenwald, 1995; Levy-Lahad et al., 1995; Sherrington et al., 1995). 

Phrase: "The presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are ~"

Phrase: "50% homologous to Sel-12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1334043:Homologous [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell signaling by Notch-based receptors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0037083:Cell Signaling [Cell Function]
           Signaling
   757   C1514762:Receptor Signaling [Molecular Function]
   748   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "they"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "limited homology to SPE-4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1334043:Homology [Gene or Genome]
   760   C2697616:Homology [Qualitative Concept]

Phrase: "which"

Phrase: "functions in spermatogenesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   858   C0037864:Spermatogenesis, function [Cell Function]
           Spermatogenesis
   790   C0031843:function [Physiologic Function]
   790   C0542341:Function [Functional Concept]
   790   C0700205:FUNCTION [Classification]
   790   C1705273:Function [Intellectual Product]

Phrase: "(Levitan"

Phrase: "and"

Phrase: "Greenwald,"

Phrase: "1995"

Phrase: "; Levy-Lahad et al.,"

Phrase: "1995"

Phrase: "; Sherrington et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.22: Evidence suggesting that these putative C.elegans homologues may indeed be related to mammalian presenilins is the apparent ability of injected human PS-1 and PS-2 cDNAs to functionally rescue a C.elegans Sel-12 mutant defective in vulva development and egg laying (Levitan et al., 1996). 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these putative C.elegans homologues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1334043:Homologue [Gene or Genome]

Phrase: "may"

Phrase: "indeed"

Phrase: "be"

Phrase: "related to mammalian presenilins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0024660:Mammalian [Mammal]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "is"

Phrase: "the apparent ability of injected human PS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "PS-2 cDNAs to functionally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "rescue"

Phrase: "a C.elegans Sel-12 mutant defective in vulva development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0332452:Defective [Functional Concept]

Phrase: "and"

Phrase: "egg laying"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029957:egg-laying [Organism Function]
  1000   C1622979:Egg Laying [Organism Function]
           LAYING

Phrase: "(Levitan et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.23: Additional evidence indicating PS involvement in development are recent reports showing molecular disruption of the PS-1 gene leads to death shortly after birth with embryos displaying central nervous system defects together with abnormal patterning of the axial skeleton and spinal ganglia (Shen et al., 1997; Wong et al., 1997). 

Phrase: "Additional evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicating"

Phrase: "PS involvement in development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "are"

Phrase: "recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "molecular disruption of the PS-1 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332453:Disruption [Functional Concept]

Phrase: "leads to death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0011065:Death [Organism Function]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C1306577:Death, NOS [Finding]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "shortly after birth with embryos"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0005615:Birth [Organism Function]
   760   C1550722:birth [Idea or Concept]
   760   C3245487:birth [Intellectual Product]
   704 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   704 E C0314603:Genetic [Functional Concept]
   704 E C0454729:Natal [Geographic Area]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "central nervous system defects together with abnormal patterning of the axial skeleton"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   736   C0243067:defects [Functional Concept]
   703 E C1457869:Defect [Functional Concept]
   703 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "spinal ganglia"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0017070:Ganglia, Spinal [Body Part, Organ, or Organ Component]
  1000   C1182736:Spinal ganglia [Body Part, Organ, or Organ Component]
   966 E C1761610:Spinal ganglion [Body Part, Organ, or Organ Component]
   861   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   827 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "(Shen et al.,"

Phrase: "1997"

Phrase: "; Wong et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.24: Both presenilin genes are ubiquitously expressed with differential accumulation of two major mRNA transcripts (Li et al., 1995; Rogaev et al., 1995; Sherrington et al., 1995; Lee et al., 1996; Vito et al., 1996a,b). 

Phrase: "Both presenilin genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "ubiquitously"

Phrase: "expressed with differential accumulation of two major mRNA transcripts"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205164:Major [Qualitative Concept]
   742   C0205448:Two [Quantitative Concept]
   742   C0443199:Differential [Qualitative Concept]
   742   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C1705242:Differential [Qualitative Concept]

Phrase: "(Li et al.,"

Phrase: "1995"

Phrase: "; Rogaev et al.,"

Phrase: "1995"

Phrase: "; Sherrington et al.,"

Phrase: "1995"

Phrase: "; Lee et al.,"

Phrase: "1996"

Phrase: "; Vito et al.,"

Phrase: "1996a,"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.25: Immunofluorescence staining of epitope-tagged presenilins indicates that the proteins are localized to the ER and Golgi, although subtle differences in localization between PS-1 and PS-2 were noted (Cook et al., 1996; Kovacs et al., 1996; Walter et al., 1996). 

Phrase: "Immunofluorescence staining of epitope-tagged presenilins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "indicates"

Phrase: "that"

Phrase: "the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "localized to the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0392752:Localized [Spatial Concept]

Phrase: "and"

Phrase: "Golgi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]

Phrase: "although"

Phrase: "subtle differences in localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "between PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "(Cook et al.,"

Phrase: "1996"

Phrase: "; Kovacs et al.,"

Phrase: "1996"

Phrase: "; Walter et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.26: The presenilins are multipass transmembrane proteins that are believed to topologically weave through ER membranes six to eight times with the NH2- and COOH-terminal domains and the large "loop" spanning the putative sixth and seventh transmembrane domains (TMDs) (according to some models) contained within the cytoplasm (see Fig. 1; Doan et al., 1996; Li and Greenwald, 1996; Lehmann et al., 1997). 

Phrase: "The presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "multipass transmembrane proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C2336735:Multipass transmembrane protein [Biologically Active Substance]
   867   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]

Phrase: "that"

Phrase: "are"

Phrase: "believed"

Phrase: "to topologically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "weave through ER membranes six"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   816   C0230770:endoplasmic reticulum membrane [Cell Component]
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0025255:Membranes [Tissue]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0205452:Six [Quantitative Concept]
   719 E C0596901:Membrane [Cell Component]
   719 E C1706182:Membrane [Manufactured Object]

Phrase: "to eight times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "with the NH2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002508:NH2 [Organic Chemical]
  1000   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "COOH-terminal domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the large """
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]

Phrase: "loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: """"

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the putative sixth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205440:Sixth [Quantitative Concept]

Phrase: "and"

Phrase: "seventh transmembrane domains (TMDs)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C1519623:Transmembrane Domain [Amino Acid Sequence]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "("

Phrase: "according to some models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: ")"

Phrase: "contained within the cytoplasm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010834:Cytoplasm [Cell Component]
   770   C0332256:contained [Functional Concept]
   770   C2700400:Contained [Activity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "; Doan et al.,"

Phrase: "1996"

Phrase: "; Li"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Greenwald,"

Phrase: "1996"

Phrase: "; Lehmann et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.27: Recent studies of PS-1 expression in fibroblasts and transgenic mice indicate that PS-1 is proteolytically cleaved since 27-28-kD NH2-terminal and 16- 17-kD COOH-terminal derivatives accumulate in cell lysates (Lee et al., 1996; Thinakaran et al., 1996). 

Phrase: "Recent studies of PS-1 expression"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "indicate"

Phrase: "that PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "proteolytically"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "since 27-28-kD NH2-terminal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0002508:NH2 [Organic Chemical]
   799   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   799   C0205088:Terminal [Temporal Concept]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "16- 17-kD COOH-terminal derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0243072:derivatives [Chemical Viewed Structurally]
   766 E C1527240:Derivative [Functional Concept]

Phrase: "accumulate"

Phrase: "in cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(Lee et al.,"

Phrase: "1996"

Phrase: "; Thinakaran et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.28: Analogous proteolytic cleavage of PS-2 has also been reported (Kim et al., 1997; Tomita et al., 1997). 

Phrase: "Analogous proteolytic cleavage of PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(Kim et al.,"

Phrase: "1997"

Phrase: "; Tomita et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.29: The function of proteolytic cleavage of the presenilins is not known. 

Phrase: "The function of proteolytic cleavage of the presenilins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.30: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.31: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.32: Schematic drawings of PS-2 expression constructs. 

Phrase: "Schematic drawings of PS-2 expression constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013113:Drawings [Intellectual Product]
Processing 00000000.tx.33: The putative structure of PS-2 is shown. 

Phrase: "The putative structure of PS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.34: The schematic with a corresponding line drawing illustrates PS-2 with eight TMDs (numbered 1-8). 

Phrase: "The schematic with a corresponding line drawing"

Phrase: "illustrates"

Phrase: "PS-2 with eight TMDs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1519623:Transmembrane Domain [Amino Acid Sequence]
   753   C0205454:Eight [Quantitative Concept]
   753   C1167322:transmembrane [Cell Component]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   753   C2752508:transmembrane [Cell Component]
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "(numbered 1-8"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449788:numbered [Quantitative Concept]
   793 E C0237753:*Number [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.35: NH2-, COOH-terminal, and the large hydrophilic loop domains are all present on the cytoplasmic side of an ER membrane. 

Phrase: "NH2-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002508:NH2 [Organic Chemical]
  1000   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "COOH-terminal,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "the large hydrophilic loop domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "are"

Phrase: "all"

Phrase: "present on the cytoplasmic side of an ER membrane."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   795   C0230770:Membrane of endoplasmic reticulum [Cell Component]
           endoplasmic reticulum membrane
   760   C0014239:Endoplasmic Reticulum [Cell Component]
   757   C0007603:Cytoplasmic Membrane [Cell Component]
   739   C0010834:Cytoplasmic [Cell Component]
   739   C0025255:Membrane [Tissue]
   739   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   739   C0150312:Present [Quantitative Concept]
   739   C0441987:Side [Spatial Concept]
   739   C0449450:Present [Idea or Concept]
   739   C0521449:Cytoplasmic [Body Location or Region]
   739   C0596901:Membrane [Cell Component]
   739   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.36: (A-I) PS-2 expression constructs used in this study. 

Phrase: "(A-I) PS-2 expression constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C2827421:Construct [Classification]

Phrase: "used in this study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.37: Some of the restriction sites used for cloning are shown. 

Phrase: "Some of the restriction sites"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   781   C2945843:Site of [Qualitative Concept]
   773   C1882940:Restriction Site [Nucleotide Sequence]
   760   C0205145:Sites [Spatial Concept]
   760   C0205392:Some [Quantitative Concept]
   760   C0443288:Restriction [Functional Concept]
   760   C3540770:Some [Intellectual Product]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "used for cloning"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0009015:Cloning [Research Activity]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.38: Transcription of all constructs was driven by the CMV promoter. 

Phrase: "Transcription of all constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]

Phrase: "was"

Phrase: "driven by the CMV promoter."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010825:Cytomegalovirus [Virus]
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   726   C0013126:Drive [Mental Process]
Processing 00000000.tx.39: The constructs that were myc- or GFP-tagged are illustrated. 

Phrase: "The constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "that"

Phrase: "were"

Phrase: "myc-"

Phrase: "or"

Phrase: "GFP-tagged"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   861   C1708632:Tagged [Qualitative Concept]
   827 E C0037293:Tag [Neoplastic Process]
   827 E C0181496:Tag [Manufactured Object]
   827 E C1710492:TAG [Gene or Genome]

Phrase: "are"

Phrase: "illustrated."
Processing 00000000.tx.40: Constructs B and I contain the AD-associated PS-2(N141I) mutation. 

Phrase: "Constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the AD-associated PS-2"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   898   C1863051:ALZHEIMER DISEASE 2 [Disease or Syndrome]
   839   C0002395:Alzheimer's Disease [Disease or Syndrome]
   839   C1521724:Alzheimer's Disease [Pathologic Function]
   830   C1425076:MALS-2 [Gene or Genome]
   827   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0012634:Disease [Disease or Syndrome]
   799   C0332281:Associated [Qualitative Concept]
   799   C1418867:Ps [Gene or Genome]
   799   C1518860:PS [Geographic Area]
   799   C1552158:Ps [Body Part, Organ, or Organ Component]
   766 E C0750490:Associate [Idea or Concept]
   766 E C1706221:Associate [Professional or Occupational Group]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: "(N141I"

Phrase: ")"

Phrase: "mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.41: Construct J is a line drawing of the Kv1.4 human potassium channel cDNA that was used as a control since it is similar in topology (shown schematically) to PS-2. 

Phrase: "Construct J"

Phrase: "is"

Phrase: "a line drawing of the Kv1.4 human potassium channel cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0013113:drawing [Intellectual Product]

Phrase: "that"

Phrase: "was"

Phrase: "used as a control"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "since"

Phrase: "it"

Phrase: "is"

Phrase: "similar in topology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "("

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "schematically"

Phrase: ")"

Phrase: "to PS-2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]
Processing 00000000.tx.42: [View Larger Version of this Image (35K GIF file)] To study the function of presenilins, we cloned and expressed wild-type, mutant, and deleted forms of human PS-2 in HeLa cells, a human cell line typically resistant to apoptosis. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(35K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the function of presenilins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "we"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "expressed wild-type, mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "deleted forms of human PS-2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "in HeLa cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "a human cell line"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0682523:Human Cell Line [Cell]
   901   C0007600:Cell Line [Cell]
   901   C0427861:human cell [Laboratory or Test Result]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "typically resistant to apoptosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332325:Resistant to [Functional Concept]
           Resistant
   770   C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.43: Our studies show that the overexpression of PS-2 in HeLa cells affects nuclear morphology and causes cell death. 

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the overexpression of PS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "in HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "nuclear morphology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1749565:nuclear morphology [Cell Function]
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.44: Furthermore, we demonstrate that 166NH2-terminal PS-2 residues are sufficient for ER localization and for inducing cell death. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that 166NH2-terminal PS-2 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "sufficient for ER localization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205410:Sufficient [Qualitative Concept]

Phrase: "and for inducing cell death."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0205263:Inducing [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1515981:And [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.45: Most interestingly, we demonstrate the AD-associated PS-2(N141I) mutation induces an increase in cell death of HeLa cells compared to wild-type PS-2. 

Phrase: "Most interestingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "the AD-associated PS-2"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   898   C1863051:ALZHEIMER DISEASE 2 [Disease or Syndrome]
   839   C0002395:Alzheimer's Disease [Disease or Syndrome]
   839   C1521724:Alzheimer's Disease [Pathologic Function]
   830   C1425076:MALS-2 [Gene or Genome]
   827   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0012634:Disease [Disease or Syndrome]
   799   C0332281:Associated [Qualitative Concept]
   799   C1418867:Ps [Gene or Genome]
   799   C1518860:PS [Geographic Area]
   799   C1552158:Ps [Body Part, Organ, or Organ Component]
   766 E C0750490:Associate [Idea or Concept]
   766 E C1706221:Associate [Professional or Occupational Group]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: "(N141I"

Phrase: ")"

Phrase: "mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "an increase in cell death of HeLa cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007587:Cell Death [Cell Function]
           cells death
   744   C0011065:Death [Organism Function]
   744   C1306577:Death, NOS [Finding]

Phrase: "compared to wild-type PS-2."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1883559:Wild Type [Organism Attribute]
   783   C0441730:Type 2 [Classification]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1547052:*Type [Quantitative Concept]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   753   C1707455:Compared [Activity]
Processing 00000000.tx.46: Materials and Methods Cloning of Human PS-2 cDNA and Construction of PS-2 Variants The PS-2 cDNA was obtained from a human brain marathon-ready cDNA library (CLONTECH Laboratories, Inc., Palo Alto, CA) by PCR amplification using two primers, a 5-end primer (5ATCGATAAGCTTCGCGAGTGTTCGTGGTGCTTCCAGAGGCA3) of which 25bases of the 3 end of the primer were identical to the coding strand of human PS-2 six bases upstream of the ATG start codon, and a 3-end primer (5GGAAGAATTCGTCGACGCAGCCTGTGGCACACCATGTCCC3 ) of which 24bases of the 3 end were complementary to sequences immediately downstream of the PS-2 stop codon. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "Cloning of Human PS-2 cDNA"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0525049:Human Cloning [Research Activity]
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0009015:Cloning [Research Activity]
   753   C0086418:Human [Human]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   719 E C0009013:Clone [Cell]
   719 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "Construction of PS-2 Variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "The PS-2 cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "obtained from a human brain marathon-ready cDNA library"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0023621:Library [Manufactured Object,Organization]
   742   C0086418:Human [Human]
   742   C0168374:marathon [Biomedical or Dental Material]
   742   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1301820:Obtained [Functional Concept]
   708 E C1706701:Obtain [Activity]

Phrase: "(CLONTECH Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Inc.,"

Phrase: "Palo Alto,"

Phrase: "CA) by PCR amplification"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two primers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a 5-end primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5ATCGATAAGCTTCGCGAGTGTTCGTGGTGCTTCCAGAGGCA3"

Phrase: ")"

Phrase: "of which 25bases"

Phrase: "of the 3 end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "of the primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "identical to the coding strand of human PS-2 six"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205280:Identical [Qualitative Concept]

Phrase: "bases upstream of the ATG start codon,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0242610:Codon, Start [Nucleotide Sequence]
   748   C0002055:base [Inorganic Chemical]
   748   C0009221:Codon [Nucleotide Sequence]
   748   C0178499:Base [Chemical Viewed Functionally]
   748   C0439659:Start [Temporal Concept]
   748   C0522505:Upstream [Spatial Concept]
   748   C1095825:Codon [Plant]
   748   C1626935:Bases [Quantitative Concept]
   748   C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "a 3-end primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5GGAAGAATTCGTCGACGCAGCCTGTGGCACACCATGTCCC3"

Phrase: ")"

Phrase: "of which 24bases"

Phrase: "of the 3 end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "complementary to sequences immediately"

Phrase: "downstream of the PS-2 stop codon."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0242611:Stop Codon [Nucleotide Sequence]
   812   C0009221:Codon [Nucleotide Sequence]
   812   C1095825:Codon [Plant]
Processing 00000000.tx.47: The PCR reaction was carried out according to instructions provided by the manufacturer. 

Phrase: "The PCR reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out according to instructions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0302828:instructions [Intellectual Product]
   770   C0439787:Out [Spatial Concept]
   770   C0680240:according [Social Behavior]
   770   C0849355:Out [Qualitative Concept]
   770   C1442085:Instructions [Idea or Concept]
   770   C3263700:Instructions [Clinical Attribute]
   737 E C0039401:Instruction [Educational Activity]

Phrase: "provided by the manufacturer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]
   770   C1999230:Provided [Activity]
Processing 00000000.tx.48: A major PCR product of ~1.4-kbp spanning the entire coding sequence of PS-2 was produced. 

Phrase: "A major PCR product of ~1.4-kbp"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0082584:KBP [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   795   C0582520:kbp [Quantitative Concept]
   795   C1428077:KBP [Gene or Genome]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the entire coding sequence of PS-2"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0079941:Coding Sequence [Gene or Genome]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0009219:Coding [Occupational Activity]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]
   714 E C0805701:Code [Intellectual Product]

Phrase: "was"

Phrase: "produced."
Processing 00000000.tx.49: The PCR product was digested with EcoRI since this site was engineered into the 3-end primer and the resulting ~1.4-kbp product was ligated into plasmid pBluescript KS() that had been previously digested with EcoRV and EcoRI. 

Phrase: "The PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "digested with EcoRI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0868946:digested [Physiologic Function]

Phrase: "since"

Phrase: "this site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "engineered into the 3-end primer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0444930:End [Spatial Concept]
   753   C0878517:engineered [Professional or Occupational Group]
   753   C2746065:End [Temporal Concept]

Phrase: "and"

Phrase: "the resulting ~1.4-kbp product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "ligated into plasmid pBluescript KS()"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C3541894:ks [Quantitative Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "previously"

Phrase: "digested with EcoRV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "EcoRI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.50: The recombinant plasmid was fully sequenced and was found to correspond to human PS-2 without any of the known AD mutations (Levy-Lahad et al., 1995a; Rogaev et al., 1995). 

Phrase: "The recombinant plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "fully"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correspond to human PS-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086418:Human [Human]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "without any"

Phrase: "of the known AD mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Levy-Lahad et al.,"

Phrase: "1995a"

Phrase: "; Rogaev et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.51: To express PS-2 in human cells, full-length PS-2 and four progressively shorter COOH-terminal deletions were cloned into a pGEM expression vector such that the PS-2 cDNA was placed in the appropriate orientation for expression from the strong cytomegalovirus (CMV) promoter (Fig. 1). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "PS-2 in human cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0427861:Human cells [Laboratory or Test Result]
   806   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0007634:Cells [Cell]
   760   C0086418:Human [Human]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "full-length PS-2"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   875   C0806636:Length 2 [Quantitative Concept]
   861   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0443225:Full [Qualitative Concept]
   812   C1418867:Ps [Gene or Genome]
   812   C1444754:Length [Quantitative Concept]
   812   C1518860:PS [Geographic Area]
   812   C1552158:Ps [Body Part, Organ, or Organ Component]
   812   C1706316:LENGTH [Research Activity]
   741 E C0205166:Long [Qualitative Concept]
   741 E C1522425:Longest [Qualitative Concept]
   741 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "four progressively shorter COOH-terminal deletions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0205088:Terminal [Temporal Concept]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   799   C1880274:Deletions [Activity]
   766 E C1442161:Deletion [Cell or Molecular Dysfunction]
   766 E C1511760:Deletion [Genetic Function]

Phrase: "were"

Phrase: "cloned into a pGEM expression vector"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0009013:cloned [Cell]
   753   C0049896:PGE-M [Eicosanoid]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "such"

Phrase: "that"

Phrase: "the PS-2 cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "placed in the appropriate orientation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0029266:Orientation [Mental Process]
   760   C1548787:Appropriate [Qualitative Concept]
   760   C1704322:orientation [Spatial Concept]
   760   C1704972:Orientation [Spatial Concept]
   760   C3539923:Orientation [Intellectual Product]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "for expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "from the strong cytomegalovirus (CMV) promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.52: The pGEM CMV-driven expression plasmid was constructed from pCMV-NF-L (Lee et al., 1993; was kindly provided by Dr. Michael Lee, Johns Hopkins University, Baltimore, MD) by first destroying the most 5 EcoRI site in the vector by standard molecular techniques. 

Phrase: "The pGEM CMV-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010825:Cytomegalovirus [Virus]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "expression plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "constructed from pCMV-NF-L"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1455438:NF-L [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1518285:NF-L [Cell Component]
   806   C2981619:NF-L [Gene or Genome]
   726   C2827421:Construct [Classification]

Phrase: "(Lee et al.,"

Phrase: "1993"

Phrase: ";"

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Dr. Michael Lee,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031831:DR [Professional or Occupational Group]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C1999230:Provided [Activity]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]

Phrase: "Johns Hopkins University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD) by first destroying"

Phrase: "the most 5 EcoRI site in the vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205145:Site [Spatial Concept]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]

Phrase: "by standard molecular techniques."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1513384:Molecular Technique [Molecular Biology Research Technique]
   827   C0025664:techniques [Intellectual Product]
   827   C0449851:Techniques [Functional Concept]
Processing 00000000.tx.53: The product was then double digested with EagI, which cleaves just 3 of the CMV promoter in NF-L 5 untranslated sequences (see Monteiro et al., 1994), and HindIII, which is located at the 3 end of the NF-L fragment (Lee et al., 1993). 

Phrase: "The product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "digested with EagI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "which"

Phrase: "cleaves"

Phrase: "just 3 of the CMV promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0010825:Cytomegalovirus [Virus]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in NF-L 5 untranslated sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Monteiro et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "HindIII,"

Phrase: "which"

Phrase: "is"

Phrase: "located at the 3 end of the NF-L fragment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C1455438:NF-L [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1518285:NF-L [Cell Component]
   760   C2981619:NF-L [Gene or Genome]
   757   C0288011:NF-AT [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0332255:fragment [Functional Concept]
   739   C0444930:End [Spatial Concept]
   739   C1708096:Fragment [Qualitative Concept]
   739   C2746065:End [Temporal Concept]

Phrase: "(Lee et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.54: Next, through a series of cloning steps an EagI-HindIII fragment from pNF(+La/head) containing lamin 5 sequences, 12codons of myc sequence, and the entire NF-L 3 region (Monteiro et al., 1994) was introduced into the CMV expression vector. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "through a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of cloning steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "an EagI-HindIII fragment from pNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332255:fragment [Functional Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "(+La/head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0018670:Head [Body Location or Region]
   861   C1281590:Head [Body Part, Organ, or Organ Component]
   861   C1706305:Head [Manufactured Object]
   805 E C0205096:Cephalic [Spatial Concept]

Phrase: ")"

Phrase: "containing lamin 5 sequences,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "12codons of myc sequence,"

Phrase: "and"

Phrase: "the entire NF-L 3 region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0017446:Region [Geographic Area]
   804   C0205147:Region [Spatial Concept]
   733 E C0205276:Regional [Spatial Concept]
   733 E C1947913:Regional [Spatial Concept]

Phrase: "(Monteiro et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: "was"

Phrase: "introduced into the CMV expression vector."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0010825:Cytomegalovirus [Virus]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   719   C1292748:introduce [Functional Concept]
Processing 00000000.tx.55: This plasmid was then double digested with SacII, which is located 3 of the EagI site in the 5 untranslated sequence of lamin A, together with SalI, which cleaves 5 of the myc sequences. 

Phrase: "This plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "digested with SacII,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "which"

Phrase: "is"

Phrase: "located"

Phrase: "3 of the EagI site"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C0439086:<3 [Quantitative Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   760   C2827736:3+ [Quantitative Concept]
   760   C2981702:3+ [Classification]

Phrase: "in the 5 untranslated sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "of lamin A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0125258:Lamin A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416877:LAMIN A [Gene or Genome]
   861   C0064635:Lamin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "together with SalI,"

Phrase: "which"

Phrase: "cleaves"

Phrase: "5 of the myc sequences."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0162326:Sequences [Nucleotide Sequence]
   760   C0439084:>5 [Quantitative Concept]
   760   C0728893:+5 [Quantitative Concept]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.56: PS-2 fragments digested with SacII and SalI were subsequently ligated into this CMV expression vector. 

Phrase: "PS-2 fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "digested with SacII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "SalI"

Phrase: "were"

Phrase: "subsequently"

Phrase: "ligated into this CMV expression vector."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0010825:Cytomegalovirus [Virus]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.57: pPS-2+MYC To express full-length PS-2 tagged with the myc epitope, the PS-2 cDNA was PCR amplified with primers that introduced a SacII site upstream of the ATG and a SalI site at the 3 end, which eliminated the stop codon and fused the protein to the myc sequence (described in Monteiro et al., 1994). 

Phrase: "pPS-2+MYC To"

Phrase: "express"

Phrase: "full-length PS-2 tagged with the myc epitope,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   742   C1708632:Tagged [Qualitative Concept]
   708 E C0037293:Tag [Neoplastic Process]
   708 E C0181496:Tag [Manufactured Object]
   708 E C1710492:TAG [Gene or Genome]

Phrase: "the PS-2 cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "amplified with primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "a SacII site upstream of the ATG"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2945843:Site of [Qualitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "a SalI site at the 3 end,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "which"

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "the stop codon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242611:Stop Codon [Nucleotide Sequence]
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "and"

Phrase: "fused"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0699952:Fused [Functional Concept]
   966 E C1414861:FUSE [Gene or Genome]
   966 E C1708111:Fuse [Manufactured Object]

Phrase: "the protein to the myc sequence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0002518:Protein Sequence [Amino Acid Sequence]
   783   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "described in Monteiro et al.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.58: The 5-end primer, 5ACGTACGTAACCGCGGGTTCGTGGTGCTTCCAG3, contained a SacII site followed by 17bases at its 3 end, which were identical in sequence to the coding strand of PS-2 with similarity beginning 10bp upstream of the ATG start codon. 

Phrase: "The 5-end primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5ACGTACGTAACCGCGGGTTCGTGGTGCTTCCAG3,"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a SacII site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "followed by 17bases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "at its 3 end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "which"

Phrase: "were"

Phrase: "identical in sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "to the coding strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704972:Strand [Spatial Concept]
   861   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "with similarity beginning 10bp"

Phrase: "upstream of the ATG start codon."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0242610:Codon, Start [Nucleotide Sequence]
   827   C0009221:Codon [Nucleotide Sequence]
   827   C1095825:Codon [Plant]
Processing 00000000.tx.59: The 3-end PCR primer, 5TATCGCTTAAGTCGACGATGTAGAGCTGATGGG3, contained 17bases complementary to sequences just upstream of the stop codon of PS-2 and was preceded by a SalI restriction site. 

Phrase: "The 3-end PCR primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5TATCGCTTAAGTCGACGATGTAGAGCTGATGGG3,"

Phrase: "contained 17bases"

Phrase: "complementary to sequences just"

Phrase: "upstream of the stop codon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242611:Stop Codon [Nucleotide Sequence]
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "of PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "was"

Phrase: "preceded by a SalI restriction site."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1882940:Restriction Site [Nucleotide Sequence]
   753   C0205145:Site [Spatial Concept]
   753   C0332152:preceded [Temporal Concept]
   753   C0443288:Restriction [Functional Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
Processing 00000000.tx.60: The ~1.4-kbp PCR product was double digested with SacII and SalI and ligated into the pGEM CMV vector (Fig. 1 C). 

Phrase: "The ~1.4-kbp PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "digested with SacII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "SalI"

Phrase: "and"

Phrase: "ligated into the pGEM CMV vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0010825:Cytomegalovirus [Virus]
   753   C0049896:PGE-M [Eicosanoid]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]

Phrase: "(Fig. 1 C)."
Processing 00000000.tx.61: pPS-2 To express full-length PS-2 (encoding 448amino acids [aa]; Fig. 1 A) that was not myc tagged, PS-2 cloned in Bluescript and pPS-2+Myc were each double digested with NotI and EcoRI. 

Phrase: "pPS-2 To"

Phrase: "express"

Phrase: "full-length PS-2"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   875   C0806636:Length 2 [Quantitative Concept]
   861   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0443225:Full [Qualitative Concept]
   812   C1418867:Ps [Gene or Genome]
   812   C1444754:Length [Quantitative Concept]
   812   C1518860:PS [Geographic Area]
   812   C1552158:Ps [Body Part, Organ, or Organ Component]
   812   C1706316:LENGTH [Research Activity]
   741 E C0205166:Long [Qualitative Concept]
   741 E C1522425:Longest [Qualitative Concept]
   741 E C1706317:Long [Qualitative Concept]

Phrase: "(encoding 448amino acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "[aa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1235746:Aa [Plant]
  1000   C1882141:aa [Qualitative Concept]

Phrase: "]"

Phrase: "; Fig. 1 A)"

Phrase: "that"

Phrase: "was"

Phrase: "not myc"

Phrase: "tagged"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
  1000   C1708632:Tagged [Qualitative Concept]
   966 E C0037293:Tag [Neoplastic Process]
   966 E C0181496:Tag [Manufactured Object]
   966 E C1710492:TAG [Gene or Genome]

Phrase: ","

Phrase: "PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "cloned in Bluescript"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0009013:cloned [Cell]
   756 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "pPS-2+Myc"

Phrase: "were"

Phrase: "each"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "digested with NotI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "EcoRI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.62: NotI cuts at codon 111of PS-2, whereas the EcoRI site was located downstream of the stop codon in both plasmids. 

Phrase: "NotI cuts at codon 111of PS-2,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0000925:cuts [Injury or Poisoning]
   714 E C1883724:CUT [Phenomenon or Process]

Phrase: "whereas"

Phrase: "the EcoRI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "located downstream of the stop codon"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0242611:Stop Codon [Nucleotide Sequence]
   753   C0009221:Codon [Nucleotide Sequence]
   753   C0522506:Downstream [Spatial Concept]
   753   C1095825:Codon [Plant]
   753   C1947925:Stop [Activity]
   753   C2746065:Stop [Temporal Concept]

Phrase: "in both plasmids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.63: The 3-end fragment of PS-2 that was devoid of myc sequences and derived from the Bluescript vector was used to replace the corresponding myc-tagged fragment in the pPS-2+Myc. 

Phrase: "The 3-end fragment of PS-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "devoid of myc sequences"

Phrase: "and"

Phrase: "derived from the Bluescript vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1441547:Derived [Qualitative Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "replace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554078:Replace [Idea or Concept]

Phrase: "the corresponding myc-tagged fragment in the pPS-2+Myc."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.64: Construction of pPS-2(268aa)+Myc, pPS-2(222aa)+Myc, and pPS-2(166aa)+ Myc Constructs To create PS-2 constructs with progressively longer COOH-terminal deletions, the previously described 5 primer containing the SacII site was used in conjunction with 3 primers designed to introduce SalI sites into the PS-2 gene, which allowed the truncated proteins to be myc tagged. 

Phrase: "Construction of pPS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "(268aa"

Phrase: ")"

Phrase: "+Myc,"

Phrase: "pPS-2"

Phrase: "(222aa"

Phrase: ")"

Phrase: "+Myc,"

Phrase: "and"

Phrase: "pPS-2"

Phrase: "(166aa"

Phrase: ")"

Phrase: "+ Myc"

Phrase: "Constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "PS-2 constructs with progressively longer COOH-terminal deletions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C2827421:Construct [Classification]

Phrase: "the previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "5 primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the SacII site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "used in conjunction with 3 primers"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C1273517:used [Finding]
   753   C2699427:Conjunction [Idea or Concept]
   719 E C0042153:use [Functional Concept]
   719   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "introduce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:introduce [Functional Concept]

Phrase: "SalI sites into the PS-2 gene,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "which"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the truncated proteins to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "be"

Phrase: "myc"

Phrase: "tagged."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
  1000   C1708632:Tagged [Qualitative Concept]
   966 E C0037293:Tag [Neoplastic Process]
   966 E C0181496:Tag [Manufactured Object]
   966 E C1710492:TAG [Gene or Genome]
Processing 00000000.tx.65: pPS-2(268aa)+Myc. 

Phrase: "pPS-2"

Phrase: "(268aa"

Phrase: ")"

Phrase: "+Myc."
Processing 00000000.tx.66: A 3 primer, 5TATCGCTTAAGTCGACCAGCACAGCCACGAGAT3, containing 17bases homologous and complementary to sequences upstream of codon 268was used to generate construct pPS-2(268aa)+Myc using essentially the same procedure previously described for the construction of pPS-2-Myc. 

Phrase: "A 3 primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5TATCGCTTAAGTCGACCAGCACAGCCACGAGAT3,"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "17bases"

Phrase: "homologous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1334043:Homologous [Gene or Genome]

Phrase: "and"

Phrase: "complementary to sequences"

Phrase: "upstream of codon 268was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "construct pPS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "(268aa"

Phrase: ")"

Phrase: "+Myc"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "essentially"

Phrase: "the same procedure previously"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "described for the construction of pPS-2-Myc."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441513:Construction [Therapeutic or Preventive Procedure]
   744   C1552738:described [Idea or Concept]
Processing 00000000.tx.67: This construct is deleted of 180COOH-terminal residues immediately 3 of the sixth putative TMD, thereby removing the large hydrophilic loop and all COOH-terminal sequences (Fig. 1 D). 

Phrase: "This construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "is"

Phrase: "deleted of 180COOH-terminal residues immediately 3 of the sixth putative TMD,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   736   C0205088:Terminal [Temporal Concept]
   736   C0205440:Sixth [Quantitative Concept]
   736   C0205548:Immediately [Temporal Concept]
   736   C1705314:Terminal [Manufactured Object]
   736   C1705315:Terminal [Spatial Concept]
   736   C1880274:Deleted [Activity]
   736   C3538714:TMD [Gene or Genome]
   703   C1709915:Residue [Conceptual Entity]
   703   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "thereby"

Phrase: "removing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0849355:remove [Qualitative Concept]
   966   C1883720:Remove [Activity]
   966   C3244314:remove [Functional Concept]

Phrase: "the large hydrophilic loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]

Phrase: "and"

Phrase: "all COOH-terminal sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "(Fig. 1 D"

Phrase: ")."
Processing 00000000.tx.68: pPS-2(222aa)+Myc. 

Phrase: "pPS-2"

Phrase: "(222aa"

Phrase: ")"

Phrase: "+Myc."
Processing 00000000.tx.69: By a similar PCR procedure, 226residues from the COOH terminus of PS-2 were deleted using a 3 primer, 5TATCGCTTAAGTCGACCTTCCAGTGGATGCACA3, which contained 17bases homologous and complementary to sequences upstream of codon 222.

Phrase: "By a similar PCR procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "226residues from the COOH terminus of PS-2"

Phrase: "were"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 3 primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5TATCGCTTAAGTCGACCTTCCAGTGGATGCACA3,"

Phrase: "which"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "17bases"

Phrase: "homologous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1334043:Homologous [Gene or Genome]

Phrase: "and"

Phrase: "complementary to sequences"

Phrase: "upstream of codon 222."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]
Processing 00000000.tx.70: The resulting construct pPS-2(222aa)+Myc is therefore deleted of PS-2 sequences beginning three residues downstream of TMD 4(Fig. 

Phrase: "The resulting construct pPS-2"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0678226:resulting [Functional Concept]
   812   C2827421:Construct [Classification]
   779 E C1274040:Result [Functional Concept]
   779 E C1546471:Result [Idea or Concept]
   779 E C2825142:Result [Finding]

Phrase: "(222aa"

Phrase: ")"

Phrase: "+Myc"

Phrase: "is"

Phrase: "therefore"

Phrase: "deleted of PS-2 sequences"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0162326:Sequences [Nucleotide Sequence]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]
   760   C1880274:Deleted [Activity]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "beginning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Beginning [Temporal Concept]

Phrase: "three residues downstream of TMD 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.71: 1 E). 

Phrase: "1 E"

Phrase: ")."
Processing 00000000.tx.72: pPS-2(166aa)+Myc. 

Phrase: "pPS-2"

Phrase: "(166aa"

Phrase: ")"

Phrase: "+Myc."
Processing 00000000.tx.73: Similarly, the primer 5TATCGCTTAAGTCGACCTTGATGCAGCGGTACT3, of which the last 17bases were homologous and complementary to sequences upstream of codon 166of PS-2, deleted 282aa beginning six residues downstream of TMD2 (Fig. 1 F). 

Phrase: "Similarly,"

Phrase: "the primer 5TATCGCTTAAGTCGACCTTGATGCAGCGGTACT3,"

Phrase: "of which"

Phrase: "the last 17bases"

Phrase: "were"

Phrase: "homologous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1334043:Homologous [Gene or Genome]

Phrase: "and"

Phrase: "complementary to sequences"

Phrase: "upstream of codon 166of PS-2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0009221:Codon [Nucleotide Sequence]
   812   C1095825:Codon [Plant]
   812   C1418867:Ps [Gene or Genome]
   812   C1518860:PS [Geographic Area]
   812   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "deleted 282aa beginning six residues downstream of TMD2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(Fig. 1 F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.74: pPS-2(138aa)+Myc. 

Phrase: "pPS-2"

Phrase: "(138aa"

Phrase: ")"

Phrase: "+Myc."
Processing 00000000.tx.75: Primer 5ACGTACGTAAGTCGACGGAGTTGAGGAGGCGCT3, of which the last 17bases were homologous and complementary to sequences upstream of codon 138of PS-2, was similarly used to delete 310COOH-terminal residues of PS-2, including TMD2 (Fig. 1 G). 

Phrase: "Primer 5ACGTACGTAAGTCGACGGAGTTGAGGAGGCGCT3,"

Phrase: "of which"

Phrase: "the last 17bases"

Phrase: "were"

Phrase: "homologous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1334043:Homologous [Gene or Genome]

Phrase: "and"

Phrase: "complementary to sequences"

Phrase: "upstream of codon 138of PS-2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0009221:Codon [Nucleotide Sequence]
   812   C1095825:Codon [Plant]
   812   C1418867:Ps [Gene or Genome]
   812   C1518860:PS [Geographic Area]
   812   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "similarly"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "delete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Delete [Activity]

Phrase: "310COOH-terminal residues of PS-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "TMD2"

Phrase: "(Fig. 1 G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.76: pGFP-PS-2 and pGFP-PS-2(Asn141Ile) To monitor PS-2 expression in living cells, PS-2 was cloned into the CLONTECH pEGFP-C1 expression vector, thus fusing PS-2 to the COOH-terminal end of Aequorea victoria GFP. 

Phrase: "pGFP-PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "pGFP-PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(Asn141Ile"

Phrase: ")"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "PS-2 expression in living cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "cloned into the CLONTECH pEGFP-C1 expression vector,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0009013:cloned [Cell]
   744   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0442335:Vector [Spatial Concept]
   744   C1705099:Vector [Idea or Concept]
   711 E C1522642:Clone [Tissue]

Phrase: "thus"

Phrase: "fusing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0699952:fusing [Functional Concept]
   966 E C1414861:FUSE [Gene or Genome]
   966 E C1708111:Fuse [Manufactured Object]

Phrase: "PS-2 to the COOH-terminal end of Aequorea victoria GFP."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   756   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1081016:Aequorea victoria [Eukaryote]
   738   C0042645:Victoria [Geographic Area]
   738   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   738   C0205088:Terminal [Temporal Concept]
   738   C0444930:End [Spatial Concept]
   738   C0997115:Victoria [Plant]
   738   C0997890:Aequorea [Eukaryote]
   738   C1418867:Ps [Gene or Genome]
   738   C1518860:PS [Geographic Area]
   738   C1552158:Ps [Body Part, Organ, or Organ Component]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C2746065:End [Temporal Concept]
Processing 00000000.tx.77: To generate this clone, a 5 primer, 5TCCGGACTCAGATCTCTCACATTCATGGCCTCT3, of which the last 18bp were identical to sequences starting at codon 2of PS-2, was used in combination with the 3 primer, 5TATCGCTTAAGTCGACGATGTAGAGCTGATGGG3 (described above), to PCR amplify PS-2 clone in Bluescript. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "this clone,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "a 5 primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5TCCGGACTCAGATCTCTCACATTCATGGCCTCT3,"

Phrase: "of which"

Phrase: "the last 18bp"

Phrase: "were"

Phrase: "identical to sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "starting at codon 2of PS-2,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0242610:Codon, Start [Nucleotide Sequence]
   753   C0009221:Codon [Nucleotide Sequence]
   753   C1095825:Codon [Plant]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   719   C0439659:Start [Temporal Concept]

Phrase: "was"

Phrase: "used in combination"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0205195:Combination [Qualitative Concept]
   790   C1273517:used [Finding]
   790   C1947911:Combination [Physical Object]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "with the 3 primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5TATCGCTTAAGTCGACGATGTAGAGCTGATGGG3"

Phrase: "(described above"

Phrase: ")"

Phrase: ","

Phrase: "to PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "amplify"

Phrase: "PS-2 clone in Bluescript."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0009013:Clone [Cell]
   760   C1522642:Clone [Tissue]
Processing 00000000.tx.78: The ~1.4-kbp product was digested with BglII, which was introduced by the 5-end primer, and HindIII, which cuts PS-2 internally. 

Phrase: "The ~1.4-kbp product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "digested with BglII,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "which"

Phrase: "was"

Phrase: "introduced by the 5-end primer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0444930:End [Spatial Concept]
   753   C2746065:End [Temporal Concept]
   719   C1292748:introduce [Functional Concept]

Phrase: "and"

Phrase: "HindIII,"

Phrase: "which"

Phrase: "cuts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000925:Cut [Injury or Poisoning]
  1000   C1883724:CUT [Phenomenon or Process]

Phrase: "PS-2 internally."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205102:Internally [Spatial Concept]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]
Processing 00000000.tx.79: The ~1-kbp fragment was then ligated between the BglII- HindIII sites of pEGFP-C1. 

Phrase: "The ~1-kbp fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "ligated between the BglII- HindIII sites of pEGFP-C1."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C2945843:Site of [Qualitative Concept]
   742   C0205145:Sites [Spatial Concept]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.80: The recombinant pGFP-PS-2(86) missing 86COOH-terminal residues of PS-2 was then digested with HindIII and EcoRI, the latter cutting 3 of the former. 

Phrase: "The recombinant pGFP-PS-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1418867:Ps [Gene or Genome]
   812   C1514798:recombinant [Organism]
   812   C1518860:PS [Geographic Area]
   812   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(86"

Phrase: ")"

Phrase: "missing 86COOH-terminal residues of PS-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "digested with HindIII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "EcoRI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the latter cutting 3 of the former."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0152060:Cutting, NOS [Therapeutic or Preventive Procedure]
   748   C0205156:Former [Temporal Concept]
   748   C0750523:FORMER [Idea or Concept]
   748   C1306235:Cutting [Qualitative Concept]
   748   C3496294:Cutting [Functional Concept]
   714 E C0000925:Cut [Injury or Poisoning]
   714 E C1883724:CUT [Phenomenon or Process]
Processing 00000000.tx.81: In conjunction, PS-2 in Bluescript was digested with the same enzymes, and the fragment containing the 3 coding sequences of PS-2 was ligated with the pGFP-PS-2(86) plasmid fragment. 

Phrase: "In conjunction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699427:Conjunction [Idea or Concept]

Phrase: "PS-2 in Bluescript"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418867:Ps [Gene or Genome]
   770   C1518860:PS [Geographic Area]
   770   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "digested with the same enzymes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "the fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the 3 coding sequences of PS-2"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   748   C0009219:Coding [Occupational Activity]
   748   C0162326:Sequences [Nucleotide Sequence]
   745   C0079941:Coding Sequence [Gene or Genome]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C0805701:Code [Intellectual Product]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "ligated with the pGFP-PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(86"

Phrase: ")"

Phrase: "plasmid fragment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.82: The resulting recombinant yielded pGFP-PS-2 corresponding to full-length PS-2 (missing only the start methionine residue) fused in frame COOH-terminal of GFP (Fig. 1 H). 

Phrase: "The resulting recombinant yielded pGFP-PS-2"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   827   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0678226:resulting [Functional Concept]
   799   C1418867:Ps [Gene or Genome]
   799   C1514798:recombinant [Organism]
   799   C1518860:PS [Geographic Area]
   799   C1552158:Ps [Body Part, Organ, or Organ Component]
   766 E C1274040:Result [Functional Concept]
   766 E C1546471:Result [Idea or Concept]
   766 E C2825142:Result [Finding]

Phrase: "corresponding to full-length PS-2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0806636:Length 2 [Quantitative Concept]
   753   C0443225:Full [Qualitative Concept]
   753   C1418867:Ps [Gene or Genome]
   753   C1444754:Length [Quantitative Concept]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   753   C1706316:LENGTH [Research Activity]

Phrase: "("

Phrase: "missing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1551393:Missing [Idea or Concept]
  1000   C1705492:Missing [Qualitative Concept]
  1000   C3272743:MISSING [Qualitative Concept]
   966 E C2349206:Miss [Conceptual Entity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the start methionine residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "fused"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0699952:Fused [Functional Concept]
   966 E C1414861:FUSE [Gene or Genome]
   966 E C1708111:Fuse [Manufactured Object]

Phrase: "in frame COOH-terminal of GFP (Fig. 1 H"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205088:Terminal [Temporal Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.83: An additional GFP-PS-2 fusion construct was made to express the PS-2(Asn141Ile) AD-associated mutation (Levy-Lahad et al., 1995a; Rogaev et al., 1995). 

Phrase: "An additional GFP-PS-2 fusion construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "the PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(Asn141Ile"

Phrase: ")"

Phrase: "AD-associated mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Levy-Lahad et al.,"

Phrase: "1995a"

Phrase: "; Rogaev et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.84: The asparagine codon at position 141in PS-2 was converted to an isoleucine by a two-step PCR amplification protocol. 

Phrase: "The asparagine codon at position 141in PS-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0009221:Codon [Nucleotide Sequence]
   744   C1095825:Codon [Plant]

Phrase: "was"

Phrase: "converted to an isoleucine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "by a two-step PCR amplification protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0442711:Protocol [Intellectual Product]
   804   C1507394:Protocol [Intellectual Product]
   804   C1522729:Protocol [Intellectual Product]
   804   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.85: In the first step, the 5 portion of PS-2 was amplified using the 5 BglII-containing primer described above in conjunction with a 3 primer, 5CGTAACGCGAATTCAGGAGGCGCTGGCCCACC3. 

Phrase: "In the first step,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1722730:First Step [Biomedical or Dental Material]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "the 5 portion of PS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "was"

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 5 BglII-containing primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above in conjunction with a 3 primer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1282910:Above [Spatial Concept]
   748   C1552828:above [Idea or Concept]

Phrase: "5CGTAACGCGAATTCAGGAGGCGCTGGCCCACC3."
Processing 00000000.tx.86: The remaining PS-2 3 segment was amplified with a 5 primer, 5TCAAGCTTGAATTCCGTGCTGATCACCCTCATCATGATCA3, and the PS-2 3-end primer described initially. 

Phrase: "The remaining PS-2 3 segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0441635:Segment [Spatial Concept]
   733 E C0205122:Segmental [Spatial Concept]

Phrase: "was"

Phrase: "amplified with a 5 primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5TCAAGCTTGAATTCCGTGCTGATCACCCTCATCATGATCA3,"

Phrase: "and"

Phrase: "the PS-2 3-end primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "initially."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]
Processing 00000000.tx.87: Both PCR products were cut with EcoRI, which was introduced by the new primers, and the segments linked in frame with GFP to yield pGFP-PS-2(N141I) (Fig. 1 I). 

Phrase: "Both PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "cut with EcoRI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0000925:Cut [Injury or Poisoning]
   790   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1883724:CUT [Phenomenon or Process]

Phrase: "which"

Phrase: "was"

Phrase: "introduced by the new primers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205314:New [Temporal Concept]
   726   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   726   C1292748:introduce [Functional Concept]

Phrase: "and"

Phrase: "the segments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0441635:Segment [Spatial Concept]
   916 E C0205122:Segmental [Spatial Concept]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "in frame with GFP to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080089:Frame [Nucleotide Sequence]
   760   C0180979:Frame [Medical Device]
   760   C1705858:Frame [Manufactured Object]

Phrase: "yield"

Phrase: "pGFP-PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(N141I"

Phrase: ")"

Phrase: "(Fig. 1 I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.88: This and the other clones that were generated by PCR were sequenced and were found to encode the expected changes. 

Phrase: "This"

Phrase: "and"

Phrase: "the other clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "that"

Phrase: "were"

Phrase: "generated by PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C3146294:Generated [Activity]

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "the expected changes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.89: pPS-2-(N141I) To express full-length PS-2 containing the AD-associated mutation, PS-2(N141I), which was neither tagged with GFP nor myc sequences (Fig. 1 B), the XmaI-HindIII fragment from pPS-2 spanning the Asn codon at 141of wild-type PS-2 was replaced with the corresponding fragment containing the mutation from pGFP-PS-2(N141I) to yield pPS-2(N141I) (Fig. 1 B). 

Phrase: "pPS-2-"

Phrase: "(N141I"

Phrase: ")"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "full-length PS-2"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   875   C0806636:Length 2 [Quantitative Concept]
   861   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0443225:Full [Qualitative Concept]
   812   C1418867:Ps [Gene or Genome]
   812   C1444754:Length [Quantitative Concept]
   812   C1518860:PS [Geographic Area]
   812   C1552158:Ps [Body Part, Organ, or Organ Component]
   812   C1706316:LENGTH [Research Activity]
   741 E C0205166:Long [Qualitative Concept]
   741 E C1522425:Longest [Qualitative Concept]
   741 E C1706317:Long [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the AD-associated mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(N141I"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "neither"

Phrase: "tagged with GFP"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   790   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   790   C1708632:Tagged [Qualitative Concept]
   756 E C0037293:Tag [Neoplastic Process]
   756 E C0181496:Tag [Manufactured Object]
   756 E C1710492:TAG [Gene or Genome]

Phrase: "nor"

Phrase: "myc sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "(Fig. 1 B"

Phrase: ")"

Phrase: ","

Phrase: "the XmaI-HindIII fragment from pPS-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the Asn codon at 141of wild-type PS-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0009221:Codon [Nucleotide Sequence]
   742   C1095825:Codon [Plant]

Phrase: "was"

Phrase: "replaced with the corresponding fragment"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0332255:fragment [Functional Concept]
   760   C0559956:Replaced [Functional Concept]
   760   C1299987:replaced [Functional Concept]
   760   C1708096:Fragment [Qualitative Concept]
   726 E C1554078:Replace [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the mutation from pGFP-PS-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(N141I"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "yield"

Phrase: "pPS-2"

Phrase: "(N141I"

Phrase: ")"

Phrase: "(Fig. 1 B"

Phrase: ")."
Processing 00000000.tx.90: pKv1.4+Myc A human fetal brain cDNA library (CLONTECH Laboratories, Inc.) was screened by DNA hybridization with a 1.5-kbp EcoRV-EcoRI subfragment of human heart potassium channel Kv1.4 cDNA (kindly provided by Dr. M.Tamkun, Vanderbilt University, Nashville, TN). 

Phrase: "pKv1.4+Myc"

Phrase: "A human fetal brain cDNA library"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0440731:Fetal brain [Embryonic Structure]
   840   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0015965:Fetal [Embryonic Structure]
   804   C0023621:Library [Manufactured Object,Organization]
   804   C0521457:Fetal [Functional Concept]
   804   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(CLONTECH Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Inc.)"

Phrase: "was"

Phrase: "screened by DNA hybridization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0221902:DNA hybridisation [Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0020202:Hybridisation [Genetic Function]
   770   C1300517:Hybridization [Laboratory Procedure]
   737   C0220908:screen [Health Care Activity]
   737   C1305399:screen [Functional Concept]
   737   C1705053:Screen [Medical Device]

Phrase: "with a 1.5-kbp EcoRV-EcoRI subfragment"

Phrase: "of human heart potassium channel Kv1.4 cDNA (kindly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]

Phrase: "M."

Phrase: "Tamkun,"

Phrase: "Vanderbilt University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Nashville,"

Phrase: "TN"

Phrase: ")."
Processing 00000000.tx.91: One positive clone, containing a 3,023-bp cDNA, was fully sequenced and had an open reading frame of 653amino acids that was homologous to potassium channel Kv1.4 (Tamkun et al., 1991). 

Phrase: "One positive clone,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a 3,023-bp cDNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "fully"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "had"

Phrase: "an open reading frame of 653amino acids"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0079941:Open Reading Frame [Gene or Genome]
   778   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   748   C0034754:Reading [Daily or Recreational Activity]
   748   C0175566:Open [Spatial Concept]
   748   C0180979:Frame [Medical Device]
   748   C1705179:Reading [Finding]
   748   C1705858:Frame [Manufactured Object]

Phrase: "that"

Phrase: "was"

Phrase: "homologous to potassium channel Kv1.4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1334043:Homologous [Gene or Genome]

Phrase: "(Tamkun et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.92: Through a series of cloning steps, the cDNA was inserted into the modified CMV expression construct, described above, such that the cDNA was fused in-frame at codon 653of its open reading frame with the myc tag for expression. 

Phrase: "Through a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of cloning steps,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "the cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "inserted into the modified CMV expression construct,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0010825:Cytomegalovirus [Virus]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0392747:Modified [Functional Concept]
   748   C0441587:Inserted [Health Care Activity]
   748   C2827421:Construct [Classification]
   714 E C1743766:Insert [Medical Device]
   714 E C1883719:Insert [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "such"

Phrase: "that"

Phrase: "the cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "fused"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0699952:Fused [Functional Concept]
   966 E C1414861:FUSE [Gene or Genome]
   966 E C1708111:Fuse [Manufactured Object]

Phrase: "in-frame at codon 653of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080089:Frame [Nucleotide Sequence]
   760   C0180979:Frame [Medical Device]
   760   C1705858:Frame [Manufactured Object]

Phrase: "its open reading frame with the myc tag"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0079941:Open Reading Frame [Gene or Genome]
   770   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   744   C0034754:Reading [Daily or Recreational Activity]
   744   C0175566:Open [Spatial Concept]
   744   C0180979:Frame [Medical Device]
   744   C1705179:Reading [Finding]
   744   C1705858:Frame [Manufactured Object]

Phrase: "for expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.93: Transfection of this construct into HeLa cells and electrophysiological recordings using the whole cell patch clamp technique revealed classical voltage-gated activation and inactivation kinetics of an A-type potassium channel. 

Phrase: "Transfection of this construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "into HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "electrophysiological recordings"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the whole cell patch clamp technique"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   884   C0242625:Technique, Patch-Clamp [Research Activity]
   840   C0920630:patch clamp [Research Activity]
   804   C0007634:Cell [Cell]
   804   C0175721:Clamp [Medical Device]
   804   C0332461:Patch [Finding]
   804   C0444667:Whole [Quantitative Concept]
   804   C0445403:Patch [Biomedical or Dental Material]
   804   C0449851:Technique [Functional Concept]
   804   C0991556:Patch [Medical Device]
   804   C1269647:Cell [Cell]
   804   C1305400:Patch [Medical Device]
   804   C1533128:Patch [Biomedical or Dental Material]
   804   C1704653:Cell [Medical Device]
   804   C1705942:Clamp [Manufactured Object]
   804   C1706366:{Patch} [Quantitative Concept]
   804   C1707974:Patch [Biomedical or Dental Material]
   804   C1883710:Clamp [Functional Concept]
   804   C1948049:Cell [Spatial Concept]
   733 E C0205413:Patchy [Qualitative Concept]
   721 E C0025664:techniques [Intellectual Product]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "classical voltage-gated activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "inactivation kinetics of an A-type potassium channel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0022702:Kinetics [Natural Phenomenon or Process]
   744   C0220865:kinetics [Functional Concept]
   744   C2825046:Kinetics [Occupation or Discipline]
Processing 00000000.tx.94: Expression of Glutathione-S-Transferase (GST)-PS-2 Fusion Proteins in Bacteria Three different portions of PS-2, the NH2-terminal, the loop spanning TMD 6and 7,and the COOH-terminal regions (see Fig. 1), were expressed as GST fusion proteins in bacteria. 

Phrase: "Expression of Glutathione-S-Transferase (GST)-PS-2 Fusion Proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1517332:Fusion Protein Expression [Cell or Molecular Dysfunction]
   745   C1171362:expression protein [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in Bacteria Three different portions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0449719:Portion [Spatial Concept]

Phrase: "of PS-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "the NH2-terminal,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0002508:NH2 [Organic Chemical]
   861   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "the loop spanning TMD 6and 7,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0419518:Loop [Medical Device]
   804   C0445022:Loop [Spatial Concept]
   804   C3538714:TMD [Gene or Genome]
   771   C1711300:Span [Conceptual Entity]
   771   C2700613:Span [Quantitative Concept]

Phrase: "and"

Phrase: "the COOH-terminal regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "expressed as GST fusion proteins"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   757   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1418948:PROTEIN S [Gene or Genome]
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332466:Fusion [Functional Concept]
   748   C1293131:Fusion [Therapeutic or Preventive Procedure]
   745   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "in bacteria."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0004611:Bacteria [Bacterium]
  1000   C1510439:bacteria [Functional Concept]
  1000   C2347473:% Bacteria [Quantitative Concept]
   928 E C0521009:Bacterial [Qualitative Concept]
Processing 00000000.tx.95: To express the PS-2 NH2-terminal sequences, the segment encoding the first 86residues of PS-2 were PCR amplified with a 5 primer, CGTACGTCGAATTCCCAATGCTCACATTCATGGC, which introduced an EcoRI site and a proline codon one amino acid upstream of the PS-2 start codon, and a 33bp 3 primer, GCTGAGTACGCTCGAGCTTCGCTCCGTATTTGA, which introduced a XhoI site after residue 86.

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "the PS-2 NH2-terminal sequences,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "the segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441635:Segment [Spatial Concept]
   928 E C0205122:Segmental [Spatial Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the first 86residues of PS-2"

Phrase: "were"

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "amplified with a 5 primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "CGTACGTCGAATTCCCAATGCTCACATTCATGGC,"

Phrase: "which"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "an EcoRI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "a proline codon one amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "upstream of the PS-2 start codon,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0242610:Codon, Start [Nucleotide Sequence]
   812   C0009221:Codon [Nucleotide Sequence]
   812   C1095825:Codon [Plant]

Phrase: "and"

Phrase: "a 33bp 3 primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "GCTGAGTACGCTCGAGCTTCGCTCCGTATTTGA,"

Phrase: "which"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "a XhoI site after residue 86."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
Processing 00000000.tx.96: Similarly, the segment encoding 120amino acids of the loop sequence, from residue 270to residue 389,were PCR amplified with a 5 primer, CGCTTCTGGAATTCCCCAAAGGGCCTCTGAG, which introduced an EcoRI site before residue 270,and a 3 primer, GCTGAGTACGCTCGAGCAGCGTGGTATTCCAGT, which introduced an XhoI site after residue 389. 

Phrase: "Similarly,"

Phrase: "the segment encoding 120amino acids of the loop sequence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0001128:Acids [Chemical]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: "from residue 270to residue 389,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1709915:Residue [Conceptual Entity]
   812   C1882936:RESIDUE [Phenomenon or Process]
   741 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "amplified with a 5 primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "CGCTTCTGGAATTCCCCAAAGGGCCTCTGAG,"

Phrase: "which"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "an EcoRI site before residue 270,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "a 3 primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "GCTGAGTACGCTCGAGCAGCGTGGTATTCCAGT,"

Phrase: "which"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "an XhoI site after residue 389."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
Processing 00000000.tx.97: The COOH-terminal segment encoding the last 39PS-2 residues was amplified with a 28-bp 5 primer, CGGTACGTGAATTCAAGAAGGCGCTGCC, which introduced an EcoRI site before residue 410and the previously described 3 primer used to introduce a SalI site into the end of full-length PS2 to myc tag it. 

Phrase: "The COOH-terminal segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441635:Segment [Spatial Concept]
   755 E C0205122:Segmental [Spatial Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the last 39PS-2 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "was"

Phrase: "amplified with a 28-bp 5 primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "CGGTACGTGAATTCAAGAAGGCGCTGCC,"

Phrase: "which"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "an EcoRI site before residue 410and"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "the previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "3 primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "introduce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:introduce [Functional Concept]

Phrase: "a SalI site into the end of full-length PS2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C2945843:Site of [Qualitative Concept]
   739   C0205145:Site [Spatial Concept]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]

Phrase: "to myc tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: "it."
Processing 00000000.tx.98: The ~260-bp NH2-terminal and 360-bp loop PCR products and the Pharmacia pGST/His T1 vector (Pharmacia Biotech, Inc., Piscataway, NJ) were all digested with EcoRI and XhoI. 

Phrase: "The ~260-bp NH2-terminal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0002508:NH2 [Organic Chemical]
   812   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   812   C0205088:Terminal [Temporal Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "360-bp loop PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "the Pharmacia pGST/"

Phrase: "His T1 vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "(Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Inc.,"

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")"

Phrase: "were"

Phrase: "all"

Phrase: "digested with EcoRI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "XhoI."
Processing 00000000.tx.99: The ~120-bp COOH-terminal PCR fragment was cut with EcoRI and SalI. 

Phrase: "The ~120-bp COOH-terminal PCR fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "cut with EcoRI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0000925:Cut [Injury or Poisoning]
   790   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "SalI."
Processing 00000000.tx.100: The fragments were all ligated into pGST/His T1 with the COOH-terminal insertion destroying the XhoI site. 

Phrase: "The fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "all"

Phrase: "ligated into pGST/"

Phrase: "His T1 with the COOH-terminal insertion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1413227:T1 [Gene or Genome]

Phrase: "destroying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Destroy [Idea or Concept]

Phrase: "the XhoI site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.101: These ligations resulted in the fusion of PS-2 sequences COOH-terminal and in-frame with GST. 

Phrase: "These ligations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023690:Ligations [Therapeutic or Preventive Procedure]

Phrase: "resulted in the fusion of PS-2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332466:Fusion [Functional Concept]
   748   C1293131:Fusion [Therapeutic or Preventive Procedure]
   748   C1418867:Ps [Gene or Genome]
   748   C1518860:PS [Geographic Area]
   748   C1552158:Ps [Body Part, Organ, or Organ Component]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "COOH-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "in-frame with GST."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080089:Frame [Nucleotide Sequence]
   753   C0180979:Frame [Medical Device]
   753   C1705858:Frame [Manufactured Object]
Processing 00000000.tx.102: The resulting recombinant plasmids were transformed into CAG456 bacteria (Mercy et al., 1992) and grown overnight at 30C in 30ml of standard Luria Broth containing 50g ampicillin per ml. 

Phrase: "The resulting recombinant plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "transformed into CAG456 bacteria"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004611:Bacteria [Bacterium]
   770   C1510411:Transformed [Pathologic Function]
   770   C1510439:bacteria [Functional Concept]
   770   C2347473:% Bacteria [Quantitative Concept]

Phrase: "(Mercy et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: "and"

Phrase: "grown overnight at 30C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "in 30ml"

Phrase: "of standard Luria Broth containing 50g ampicillin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0002680:Ampicillin [Antibiotic,Organic Chemical]
   743 E C0700944:Polycillin [Antibiotic,Organic Chemical]
   743 E C0700946:Omnipen [Antibiotic,Organic Chemical]

Phrase: "per ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.103: The cultures were then diluted into 500ml of fresh medium and grown for a further 2h. 

Phrase: "The cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "diluted into 500ml of fresh medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C0443224:Fresh [Qualitative Concept]
   753   C0470470:500ml [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C2827486:Fresh [Body Substance]
   753   C3244283:medium [Intellectual Product]
   719   C1720119:Dilute [Functional Concept]
   719   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "grown for a further 2h."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1292425:2H [Temporal Concept]
   760   C1517331:Further [Spatial Concept]
   726 E C0205108:far [Spatial Concept]
Processing 00000000.tx.104: IPTG was then added to 0.1mM, and the cultures grown for 3-4 h. 

Phrase: "IPTG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022239:IPTG [Carbohydrate]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to 0.1mM,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "the cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "grown for 3-4 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0041119:h 3 [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.105: The bacteria were collected by centrifugation for 30min at 3,000 g and resuspended in 1/10 vol chilled 50mM Tris, pH 7.5,10% sucrose solution. 

Phrase: "The bacteria"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0004611:Bacteria [Bacterium]
  1000   C1510439:bacteria [Functional Concept]
  1000   C2347473:% Bacteria [Quantitative Concept]
   928 E C0521009:Bacterial [Qualitative Concept]

Phrase: "were"

Phrase: "collected by centrifugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "for 30min"

Phrase: "at 3,000 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "resuspended in 1/10 vol chilled 50mM Tris,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0449468:VOL [Quantitative Concept]
   744   C0450400:50mm [Quantitative Concept]
   744   C0560268:vol% [Quantitative Concept]
   744   C0814229:TRI [Intellectual Product]
   744   C1690016:% vol [Qualitative Concept]
   711   C0085593:Chill [Sign or Symptom]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "10% sucrose solution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.106: The following steps were all done on ice: Lysozyme was added to 0.2mg/ml and left for 20min with occasional mixing followed by EDTA to 5mM, NP-40 to 0.1%, and sarkosyl to 0.25%. 

Phrase: "The following steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "were"

Phrase: "all"

Phrase: "done on ice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]

Phrase: ":"

Phrase: "Lysozyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026794:Lysosyme [Enzyme,Pharmacologic Substance]
  1000   C1416945:LYSOZYME [Gene or Genome]
  1000   C3541379:lysozyme [Enzyme,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to 0.2mg/ml"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0439526:/mL [Quantitative Concept]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "left for 20min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205091:Left [Spatial Concept]
   790   C1552822:left [Functional Concept]

Phrase: "with occasional mixing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205430:mixing [Functional Concept]
   827 E C1421951:MIX [Gene or Genome]
   827 E C1720722:Mix [Qualitative Concept]

Phrase: "followed by EDTA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "to 5mM,"

Phrase: "NP-40 to 0.1%,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0068941:NP-40 [Organic Chemical,Pharmacologic Substance]
   760   C0439509:/40 [Temporal Concept]
   760   C1706141:NP [Gene or Genome]

Phrase: "and"

Phrase: "sarkosyl to 0.25%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0074071:sarkosyl [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.107: After a 10-min incubation on ice, the lysed bacteria were sonicated and spun at 4C for 30min at 30,000g. 

Phrase: "After a 10-min incubation"

Phrase: "on ice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "the lysed bacteria"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0004611:Bacteria [Bacterium]
   861   C1510439:bacteria [Functional Concept]
   861   C2347473:% Bacteria [Quantitative Concept]
   789 E C0521009:Bacterial [Qualitative Concept]

Phrase: "were"

Phrase: "sonicated"

Phrase: "and"

Phrase: "spun at 4C"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1446863:Spun [Laboratory Procedure]
   756 E C1415347:SPIN [Gene or Genome]
   756 E C1823107:SPIN [Gene or Genome]

Phrase: "for 30min"

Phrase: "at 30,"

Phrase: "000g."
Processing 00000000.tx.108: The pellet was removed and the soluble bacterial proteins were incubated for 17h on a rocker with swollen and equilibrated glutathione agarose beads (Sigma Chemical Co., St. Louis, MO). 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "the soluble bacterial proteins"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0004627:Bacterial Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0521009:Bacterial [Qualitative Concept]
   755 E C0004611:Bacteria [Bacterium]
   755 E C1510439:bacteria [Functional Concept]
   755 E C2347473:% Bacteria [Quantitative Concept]

Phrase: "were"

Phrase: "incubated for 17h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "on a rocker"

Phrase: "with swollen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038999:Swollen [Finding]

Phrase: "and"

Phrase: "equilibrated glutathione agarose beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]

Phrase: "(Sigma Chemical Co.,"

Phrase: "St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.109: The slurry was centrifuged at 3,000g for 5min, the supernatant was removed, and the agarose pellet was washed in chilled PBS five or six times. 

Phrase: "The slurry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883043:Slurry [Substance]

Phrase: "was"

Phrase: "centrifuged at 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 5min,"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the agarose pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "washed in chilled PBS five"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205451:Five [Quantitative Concept]
   760   C1548982:Washed [Idea or Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   726   C0085593:Chill [Sign or Symptom]
   726 E C0441648:Wash [Activity]

Phrase: "or"

Phrase: "six times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.110: GST fusion proteins were eluted in batch with four consecutive bed volume elutions of 10mM reduced glutathione in 50mM Tris, pH 8.

Phrase: "GST fusion proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "eluted in batch"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1550176:Batch [Idea or Concept]
   790   C1948031:Batch [Quantitative Concept]

Phrase: "with four consecutive bed volume elutions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1441565:Elution [Laboratory Procedure]

Phrase: "of 10mM reduced glutathione"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0034917:Reduced Glutathione [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0392756:Reduced [Qualitative Concept]

Phrase: "in 50mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 8."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.111: The eluted fractions were dialyzed in 50mM Tris, pH 7.5,10% sucrose, and 5mM EDTA. 

Phrase: "The eluted fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "dialyzed in 50mM Tris,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   770   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   770   C0450400:50mm [Quantitative Concept]
   770   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "10% sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "5mM EDTA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.112: The purified proteins and soluble fractions, together with soluble fractions of IPTG- induced bacteria, were boiled in Laemmli buffer and separated by SDS-PAGE. 

Phrase: "The purified proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "soluble fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "together with soluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "of IPTG- induced bacteria,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0004611:Bacteria [Bacterium]
   827   C1510439:bacteria [Functional Concept]
   827   C2347473:% Bacteria [Quantitative Concept]
   755 E C0521009:Bacterial [Qualitative Concept]

Phrase: "were"

Phrase: "boiled in Laemmli buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0258024:Laemmli buffer [Organic Chemical]
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]

Phrase: "and"

Phrase: "separated by SDS-PAGE."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]
Processing 00000000.tx.113: The purified protein fractions were also used in antibody blocking experiments. 

Phrase: "The purified protein fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "also"

Phrase: "used in antibody blocking experiments."
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
   797   C0282682:Blocking antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1273517:used [Finding]
   726 E C0028778:Block [Pathologic Function]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1947944:Use [Intellectual Product]
   726 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.114: Tissue Culture and DNA Transfection HeLa cells were grown in DME supplemented with 10% FBS (Monteiro and Mical, 1996). 

Phrase: "Tissue Culture"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0040284:Tissue culture [Laboratory Procedure]
   861   C0010453:Culture [Idea or Concept]
   861   C0040300:Tissue [Tissue]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1547928:Tissue [Intellectual Product]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "DNA Transfection HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0018873:HeLa Cells [Cell]
           HeLa
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in DME"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0058217:DME [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0641456:dme [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "supplemented with 10% FBS (Monteiro"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "Mical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537694:MICAL [Gene or Genome]

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.115: Exponentially growing cells were transfected with 10-20 g of plasmid DNAs as calcium phosphate precipitates (Graham and van der Eb, 1973). 

Phrase: "Exponentially growing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 10-20 g of plasmid DNAs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1630409:20/10 [Finding]
   744   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0439267:g% [Quantitative Concept]
   711   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as calcium phosphate precipitates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1882443:PRECIPITATE [Phenomenon or Process]
   734   C0006711:calcium phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C0006712:Calcium/Phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C1161320:calcium phosphate [Pharmacologic Substance]

Phrase: "(Graham"

Phrase: "and"

Phrase: "van der Eb,"

Phrase: "1973"

Phrase: ")."
Processing 00000000.tx.116: Staining of Cells and Analysis by Immunofluorescence Light Microscopy For immunofluorescence microscopy, cells were transfected directly on glass coverslips. 

Phrase: "Staining of Cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "Analysis by Immunofluorescence Light Microscopy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "For immunofluorescence microscopy,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079604:Immunofluorescence Microscopy [Laboratory Procedure]
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected"

Phrase: "directly on glass coverslips."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017596:Glass [Manufactured Object]
   770   C1947931:Directly [Qualitative Concept]
   770   C1947936:Glass [Medical Device]
Processing 00000000.tx.117: At various times after transfection, the coverslips were fixed in 1% paraformaldehyde on ice for 15 min and then immersed in 20C 70% ethanol for 20min or overnight. 

Phrase: "At various times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "after transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "the coverslips"

Phrase: "were"

Phrase: "fixed in 1% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immersed in 20C 70% ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1381542:70% Ethanol [Clinical Drug]
   760   C0001962:Ethanol [Organic Chemical]

Phrase: "for 20min"

Phrase: "or"

Phrase: "overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.118: The cells on the coverslips were rehydrated in PBS, blocked in 0.8% BSA, stained with primary and secondary antibodies, and finally stained with 1g/ml 46-diamidino- 2-phenylindole (DAPI) as previously described (Monteiro et al., 1994). 

Phrase: "The cells on the coverslips"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:THE CELL [Cell]
           Cells
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rehydrated in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]

Phrase: "blocked in 0.8% BSA,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "stained with primary"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205225:Primary [Qualitative Concept]
   790   C0439631:Primary [Therapeutic or Preventive Procedure]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "secondary antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "finally"

Phrase: "stained with 1g/ml 46-diamidino- 2-phenylindole (DAPI)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0439526:/mL [Quantitative Concept]
   744   C2986582:Stained [Qualitative Concept]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Monteiro et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.119: The primary antibodies used were the mouse monoclonal anti-myc 9E10 antibody (Monteiro et al., 1994), a goat polyclonal anti-PS-2 antibody generated using a 20-aa peptide corresponding to NH2-terminal sequences for PS-2 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), a rabbit polyclonal anti-GFP antibody (CLONTECH Laboratories, Inc.), a rabbit polyclonal anticalreticulin (StressGen, Victoria, Canada), and a rabbit polyclonal antilamin antibody generated against purified bacterially expressed human lamin C.

Phrase: "The primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "the mouse monoclonal anti-myc 9E10 antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   904   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   876   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Monteiro et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: ","

Phrase: "a goat polyclonal anti-PS-2 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   876   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 20-aa peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "corresponding to NH2-terminal sequences"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0002508:NH2 [Organic Chemical]
   760   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0162326:Sequences [Nucleotide Sequence]
   760   C0205088:Terminal [Temporal Concept]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "for PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc.,"

Phrase: "Santa Cruz,"

Phrase: "CA),"

Phrase: "a rabbit polyclonal anti-GFP antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(CLONTECH Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."

Phrase: ")"

Phrase: ","

Phrase: "a rabbit polyclonal anticalreticulin"

Phrase: "(StressGen,"

Phrase: "Victoria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042645:Victoria [Geographic Area]
  1000   C0997115:Victoria [Plant]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a rabbit polyclonal antilamin antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "generated against purified bacterially expressed human lamin C."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0125261:lamin C [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1416877:LAMIN C [Gene or Genome]
   744   C0064635:Lamin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0086418:Human [Human]
   744   C1998793:Purified [Functional Concept]
   744   C3146294:Generated [Activity]
Processing 00000000.tx.120: For antibody-ligand competition experiments, the goat anti-PS-2 antibody diluted 1:150 was incubated overnight with equal molar amounts (~250 g) of either bacterially purified GST protein or the GST-NH2-terminal PS-2 fusion protein before application to the transfected coverslips. 

Phrase: "For antibody-ligand competition experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "the goat anti-PS-2 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "150"

Phrase: "was"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight with equal molar amounts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0026367:Molar [Body Part, Organ, or Organ Component]
   760   C0205163:Equal [Qualitative Concept]
   760   C0439583:Overnight [Temporal Concept]
   760   C1265611:amounts [Quantitative Concept]
   760   C1549782:Equal [Idea or Concept]

Phrase: "(~250 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of either bacterially purified GST protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "the GST-NH2-terminal PS-2 fusion protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   807   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0332466:Fusion [Functional Concept]
   791   C1293131:Fusion [Therapeutic or Preventive Procedure]
   711   C1415329:GLUTATHIONE S-TRANSFERASE 2 [Gene or Genome]

Phrase: "before application"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0185125:Application [Health Care Activity]
  1000   C1947919:Application [Intellectual Product]
  1000   C2347934:Application [Intellectual Product]
  1000   C3539080:APPLICATION [Quantitative Concept]

Phrase: "to the transfected coverslips."
Processing 00000000.tx.121: Secondary antibodies used were affinity purified fluorescein- or rhodamine-conjugated rabbit anti-mouse, rabbit anti- goat, donkey anti-rabbit, donkey anti-goat, goat anti-mouse, and goat anti-rabbit antibodies (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). 

Phrase: "Secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "fluorescein-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "or"

Phrase: "rhodamine-conjugated rabbit anti-mouse, rabbit anti- goat, donkey anti-rabbit, donkey anti-goat, goat"

Phrase: "anti-mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "goat anti-rabbit antibodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   844   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0034493:Rabbit [Mammal]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Jackson ImmunoResearch Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Inc.,"

Phrase: "West Grove,"

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.122: Fluorescence staining and phase contrast images of cells were visualized on an inverted Zeiss Axiovert 135microscope (Thornwood, NY). 

Phrase: "Fluorescence staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "phase contrast images of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "visualized on an inverted Zeiss Axiovert 135microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0234621:Visualized [Functional Concept]
   748   C0443241:Inverted [Qualitative Concept]

Phrase: "(Thornwood,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.123: Images were captured either on 35-mm TMAX 400professional film (Eastman Kodak Corp., Rochester, NY), or using an Image Explorer II system incorporating a Dage MTI CCD72 camera and frame grabber together with IPLab Spectrum software (Signal Analytics Corp., Vienna, VA) on a Power Macintosh (Apple Computer Co., Cupertino, CA). 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured"

Phrase: "either on 35-mm TMAX 400professional film"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0086296:Film [Manufactured Object]
   748   C1561571:film [Biomedical or Dental Material]
   748   C1561572:film [Substance]
   748   C2348796:Tmax [Quantitative Concept]

Phrase: "(Eastman Kodak Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: "Rochester,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Image Explorer II system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "incorporating"

Phrase: "a Dage MTI CCD72 camera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0179533:Camera [Medical Device]
   812   C1654607:Camera [Eukaryote]
   812   C1706254:CAMERA [Medical Device]

Phrase: "and"

Phrase: "frame grabber together with IPLab Spectrum software"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080089:Frame [Nucleotide Sequence]
   748   C0180979:Frame [Medical Device]
   748   C1705858:Frame [Manufactured Object]

Phrase: "(Signal Analytics Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: "Vienna,"

Phrase: "VA) on a Power Macintosh"

Phrase: "(Apple Computer Co.,"

Phrase: "Cupertino,"

Phrase: "CA)."
Processing 00000000.tx.124: Analysis of GFP Fluorescence and Visual Monitoring of Cell Death HeLa cells plated on gridded coverslips (Eppendorf, Milwaukee, WI) were transfected with GFP-expressing constructs, and at various times after transfection, the coverslips were washed with sterile PBS, and GFP fluorescence was visualized using the FITC filter 10set (Carl Zeiss, Inc.). 

Phrase: "Analysis of GFP Fluorescence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "Visual Monitoring of Cell Death HeLa cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150369:Monitoring [Health Care Activity]
   748   C1516647:monitoring [Research Activity]

Phrase: "plated on gridded coverslips"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "(Eppendorf,"

Phrase: "Milwaukee,"

Phrase: "WI)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: "were"

Phrase: "transfected with GFP-expressing constructs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   726   C2827421:Construct [Classification]

Phrase: "and at various times"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0040223:times [Temporal Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1515981:And [Idea or Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "after transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "the coverslips"

Phrase: "were"

Phrase: "washed with sterile PBS,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0232920:Sterile [Qualitative Concept]
   770   C0678108:Sterile [Pathologic Function]
   770   C1548982:Washed [Idea or Concept]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]
   737 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "GFP fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the FITC filter 10set"

Phrase: "(Carl Zeiss,"

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.125: The fluorescence and phase contrast images of transfected cells in the same gridded areas were captured 17,41,and 65h after transfection using the Image explorer II camera. 

Phrase: "The fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "phase contrast images of transfected cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1704254:Image [Intellectual Product]
   719   C1704922:Image [Entity]
   719   C3542466:Image [Intellectual Product]

Phrase: "in the same gridded areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0205146:areas [Spatial Concept]
   793 E C0017446:Area [Geographic Area]

Phrase: "were"

Phrase: "captured"

Phrase: "17,"

Phrase: "41,"

Phrase: "and"

Phrase: "65h after transfection"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Image explorer II camera."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0179533:Camera [Medical Device]
   812   C1654607:Camera [Eukaryote]
   812   C1706254:CAMERA [Medical Device]
Processing 00000000.tx.126: After image analysis, the PBS was replaced with fresh DMEM medium, and the coverslips were quickly returned to the CO2 incubator. 

Phrase: "After image analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0200765:Image analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0001762:After image [Mental Process]

Phrase: "the PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "was"

Phrase: "replaced with fresh DMEM medium,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C0443224:Fresh [Qualitative Concept]
   760   C0559956:Replaced [Functional Concept]
   760   C1299987:replaced [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C2827486:Fresh [Body Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C1554078:Replace [Idea or Concept]

Phrase: "and"

Phrase: "the coverslips"

Phrase: "were"

Phrase: "quickly"

Phrase: "returned to the CO2 incubator."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332156:Return to [Qualitative Concept]
           Return
   760   C0021178:Incubator [Manufactured Object]
   760   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.127: In an alternative procedure, cell death was quantitated by counting the number of floating cells that accumulated 20and 44 h after transfection. 

Phrase: "In an alternative procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "quantitated by counting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]

Phrase: "the number of floating cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "that accumulated 20and 44 h after transfection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.128: For this analysis, 1-1.5105 HeLa cells grown in 100-mm dishes were transfected with either 15or 20g DNA of the various PS-2 expression constructs. 

Phrase: "For this analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "1-1.5105 HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0018873:HeLa Cells [Cell]
           HeLa
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "grown in 100-mm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0020498:DISH [Disease or Syndrome]

Phrase: "were"

Phrase: "transfected with either 15or 20g DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the various PS-2 expression constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C2827421:Construct [Classification]
Processing 00000000.tx.129: 20 h after transfection, the medium was collected from each dish and fresh medium was added to the dishes. 

Phrase: "20 h after transfection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "collected from each dish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020498:DISH [Disease or Syndrome]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "fresh medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "added to the dishes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1524062:Added [Functional Concept]
   737   C0020498:DISH [Disease or Syndrome]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.130: The number of floating cells in medium obtained 20and 44h after transfection were counted using a hemacytometer. 

Phrase: "The number of floating cells in medium obtained 20and 44h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   741   C0007584:Cell Number [Laboratory Procedure]
   739   C0237753:*Number [Quantitative Concept]
   739   C0449788:Number [Quantitative Concept]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a hemacytometer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0181168:hemacytometer [Medical Device]
Processing 00000000.tx.131: The number of floating apoptotic cells (of which 50- 60% failed to exclude trypan bluenot untypical of apoptotic cells since loss of membrane integrity occurs very late during apoptosis) and not including mitotic cells (distinguished by the presence of metaphase plates) in the PS-2 transfected dishes were normalized to the number found in mock-transfected dishes. 

Phrase: "The number of floating apoptotic cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "("

Phrase: "of which 50- 60%"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "trypan bluenot"

Phrase: "untypical of apoptotic cells"

Phrase: "since"

Phrase: "loss of membrane integrity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "very late during apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0162638:Apoptosis [Cell Function]
   770   C0205087:Late [Temporal Concept]
   770   C0442824:Very [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "mitotic cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0230518:Mitotic cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "distinguished by the presence of metaphase plates"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0025564:Metaphase [Cell Function]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1139930:plates [Medical Device]
   748   C1621812:Metaphase [Cell Function]
   745   C0230532:Metaphase plate [Cell Component]
   714 E C0005971:Plate [Medical Device]
   714 E C3537155:Plate [Manufactured Object]

Phrase: ")"

Phrase: "in the PS-2 transfected dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0020498:DISH [Disease or Syndrome]

Phrase: "were"

Phrase: "normalized to the number"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]
   770   C1882115:Normalized [Research Activity]

Phrase: "found in mock-transfected dishes."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0150312:Found [Quantitative Concept]
   760   C0562577:mock [Finding]
   726   C0020498:DISH [Disease or Syndrome]
   726 E C0243095:Find [Finding]
Processing 00000000.tx.132: Protein Preparation, SDS Gel Electrophoresis, and Immunoblotting Cells were lysed in 0.5% SDS lysis buffer containing protease inhibitors (Monteiro and Mical, 1996) and the unboiled lysates were analyzed on 8.5and 10% SDS-PAGE gels (Laemmli, 1970). 

Phrase: "Protein Preparation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "SDS Gel Electrophoresis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "Immunoblotting Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in 0.5% SDS lysis buffer containing protease inhibitors"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   761   C0250870:Protease Inhibitor 5 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   761   C0919445:PROTEASE INHIBITOR 5 [Gene or Genome]
   760   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   760   C0444499:0/5 [Quantitative Concept]
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0024348:Lysis [Pathologic Function]
           lysed
   739   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0243077:inhibitors [Chemical Viewed Functionally]
   739   C0332256:Containing [Functional Concept]
   739   C1536403:lysis [Cell Function]
   739   C1947941:Protease [Enzyme]
   739   C2700400:Containing [Activity]
   726 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   706 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Monteiro"

Phrase: "and"

Phrase: "Mical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537694:MICAL [Gene or Genome]

Phrase: "1996"

Phrase: ")"

Phrase: "and"

Phrase: "the unboiled lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed on 8.5and 10% SDS-PAGE gels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   744   C0017243:Gels [Biomedical or Dental Material]
   744   C0936012:Analyzed [Research Activity]
   744   C1704732:Page [Intellectual Product]
   711 E C1382104:Gel [Substance]

Phrase: "(Laemmli,"

Phrase: "1970"

Phrase: ")."
Processing 00000000.tx.133: The gels were calibrated by electrophoresing known molecular mass standards; 

Phrase: "The gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "calibrated by electrophoresing known molecular mass standards"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   748   C0038137:standards [Intellectual Product]
   748   C0175675:Standards [Qualitative Concept]
   748   C0205309:Known [Qualitative Concept]
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1521991:Molecular [Qualitative Concept]
   714   C0013855:electrophorese [Laboratory Procedure]
   714 E C1442989:Standard [Qualitative Concept]
   714 E C2828392:Standard [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.134: rabbit muscle myosin (205kD), Escherichia coli -galactosidase (116kD), rabbit muscle phosphorylase B (97.4kD), bovine albumin (66kD), egg albumin (45kD), and carbonic anhydrase (29kD) (Sigma Chemical Co.). 

Phrase: "rabbit muscle myosin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0026845:Muscle [Tissue]
   827   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "(205kD"

Phrase: ")"

Phrase: ","

Phrase: "Escherichia coli -galactosidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0014834:Escherichia coli [Bacterium]

Phrase: "(116kD"

Phrase: ")"

Phrase: ","

Phrase: "rabbit muscle phosphorylase B (97.4kD"

Phrase: ")"

Phrase: ","

Phrase: "bovine albumin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0007452:Bovine [Mammal]
   861   C1140701:bovine [Mammal]

Phrase: "(66kD"

Phrase: ")"

Phrase: ","

Phrase: "egg albumin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0013710:EGG [Food]
   861   C0029974:Egg [Cell]
   861   C1508746:Egg [Organic Chemical,Pharmacologic Substance]

Phrase: "(45kD"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "carbonic anhydrase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007028:Carbonic Anhydrase [Amino Acid, Peptide, or Protein,Enzyme]
   789   C0007009:Carbon [Element, Ion, or Isotope]

Phrase: "(29kD"

Phrase: ")"

Phrase: "(Sigma Chemical Co."

Phrase: ")."
Processing 00000000.tx.135: The fractionated proteins were transferred onto 0.1-m nitrocellulose membranes (Schleicher &Schuell, Keene, NH) by electroblotting, and immunoblots were processed as described previously (Xiao and Monteiro, 1994). 

Phrase: "The fractionated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transferred onto 0.1-m nitrocellulose membranes"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   748   C0025255:Membranes [Tissue]
   748   C0348011:transferred [Functional Concept]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   714 E C0040671:Transfer [Mental Process]
   714 E C0596901:Membrane [Cell Component]
   714 E C1705822:Transfer [Activity]
   714 E C1706182:Membrane [Manufactured Object]

Phrase: "(Schleicher &Schuell,"

Phrase: "Keene,"

Phrase: "NH) by electroblotting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0268059:NH [Disease or Syndrome]

Phrase: "and"

Phrase: "immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "were"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Xiao"

Phrase: "and"

Phrase: "Monteiro,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.136: Double Labeling of PS-2-transfected HeLa Cells with the myc Monoclonal Antibody and Terminal Transferase Fluorescence In Situ Apoptosis Detection Transfected cells were analyzed for apoptosis using the in situ Apop Tag detection kit (Oncor, Inc., Gaithersburg, MD) essentially as described by the manufacturer. 

Phrase: "Double Labeling of PS-2-transfected HeLa Cells"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0205173:Double [Functional Concept]
   744   C1167624:Labeling [Mental Process]
   744   C1705764:Double [Activity]
   744   C1705765:Double [Qualitative Concept]
   744   C1947902:Labeling [Manufactured Object]
   744   C2827499:Labeling [Governmental or Regulatory Activity]
   711 E C0181496:Label [Manufactured Object]

Phrase: "with the myc Monoclonal Antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "and"

Phrase: "Terminal Transferase Fluorescence In Situ Apoptosis Detection Transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   791   C0007634:Cells [Cell]
   791   C3282337:Cells [Cell]
   758 E C1269647:Cell [Cell]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "analyzed for apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C0936012:Analyzed [Research Activity]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the in situ Apop Tag detection kit (Oncor,"

Phrase: "Inc.,"

Phrase: "Gaithersburg,"

Phrase: "MD) essentially"

Phrase: "as"

Phrase: "described by the manufacturer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1705426:Manufacturer [Population Group]
Processing 00000000.tx.137: HeLa cells transfected on coverslips were fixed in 1% paraformaldehyde on ice for 15min, transferred to 0.5% Triton in PBS for 3min, and placed in 20C 70% ethanol for 20min. 

Phrase: "HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected on coverslips"

Phrase: "were"

Phrase: "fixed in 1% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "for 15min,"

Phrase: "transferred to 0.5% Triton"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0444499:0/5 [Quantitative Concept]
   760   C0242759:Triton [Geographic Area]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "for 3min,"

Phrase: "and"

Phrase: "placed in 20C 70% ethanol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1381542:70% Ethanol [Clinical Drug]
   760   C0001962:Ethanol [Organic Chemical]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "for 20min."
Processing 00000000.tx.138: The cells on coverslips were rehydrated by two incubations with PBS for 5min each and then transferred to a humidified chamber and covered with Equilibration buffer (Oncor S7110 kit) for 5 min, after which the buffer was replaced with the working strength terminal deoxynucleotide transferase enzyme. 

Phrase: "The cells on coverslips"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   816   C0007634:THE CELL [Cell]
           Cells
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rehydrated by two incubations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205448:Two [Quantitative Concept]

Phrase: "with PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "for 5min"

Phrase: "each"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transferred to a humidified chamber"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0348011:transferred [Functional Concept]
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "covered with Equilibration buffer"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0439844:Covered [Functional Concept]
   770   C1999244:Covered [Functional Concept]
   737 E C0180153:cover [Medical Device]
   737 E C1707529:Cover [Medical Device]

Phrase: "(Oncor S7110 kit) for 5 min,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0812225:KIT [Medical Device]
   753   C1150635:KIT [Molecular Function]
   753   C1705212:Kit [Medical Device]
   753   C1705213:KIT [Medical Device]
   753   C3273202:Kit [Manufactured Object]

Phrase: "after"

Phrase: "which the buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "replaced with the working strength terminal deoxynucleotide transferase enzyme."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   762   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0043227:Working [Occupational Activity]
   742   C0205088:Terminal [Temporal Concept]
   742   C0237897:Strength [Quantitative Concept]
   742   C0559956:Replaced [Functional Concept]
   742   C0808080:Strength [Idea or Concept]
   742   C1299987:replaced [Functional Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C1705922:Strength [Qualitative Concept]
   708 E C1554078:Replace [Idea or Concept]
Processing 00000000.tx.139: The chamber containing the coverslips was placed in a 37C incubator, and after 3.5h, the coverslips were submerged in the working strength stop/wash buffer for 0.5h and rinsed in three changes of PBS for 3min each. 

Phrase: "The chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the coverslips"

Phrase: "was"

Phrase: "placed in a 37C incubator,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0021178:Incubator [Manufactured Object]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "and after 3.5h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1442467:5H [Temporal Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "the coverslips"

Phrase: "were"

Phrase: "submerged in the working strength stop/wash buffer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0425082:stop working [Finding]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0043227:Working [Occupational Activity]
   744   C0237897:Strength [Quantitative Concept]
   744   C0441648:Wash [Activity]
   744   C0808080:Strength [Idea or Concept]
   744   C1705922:Strength [Qualitative Concept]
   744   C1947925:Stop [Activity]
   744   C2746065:Stop [Temporal Concept]

Phrase: "for 0.5h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442467:5H [Temporal Concept]

Phrase: "and"

Phrase: "rinsed in three changes of PBS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0205449:Three [Quantitative Concept]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C1720830:PBS [Disease or Syndrome]
   753   C1823521:PBS [Gene or Genome]
   719   C1701810:Rinse [Functional Concept]
   719 E C1705241:Change [Quantitative Concept]
   719   C1882955:Rinse [Activity]

Phrase: "for 3min"

Phrase: "each."
Processing 00000000.tx.140: Working strength antidigoxigenin-fluorescein was applied for 0.5h, and the cells were washed again first in 1% Triton in PBS for 3min and twice more in PBS for 5min each. 

Phrase: "Working strength antidigoxigenin-fluorescein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "applied for 0.5h,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0185125:Applied [Health Care Activity]
   770   C1442467:5H [Temporal Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "again first in 1% Triton"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205435:First [Quantitative Concept]
   760   C0242759:Triton [Geographic Area]
   760   C1279901:First [Qualitative Concept]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "for 3min"

Phrase: "and"

Phrase: "twice more in PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1720725:Twice [Intellectual Product]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "for 5min"

Phrase: "each."
Processing 00000000.tx.141: The coverslips were then counterstained with the myc monoclonal antibody followed by rhodamine-conjugated goat anti-mouse antibody as described above. 

Phrase: "The coverslips"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "counterstained with the myc monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]

Phrase: "followed by rhodamine-conjugated goat anti-mouse antibody"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   770   C0332283:Followed by [Temporal Concept]
           followed
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0018019:goat [Mammal]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0522529:Conjugated [Spatial Concept]
   744   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C1265549:goat [Mammal]
   744   C1510458:Goat [Mammal]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "as described above."
Processing 00000000.tx.142: Results The First 166Residues of PS-2 Are Sufficient for ER Targeting To investigate PS-2 function, full-length PS-2 and progressive COOH-terminal truncations, tagged at their COOH terminus with a myc epitope and under transcriptional control of a CMV promoter (Fig. 1), were expressed in HeLa cells by transient transfection. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "The First 166Residues of PS-2"

Phrase: "Are"

Phrase: "Sufficient for ER Targeting To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205410:Sufficient [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "PS-2 function,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "full-length PS-2"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   875   C0806636:Length 2 [Quantitative Concept]
   861   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0443225:Full [Qualitative Concept]
   812   C1418867:Ps [Gene or Genome]
   812   C1444754:Length [Quantitative Concept]
   812   C1518860:PS [Geographic Area]
   812   C1552158:Ps [Body Part, Organ, or Organ Component]
   812   C1706316:LENGTH [Research Activity]
   741 E C0205166:Long [Qualitative Concept]
   741 E C1522425:Longest [Qualitative Concept]
   741 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "progressive COOH-terminal truncations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1706395:Truncation [Cell or Molecular Dysfunction]

Phrase: "tagged at their COOH terminus"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708632:Tagged [Qualitative Concept]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "with a myc epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "and under transcriptional control of a CMV promoter"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C1158770:Transcriptional Control [Genetic Function]
   744   C0010825:Cytomegalovirus [Virus]
   744   C0040649:Transcriptional [Genetic Function]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0243148:control [Qualitative Concept]
   744   C1515981:And [Idea or Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "expressed in HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0018873:HeLa Cells [Cell]
           HeLa
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by transient transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.143: Immunoblot analysis of protein lysates prepared from cells transfected with either myc-tagged or nontagged full-length PS-2 contained immunoreactive bands of ~50-54 kD when probed with a polyclonal antibody specific for NH2-terminal PS-2 sequences (Fig. 2 C, lanes 2and 4, respectively) that were not detectable in mock-transfected lysates (Fig. 2 C, lanes 1and 3). 

Phrase: "Immunoblot analysis of protein lysates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   797   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "prepared from cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756   C1521827:Prepare [Functional Concept]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with either myc-tagged"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708632:Tagged [Qualitative Concept]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "nontagged full-length PS-2 contained immunoreactive bands of ~50-54 kD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   787   C0026691:KD [Disease or Syndrome]
   787   C1705240:KD [Gene or Genome]
   787   C1839259:KD [Disease or Syndrome]

Phrase: "when"

Phrase: "probed with a polyclonal antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "specific for NH2-terminal PS-2 sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]

Phrase: "(Fig. 2 C,"

Phrase: "lanes 2and 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "that"

Phrase: "were"

Phrase: "not detectable in mock-transfected lysates"

Phrase: "(Fig. 2 C,"

Phrase: "lanes 1and 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.144: The PS-2 antibody recognized GST fusion proteins containing NH2-terminal but not loop or COOH-terminal PS-2 sequences (Fig. 2, A and B). 

Phrase: "The PS-2 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "recognized"

Phrase: "GST fusion proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "NH2-terminal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0002508:NH2 [Organic Chemical]
   861   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "or"

Phrase: "COOH-terminal PS-2 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.145: PS-2 deletions in which the COOH-terminal 180,226,and 282residues were removed (see Fig. 1 and Materials and Methods) migrated as doublet bands in SDS-PAGE gels (evident in shorter exposures of autoradiographs, data not shown) with apparent molecular sizes of ~35-37, 33-35, and 31-33 kD, respectively (Fig. 2 C, lanes 4-7). 

Phrase: "PS-2 deletions in which"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C1880274:Deletions [Activity]
   726 E C1442161:Deletion [Cell or Molecular Dysfunction]
   726 E C1511760:Deletion [Genetic Function]

Phrase: "the COOH-terminal 180,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "226,"

Phrase: "and"

Phrase: "282residues"

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: "migrated as doublet bands"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0175723:Bands [Medical Device]
   770   C0232902:Migrated [Functional Concept]
   737 E C0439645:Band [Spatial Concept]
   737 E C1521913:band [Cell Component]

Phrase: "in SDS-PAGE gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]
   734   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]

Phrase: "(evident in shorter exposures of autoradiographs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence of [Functional Concept]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "with apparent molecular sizes of ~35-37,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   822   C0237883:Apparent Size [Quantitative Concept]
   810   C0596969:molecular size [Quantitative Concept]
   799   C0456389:SIZES [Spatial Concept]
   799   C0750489:apparent [Idea or Concept]
   799   C1521991:Molecular [Qualitative Concept]
   727 E C0567416:Molecule [Substance]

Phrase: "33-35,"

Phrase: "and"

Phrase: "31-33 kD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0026691:KD [Disease or Syndrome]
   827   C1705240:KD [Gene or Genome]
   827   C1839259:KD [Disease or Syndrome]

Phrase: "respectively"

Phrase: "(Fig. 2 C,"

Phrase: "lanes 4-7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.146: Apart from these bands, larger immunoreactive complexes were routinely seen in PS-2-transfected cells but not in mock-transfected cells and appeared to represent dimers, trimers, and higher molecular mass complexes of PS-2 proteins (Fig. 2 C, lanes 4-7, small arrowheads). 

Phrase: "Apart from these bands,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "larger immunoreactive complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "routinely"

Phrase: "seen in PS-2-transfected cells"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007634:Cells [Cell]
   753   C0205397:Seen [Qualitative Concept]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   753   C3282337:Cells [Cell]
   719 E C0042789:see [Organism Function]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1947903:See [Activity]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not in mock-transfected cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0562577:mock [Finding]
   760   C1518422:Not [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "dimers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "trimers,"

Phrase: "and"

Phrase: "higher molecular mass complexes of PS-2 proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C1704241:Complexes [Chemical Viewed Structurally]
   734   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1523872:protein complex [Cell Component]
   711 E C0439855:Complex [Qualitative Concept]

Phrase: "(Fig. 2 C,"

Phrase: "lanes 4-7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "small arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1080898:Arrowheads [Plant]
   827 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.147: We did not observe any significant proteolytic cleavage of the PS-2-expressed products as has been previously reported (Kim et al., 1997; Tomita et al., 1997). 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "any significant proteolytic cleavage of the PS-2-expressed products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0010813:cleavage [Cell Function]
   739   C0596311:Cleavage [Phenomenon or Process]
   739   C1330957:cleavage [Cell Function]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(Kim et al.,"

Phrase: "1997"

Phrase: "; Tomita et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.148: In fact, immunoblot analyses of a parallel gel probed with the myc antibody, which recognized the COOH terminus of PS-2, contained bands identical in size to those recognized by the anti-NH2-terminal PS-2 antibody, indicating full-length accumulation of the various PS-2 polypeptides with the presence of both NH2- and COOH-terminal epitopes (compare Fig. 2 C, lanes 3-7, with Fig. 2 D, lanes 1-5). 

Phrase: "In fact,"

Phrase: "immunoblot analyses of a parallel gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "probed with the myc antibody,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "which"

Phrase: "recognized"

Phrase: "the COOH terminus of PS-2,"

Phrase: "contained bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "identical in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "to those"

Phrase: "recognized by the anti-NH2-terminal PS-2 antibody,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0002508:NH2 [Organic Chemical]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   742   C0205088:Terminal [Temporal Concept]
   742   C1418867:Ps [Gene or Genome]
   742   C1518860:PS [Geographic Area]
   742   C1552158:Ps [Body Part, Organ, or Organ Component]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]

Phrase: "indicating"

Phrase: "full-length accumulation of the various PS-2 polypeptides"

Phrase: "with the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of both NH2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002508:NH2 [Organic Chemical]
  1000   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "COOH-terminal epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitopes [Immunologic Factor]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "Fig. 2 C,"

Phrase: "lanes 3-7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "with Fig. 2 D, lanes 1-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0349966:Fig [Food]
   799   C1337208:FIG [Food]
   766   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.149: The myc-reactive PS-2 bands were clearly distinguished from the ~35 and 65kD endogenous bands present in all HeLa cell lysates (Fig. 2 D, small arrowhead). 

Phrase: "The myc-reactive PS-2 bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0175723:Bands [Medical Device]
   771 E C0439645:Band [Spatial Concept]
   771 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "clearly"

Phrase: "distinguished from the ~35"

Phrase: "and"

Phrase: "65kD endogenous bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "present in all HeLa cell lysates"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0018873:HeLa cell [Cell]
           HeLa
   773   C1881488:Cell Lysate [Physical Object]
           Lysate
   753   C0007634:Cell [Cell]
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2 D, small arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0453107:Arrowhead [Food]
   804   C1080898:Arrowhead [Plant]

Phrase: ")."
Processing 00000000.tx.150: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.151: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.152: Immunoblot analysis of PS-2 proteins. 

Phrase: "Immunoblot analysis of PS-2 proteins."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   767   C1514534:Protein Analysis [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.153: (A and B) PS-2 NH2-terminal, loop, and COOH-terminal sequences were expressed as GST fusion proteins and separated by SDS-PAGE on 8.5% polyacrylamide gels. 

Phrase: "(A"

Phrase: "and"

Phrase: "B) PS-2 NH2-terminal,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0002508:NH2 [Organic Chemical]
   804   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0205088:Terminal [Temporal Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]

Phrase: "loop,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "and"

Phrase: "COOH-terminal sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "expressed as GST fusion proteins"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   757   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1418948:PROTEIN S [Gene or Genome]
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332466:Fusion [Functional Concept]
   748   C1293131:Fusion [Therapeutic or Preventive Procedure]
   745   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "on 8.5% polyacrylamide gels."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0017243:Gels [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   779 E C1382104:Gel [Substance]
Processing 00000000.tx.154: The separated proteins were either stained with Coomassie blue (A) or transferred onto nitrocellulose filters and immunoblotted with the PS-2 NH2-terminal antibody (B). 

Phrase: "The separated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "either"

Phrase: "stained with Coomassie blue"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(A)"

Phrase: "or"

Phrase: "transferred onto nitrocellulose filters"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   770   C0180860:Filters [Manufactured Object]
   770   C0348011:transferred [Functional Concept]
   770   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   737 E C0040671:Transfer [Mental Process]
   737 E C0581406:Filter [Medical Device]
   737 E C1522664:Filter [Intellectual Product]
   737 E C1704449:Filter [Conceptual Entity]
   737 E C1704684:Filter [Medical Device]
   737 E C1705822:Transfer [Activity]
   737 E C1875155:FILTER [Medical Device]

Phrase: "and"

Phrase: "immunoblotted with the PS-2 NH2-terminal antibody"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0002508:NH2 [Organic Chemical]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   744   C0205088:Terminal [Temporal Concept]
   744   C1418867:Ps [Gene or Genome]
   744   C1518860:PS [Geographic Area]
   744   C1552158:Ps [Body Part, Organ, or Organ Component]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   711   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.155: Lanes 1-4 are whole cell lysates of bacteria induced for expression of GST fusion proteins by addition of IPTG, and lanes 5-8 are the corresponding purified GST fusion proteins. 

Phrase: "Lanes 1-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "are"

Phrase: "whole cell lysates of bacteria"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   762   C0563199:Bacterial cell [Bacterium]
   760   C0007634:Cell [Cell]
   760   C0444667:Whole [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   745   C1569170:bacterial lysate [Immunologic Factor,Organic Chemical,Pharmacologic Substance]

Phrase: "induced for expression of GST fusion proteins"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   767   C1517332:Fusion Protein Expression [Cell or Molecular Dysfunction]
   745   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C1171362:expression protein [Genetic Function]
   745   C1418948:PROTEIN S [Gene or Genome]
   742   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205263:Induced [Functional Concept]
   742   C0332466:Fusion [Functional Concept]
   742   C1293131:Fusion [Therapeutic or Preventive Procedure]
   731   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "by addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of IPTG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022239:IPTG [Carbohydrate]

Phrase: "and"

Phrase: "lanes 5-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "are"

Phrase: "the corresponding purified GST fusion proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0332466:Fusion [Functional Concept]
   795   C1293131:Fusion [Therapeutic or Preventive Procedure]
   785   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.156: The GST fusion proteins that were expressed are as follows: Lanes 1and 5, GST alone; 

Phrase: "The GST fusion proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "were"

Phrase: "expressed"

Phrase: "are"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "Lanes 1and 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "GST"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ";"
Processing 00000000.tx.157: lanes 2and 6, GST- NH2-terminal fusion protein; 

Phrase: "lanes 2and 6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "GST- NH2-terminal fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0332466:Fusion [Functional Concept]
   795   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.158: lanes 3and 7, GST-loop fusion protein; 

Phrase: "lanes 3and 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "GST-loop fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332466:Fusion [Functional Concept]
   799   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.159: and lanes 4and 8, GST-COOH-terminal fusion protein. 

Phrase: "and"

Phrase: "lanes 4and 8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "GST-COOH-terminal fusion protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0332466:Fusion [Functional Concept]
   795   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.160: The arrowheads indicate the position of full-length GST fusion proteins. 

Phrase: "The arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: "indicate"

Phrase: "the position of full-length GST fusion proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0733755:Position [Spatial Concept]
Processing 00000000.tx.161: (C-F) Protein lysates of transfected HeLa cells separated by SDS-PAGE on 8.5% gels and immunoblotted with antibodies that recognize the transfected proteins. 

Phrase: "(C-F) Protein lysates of transfected HeLa cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "on 8.5% gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "immunoblotted with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756   C0020985:Immunoblot [Laboratory Procedure]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "recognize"

Phrase: "the transfected proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.162: (C) Immunoblot with the anti-PS-2-specific antibody. 

Phrase: "(C) Immunoblot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "with the anti-PS-2-specific antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.163: Lanes 1-7 are lysates of cells transfected with the following constructs: Lanes 1and 3, mock-transfected cells; 

Phrase: "Lanes 1-7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "are"

Phrase: "lysates of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   824   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "transfected with the following constructs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
   726   C2827421:Construct [Classification]

Phrase: ":"

Phrase: "Lanes 1and 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "mock-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.164: lane 2, pPS-2; 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "pPS-2"

Phrase: ";"
Processing 00000000.tx.165: lane 4, pPS-2+Myc; 

Phrase: "lane 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "pPS-2+Myc"

Phrase: ";"
Processing 00000000.tx.166: lane 5, pPS-2(268aa)+Myc; 

Phrase: "lane 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "pPS-2"

Phrase: "(268aa"

Phrase: ")"

Phrase: "+Myc"

Phrase: ";"
Processing 00000000.tx.167: lane 6, pPS-2(222aa)+Myc; 

Phrase: "lane 6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "pPS-2"

Phrase: "(222aa"

Phrase: ")"

Phrase: "+Myc"

Phrase: ";"
Processing 00000000.tx.168: and lane 7, pPS-2(166aa)+Myc. 

Phrase: "and"

Phrase: "lane 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "pPS-2"

Phrase: "(166aa"

Phrase: ")"

Phrase: "+Myc."
Processing 00000000.tx.169: (D) Immunoblot of corresponding lysates shown in C with the anti-myc antibody. 

Phrase: "("

Phrase: "D)"

Phrase: "Immunoblot of corresponding lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "shown in C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "with the anti-myc antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.170: Lysates in lanes 1-5 in D correspond to lysates in lanes 3-7 in C. 

Phrase: "Lysates in lanes 1-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1881488:Lysate [Physical Object]

Phrase: "in D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "correspond to lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1881488:Lysate [Physical Object]

Phrase: "in lanes 3-7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "in C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.171: (E) Immunoblot with the anti-GFP-specific antibody. 

Phrase: "(E) Immunoblot with the anti-GFP-specific antibody."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.172: Lanes 1-4 are protein lysates of cells transfected with the following constructs: Lane 1, mock-transfected cells (control); 

Phrase: "Lanes 1-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "are"

Phrase: "protein lysates of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   786   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "transfected with the following constructs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
   726   C2827421:Construct [Classification]

Phrase: ":"

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "mock-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.173: lane 2, pGFP; 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "pGFP"

Phrase: ";"
Processing 00000000.tx.174: lane 3, pGFP-PS-2; 

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "pGFP-PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.175: and lane 4, pGFP-PS-2(N141I). 

Phrase: "and"

Phrase: "lane 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "pGFP-PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(N141I"

Phrase: ")."
Processing 00000000.tx.176: (F) Immunoblot of nonfusion PS-2 proteins with the NH2-terminal PS-2 antibody. 

Phrase: "(F) Immunoblot of nonfusion PS-2 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "with the NH2-terminal PS-2 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.177: Lanes 1-3 are 100g of protein lysates of cells transfected with equivalent amounts of the following nonfusion PS-2 constructs: Lane 1, mock-transfected; 

Phrase: "Lanes 1-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "are"

Phrase: "100g of protein lysates of cells"

Phrase: "transfected with equivalent amounts of the following nonfusion PS-2 constructs"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0205163:Equivalent [Qualitative Concept]
   738   C0439185:equivalent [Quantitative Concept]
   738   C1265611:amounts [Quantitative Concept]
   738   C1418867:Ps [Gene or Genome]
   738   C1518860:PS [Geographic Area]
   738   C1552158:Ps [Body Part, Organ, or Organ Component]
   704   C0332283:follow [Temporal Concept]
   704   C1719822:Follow [Intellectual Product]
   704   C2827421:Construct [Classification]

Phrase: ":"

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "mock-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: "transfected"

Phrase: ";"
Processing 00000000.tx.178: lane 2, pPS-2 (wild-type); 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "pPS-2"

Phrase: "(wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.179: and lane 3, pPS-2(Asn141Ile) mutant. 

Phrase: "and"

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "pPS-2"

Phrase: "(Asn141Ile"

Phrase: ")"

Phrase: "mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.180: The positions of protein molecular weight markers are indicated. 

Phrase: "The positions of protein molecular weight markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0733755:positions [Spatial Concept]

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.181: Full-length PS-2 containing polypeptide bands seen only in transfected cell lysates are marked with large arrowheads. 

Phrase: "Full-length PS-2 containing polypeptide bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   795   C0175723:Bands [Medical Device]
   762 E C0439645:Band [Spatial Concept]
   762 E C1521913:band [Cell Component]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "only in transfected cell lysates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C0205171:Only [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1720467:Only [Intellectual Product]
   760   C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "marked with large arrowheads."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0522501:Marked [Qualitative Concept]
   770   C0549177:Large [Quantitative Concept]
   770   C1080898:Arrowheads [Plant]
   770   C1706089:Marked [Qualitative Concept]
   737 E C0453107:Arrowhead [Food]
Processing 00000000.tx.182: The small arrowheads indicate the positions of larger PS-2 complexes. 

Phrase: "The small arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1080898:Arrowheads [Plant]
   827 E C0453107:Arrowhead [Food]

Phrase: "indicate"

Phrase: "the positions of larger PS-2 complexes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0733755:positions [Spatial Concept]
Processing 00000000.tx.183: [View Larger Version of this Image (84K GIF file)] Immunofluorescence staining of HeLa cells transiently transfected with full-length myc-tagged PS-2 (pPS-2+Myc) displayed nuclear envelope and ER staining when probed with either the anti-NH2-terminal PS-2 or myc antibodies (Fig. 3, A and B). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(84K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Immunofluorescence staining of HeLa cells transiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "transfected with full-length myc-tagged PS-2"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0806636:Length 2 [Quantitative Concept]
   744   C0443225:Full [Qualitative Concept]
   744   C1418867:Ps [Gene or Genome]
   744   C1444754:Length [Quantitative Concept]
   744   C1518860:PS [Geographic Area]
   744   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   744   C1552158:Ps [Body Part, Organ, or Organ Component]
   744   C1706316:LENGTH [Research Activity]
   744   C1708632:Tagged [Qualitative Concept]
   711 E C0037293:Tag [Neoplastic Process]
   711 E C0181496:Tag [Manufactured Object]
   711 E C1710492:TAG [Gene or Genome]

Phrase: "(pPS-2+Myc)"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "nuclear envelope"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028584:Nuclear Envelope [Cell Component]
   861   C0521447:Nuclear [Spatial Concept]
   861   C1622204:envelope [Cell Component]

Phrase: "and"

Phrase: "ER staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "when"

Phrase: "probed with either"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "the anti-NH2-terminal PS-2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   840   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002508:NH2 [Organic Chemical]
   804   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0205088:Terminal [Temporal Concept]
   804   C1418867:Ps [Gene or Genome]
   804   C1518860:PS [Geographic Area]
   804   C1552158:Ps [Body Part, Organ, or Organ Component]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]

Phrase: "or"

Phrase: "myc antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.184: In fact there was complete colocalization upon double staining with the two antibodies, corroborating the immunoblot data for lack of cleavage and separation of NH2- and COOH-terminal PS-2 epitopes. 

Phrase: "In fact there"

Phrase: "was"

Phrase: "complete colocalization upon double staining"

Phrase: "with the two antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "corroborating"

Phrase: "the immunoblot data for lack of cleavage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "separation of NH2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036679:Separation [Pathologic Function]
   790   C0237868:Separation [Social Behavior]
   790   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "and"

Phrase: "COOH-terminal PS-2 epitopes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003316:Epitopes [Immunologic Factor]
Processing 00000000.tx.185: The specificity of this double staining was demonstrated by preincubation of the PS-2 NH2-terminal antibody with purified GST-PS-2 NH2-terminal fusion protein (shown in Fig. 2 A, lane 6), which abolished PS-2 NH2-terminal staining almost completely, but myc staining was retained (Fig. 3, C and D, respectively). 

Phrase: "The specificity of this double staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "was"

Phrase: "demonstrated by preincubation of the PS-2 NH2-terminal antibody"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0002508:NH2 [Organic Chemical]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   739   C0205088:Terminal [Temporal Concept]
   739   C1418867:Ps [Gene or Genome]
   739   C1518860:PS [Geographic Area]
   739   C1552158:Ps [Body Part, Organ, or Organ Component]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]

Phrase: "with purified GST-PS-2 NH2-terminal fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332466:Fusion [Functional Concept]
   790   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "shown in Fig. 2 A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0349966:Fig [Food]
   760   C1337208:FIG [Food]
   726   C1547282:Show [Intellectual Product]

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "abolished"

Phrase: "PS-2 NH2-terminal staining almost completely,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   818   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0002508:NH2 [Organic Chemical]
   795   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   795   C0205088:Terminal [Temporal Concept]
   795   C0205197:Completely [Qualitative Concept]
   795   C0487602:Staining [Laboratory Procedure]
   795   C1418867:Ps [Gene or Genome]
   795   C1518860:PS [Geographic Area]
   795   C1552158:Ps [Body Part, Organ, or Organ Component]
   795   C1704680:Staining [Finding]
   795   C1705314:Terminal [Manufactured Object]
   795   C1705315:Terminal [Spatial Concept]

Phrase: "but"

Phrase: "myc staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.186: To confirm PS-2 was localized to the ER, we double stained transfected cells for calreticulin, a calcium-binding protein that is localized to the ER (Opas et al., 1991), and for PS-2 using the NH2-terminal antibody. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "localized to the ER,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0392752:Localized [Spatial Concept]

Phrase: "we"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "stained transfected cells for calreticulin,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "a calcium-binding protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0006732:Calcium-binding protein [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1822659:calcium binding protein [Gene or Genome]
   913   C0805431:Calcium/Protein [Quantitative Concept]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1516144:Calcium Binding [Molecular Function]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "that"

Phrase: "is"

Phrase: "localized to the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0392752:Localized [Spatial Concept]

Phrase: "(Opas et al.,"

Phrase: "1991"

Phrase: ")"

Phrase: ","

Phrase: "and for PS-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418867:Ps [Gene or Genome]
   770   C1515981:And [Idea or Concept]
   770   C1518860:PS [Geographic Area]
   770   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the NH2-terminal antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.187: Full-length myc-tagged PS-2, as well as the three deletion constructs in which 180,226,and 282COOH-terminal PS-2 residues were deleted, showed colocalization with calreticulin (Fig. 3, E-H and data not shown). 

Phrase: "Full-length myc-tagged PS-2,"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   876   C0806636:Length 2 [Quantitative Concept]
   827   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0443225:Full [Qualitative Concept]
   799   C1418867:Ps [Gene or Genome]
   799   C1444754:Length [Quantitative Concept]
   799   C1518860:PS [Geographic Area]
   799   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   799   C1552158:Ps [Body Part, Organ, or Organ Component]
   799   C1706316:LENGTH [Research Activity]
   799   C1708632:Tagged [Qualitative Concept]
   766 E C0037293:Tag [Neoplastic Process]
   766 E C0181496:Tag [Manufactured Object]
   766 E C1710492:TAG [Gene or Genome]
   727 E C0205166:Long [Qualitative Concept]
   727 E C1522425:Longest [Qualitative Concept]
   727 E C1706317:Long [Qualitative Concept]

Phrase: "as well as"

Phrase: "the three deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "constructs in which 180,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2827421:Construct [Classification]

Phrase: "226,"

Phrase: "and"

Phrase: "282COOH-terminal PS-2 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: ","

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "colocalization with calreticulin"

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "E-H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.188: In contrast, construct pPS-2(138aa)+Myc, deleted of 310COOH-terminal residues, including TMD2, did not show colocalization with calreticulin (Fig. 3, I and J). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "construct pPS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "(138aa"

Phrase: ")"

Phrase: "+Myc,"

Phrase: "deleted of 310COOH-terminal residues,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205088:Terminal [Temporal Concept]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
   760   C1880274:Deleted [Activity]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "TMD2,"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "colocalization with calreticulin"

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "J"

Phrase: ")."
Processing 00000000.tx.189: These results indicated that 166NH2-terminal residues of PS-2 are sufficient for ER targeting. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that 166NH2-terminal residues of PS-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "are"

Phrase: "sufficient for ER targeting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205410:Sufficient [Qualitative Concept]
Processing 00000000.tx.190: Since pPS-2(138aa)+Myc did not localize correctly to the ER, it was not studied further. 

Phrase: "Since"

Phrase: "pPS-2"

Phrase: "(138aa"

Phrase: ")"

Phrase: "+Myc"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:localize [Spatial Concept]

Phrase: "correctly to the ER,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "it"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "further."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]
Processing 00000000.tx.191: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.192: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.193: Immunofluorescence localization of PS-2 proteins in HeLa cells. 

Phrase: "Immunofluorescence localization of PS-2 proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597704:protein localisation [Cell Function]
   767   C1159772:Protein Localization [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in HeLa cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.194: (A-D) HeLa cells transiently transfected with PS-2+ Myc and stained for PS-2 expression using antibodies specific for either the PS-2 NH2 terminus (A and C) or the myc tag at the COOH terminus (B and D). 

Phrase: "(A-D) HeLa cells transiently"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0018873:HeLa Cells [Cell]
           HeLa
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with PS-2+ Myc"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "stained for PS-2 expression"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "the PS-2 NH2 terminus"

Phrase: "(A"

Phrase: "and"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "the myc tag at the COOH terminus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037293:Tag [Neoplastic Process]
   748   C0181496:Tag [Manufactured Object]
   748   C1710492:TAG [Gene or Genome]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.195: The anti-PS-2 antibody was preincubated with either purified GST nonfusion protein for A and B or GST-NH2-terminal fusion protein for C and D to demonstrate specificity of the anti-PS-2 NH2-terminal antibody. 

Phrase: "The anti-PS-2 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "preincubated with either purified GST nonfusion protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   762   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1418948:PROTEIN S [Gene or Genome]
   742   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1998793:Purified [Functional Concept]

Phrase: "for A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "GST-NH2-terminal fusion protein for C"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C1418948:PROTEIN S [Gene or Genome]
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332466:Fusion [Functional Concept]
   742   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "D to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "demonstrate"

Phrase: "specificity of the anti-PS-2 NH2-terminal antibody."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C0003264:Antibody Specificity [Molecular Function]
   742   C0037791:Specificity [Quantitative Concept]
   742   C1511884:Specificity [Quantitative Concept]
   726 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.196: Double staining of the transfected cells with the preincubated PS-2 and anti-myc antibodies demonstrate that staining is abolished only upon incubation with GST fusion proteins containing NH2-terminal PS-2 sequences. 

Phrase: "Double staining of the transfected cells"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0205173:Double [Functional Concept]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "with the preincubated PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "anti-myc antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "demonstrate"

Phrase: "that staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "abolished"

Phrase: "only upon incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "with GST fusion proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "NH2-terminal PS-2 sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.197: Staining for both NH2- and COOH-terminal epitopes showed complete colocalization (compare A and B), suggesting the two epitopes are not dissociated (not proteolytically cleaved and differentially localized). 

Phrase: "Staining for both NH2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "COOH-terminal epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitopes [Immunologic Factor]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "complete colocalization"

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the two epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "dissociated"

Phrase: "("

Phrase: "not proteolytically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "and"

Phrase: "differentially"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.198: (E-J) HeLa cells transiently transfected with constructs pPS-2+Myc (E and F), pPS-2(166aa)+Myc (G and H), and pPS-2(138aa)+Myc (I and J) and double stained for PS-2 and calreticulin. 

Phrase: "(E-J) HeLa cells transiently"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0018873:HeLa Cells [Cell]
           HeLa
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with constructs pPS-2+Myc (E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "pPS-2"

Phrase: "(166aa"

Phrase: ")"

Phrase: "+Myc (G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "pPS-2"

Phrase: "(138aa"

Phrase: ")"

Phrase: "+Myc (I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "J)"

Phrase: "and"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "stained for PS-2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418867:Ps [Gene or Genome]
   770   C1518860:PS [Geographic Area]
   770   C1552158:Ps [Body Part, Organ, or Organ Component]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "calreticulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413096:CALRETICULIN [Gene or Genome]
Processing 00000000.tx.199: The left and right panels show the same cells double-stained for either PS-2 expression, using the anti- NH2-terminal PS-2 antibody (E, G, and I), or for endogenous calreticulin (F, H, and J). 

Phrase: "The left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "and"

Phrase: "right panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the same cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "-"

Phrase: "stained for either PS-2 expression,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the anti- NH2-terminal PS-2 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(E,"

Phrase: "G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "or for endogenous calreticulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205227:Endogenous [Functional Concept]
   770   C1413096:CALRETICULIN [Gene or Genome]

Phrase: "(F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "J"

Phrase: ")."
Processing 00000000.tx.200: Please note complete colocalization of PS staining with calreticulin in pPS-2+Myc- and pPS-2(166aa)+Myc- expressing cells but not with pPS-2(138aa)+Myc-transfected cells. 

Phrase: "Please"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "complete colocalization of PS staining"

Phrase: "with calreticulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054543:calreticulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413096:CALRETICULIN [Gene or Genome]

Phrase: "in pPS-2+Myc-"

Phrase: "and"

Phrase: "pPS-2"

Phrase: "(166aa"

Phrase: ")"

Phrase: "+Myc- expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not with pPS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1518422:Not [Functional Concept]

Phrase: "(138aa"

Phrase: ")"

Phrase: "+Myc-transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.201: Bar, 10m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "10m."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]
Processing 00000000.tx.202: [View Larger Version of this Image (114K GIF file)] PS-2 Expression in HeLa Cells Causes Abnormal Nuclear Morphology An obvious consequence of increased synthesis of PS-2 in transfected HeLa cells was the development of abnormal nuclear morphologies. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(114K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] PS-2 Expression in HeLa Cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Abnormal Nuclear Morphology"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1849376:Abnormal nuclear morphology [Finding]
   901   C1749565:nuclear morphology [Cell Function]
   827   C0332437:Morphology [Qualitative Concept]
   827   C0543482:morphology [Spatial Concept]
   827   C0700329:Morphology, NOS [Finding]
   827   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "An obvious consequence of increased synthesis of PS-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "in transfected HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0018873:HeLa Cells [Cell]
           HeLa
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "the development of abnormal nuclear morphologies."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0000768:Abnormal development [Congenital Abnormality]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]
Processing 00000000.tx.203: An examination of PS-2 staining, DNA staining, and the phase contrast images of cells expressing full-length PS-2+myc and the three PS-2 deletion mutants 24h after transfection, clearly revealed that PS-2 expression results in abnormal changes in nuclear shape (Fig. 4, A-F, and data not shown). 

Phrase: "An examination of PS-2 staining,"

Phrase: "DNA staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "the phase contrast images of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1704254:Image [Intellectual Product]
   719   C1704922:Image [Entity]
   719   C3542466:Image [Intellectual Product]

Phrase: "expressing"

Phrase: "full-length PS-2+myc"

Phrase: "and"

Phrase: "the three PS-2 deletion mutants 24h after transfection,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0456696:/24h [Temporal Concept]
   742   C1442770:24H [Temporal Concept]

Phrase: "clearly"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that PS-2 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "results in abnormal changes"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   819   C0459424:Abnormal result [Finding]
   770   C0205161:Abnormal [Qualitative Concept]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2347472:% Abnormal [Quantitative Concept]
   770   C2699333:ABNORMAL [Intellectual Product]
   770   C2825142:Result [Finding]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in nuclear shape"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332479:Shape [Spatial Concept]
   861   C0348078:shape [Qualitative Concept]
   861   C0522512:Shape [Spatial Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A-F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.204: For example, in Fig. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.205: 4 A, the two positively stained PS-2-transfected cells have condensed and shrunken nuclei compared to the untransfected cells in the same field. 

Phrase: "4 A,"

Phrase: "the two positively stained PS-2-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "condensed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1155631:Condensed [Cell Function]

Phrase: "and"

Phrase: "shrunken nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007610:Nucleus [Cell Component]

Phrase: "compared to the untransfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in the same field."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   861   C1521738:Field [Conceptual Entity]
   861   C2346620:Field [Conceptual Entity]
   861   C2349184:Field [Conceptual Entity]
   861   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.206: Interestingly, the change in nuclear morphology appeared to correlate with the amount of PS-2 protein expressed as revealed by differences in the staining intensity. 

Phrase: "Interestingly,"

Phrase: "the change in nuclear morphology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0025320:The change [Physiologic Function]
   762   C1260954:Morphologic change [Anatomical Abnormality]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate with the amount of PS-2 protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1265611:Amount [Quantitative Concept]
   744   C1418867:Ps [Gene or Genome]
   744   C1518860:PS [Geographic Area]
   744   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "expressed"

Phrase: "as"

Phrase: "revealed by differences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0443289:Revealed [Qualitative Concept]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in the staining intensity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.207: These features were consistently seen in PS-2-overexpressing cells but not in mock-transfected controls and HeLa cells transfected with lamin or potassium channel cDNAs (Fig. 4, G-I). 

Phrase: "These features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1521970:Feature [Qualitative Concept]
   966   C1706388:Feature [Conceptual Entity]
   966   C2346469:Feature [Qualitative Concept]
   966   C2348519:Feature [Qualitative Concept]

Phrase: "were"

Phrase: "consistently"

Phrase: "seen in PS-2-overexpressing cells"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007634:Cells [Cell]
   753   C0205397:Seen [Qualitative Concept]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   753   C3282337:Cells [Cell]
   719 E C0042789:see [Organism Function]
   719 E C1269647:Cell [Cell]
   719   C1514559:overexpress [Genetic Function]
   719 E C1704653:Cell [Medical Device]
   719 E C1947903:See [Activity]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not in mock-transfected controls"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0562577:mock [Finding]
   760   C1518422:Not [Functional Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with lamin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0064635:Lamin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "potassium channel cDNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0032824:Potassium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "G-I)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0086706:G I [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.208: The overt changes in nuclear morphology were therefore not simply due to the overexpression of a protein targeted to the nuclear envelope, as in the case of lamins, or a transmembrane protein since the Kv1.4 channel has almost the same number of transmembrane domains and has a general topology to that of the presenilins (see Fig. 1). 

Phrase: "The overt changes in nuclear morphology"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C0025320:The change [Physiologic Function]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   731   C1260954:Morphologic change [Anatomical Abnormality]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "therefore"

Phrase: "not simply due to the overexpression of a protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0678226:Due to [Functional Concept]
           due
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1518422:Not [Functional Concept]
   742   C3146286:Due [Idea or Concept]

Phrase: "targeted to the nuclear envelope,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0028584:Nuclear Envelope [Cell Component]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1521840:Targeted [Functional Concept]
   760   C1622204:envelope [Cell Component]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "as in the case of lamins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0064635:Lamins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0868928:Case [Functional Concept]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]

Phrase: "or"

Phrase: "a transmembrane protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1167322:transmembrane [Cell Component]
   861   C2752508:transmembrane [Cell Component]

Phrase: "since"

Phrase: "the Kv1.4 channel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
   734   C1416547:Kv1.4 [Gene or Genome]

Phrase: "has"

Phrase: "almost"

Phrase: "the same number of transmembrane domains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "has"

Phrase: "a general topology to that of the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002812:Topology [Biomedical Occupation or Discipline]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.209: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.210: 4. 

Phrase: "4."
Processing 00000000.tx.211: Overexpression of PS-2 proteins in HeLa cells leads to overt changes in nuclear morphology. 

Phrase: "Overexpression of PS-2 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "in HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "leads to overt changes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in nuclear morphology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1749565:nuclear morphology [Cell Function]
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.212: HeLa cells were transfected with pPS-2+Myc (A-C), pPS-2(268aa)+Myc (D-F), or pKv1.4+Myc (G-I). 

Phrase: "HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected"

Phrase: "with pPS-2+Myc (A-C), pPS-2"

Phrase: "(268aa"

Phrase: ")"

Phrase: "+Myc ("

Phrase: "D-"

Phrase: "F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "or"

Phrase: "pKv1.4+Myc (G-I)."
Processing 00000000.tx.213: (A, D, and G) Anti-myc staining of cells 24h after transfection. 

Phrase: "(A,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "G) Anti-myc staining of cells 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "after transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.214: The center panels are the corresponding DNA images of the cells revealed by DAPI staining, and the right panels are the phase contrast images of the same cells. 

Phrase: "The center panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "are"

Phrase: "the corresponding DNA images of the cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "revealed by DAPI staining,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0443289:Revealed [Qualitative Concept]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "the right panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "are"

Phrase: "the phase contrast images of the same cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1704254:Image [Intellectual Product]
   711   C1704922:Image [Entity]
   711   C3542466:Image [Intellectual Product]
Processing 00000000.tx.215: Please note that the majority of cells expressing high levels of PS-2 have dismorphic nuclei. 

Phrase: "Please"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the majority of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "expressing"

Phrase: "high levels of PS-2"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0456948:Level 2 [Intellectual Product]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "dismorphic nuclei."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.216: In some of these cells, the nuclei are highly condensed with rounded-up and shrunken cytoplasms (arrowheads). 

Phrase: "In some"

Phrase: "of these cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "the nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "condensed with rounded-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332490:Rounded [Spatial Concept]
   790   C1155631:Condensed [Cell Function]

Phrase: "up"

Phrase: "and"

Phrase: "shrunken cytoplasms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0010834:Cytoplasms [Cell Component]
   777 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "(arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.217: [View Larger Version of this Image (100K GIF file)] The rate at which nuclear changes became apparent was construct dependent, with pPS-2+Myc, pPS-2(268aa)+ Myc, and pPS-2(222aa)+Myc all causing more rapid changes than pPS-2(166aa)+Myc-transfected cells. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(100K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "]"

Phrase: "The rate at which nuclear changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "became"

Phrase: "apparent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750489:apparent [Idea or Concept]

Phrase: "was"

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "dependent,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "with pPS-2+Myc,"

Phrase: "pPS-2"

Phrase: "(268aa"

Phrase: ")"

Phrase: "+ Myc,"

Phrase: "and"

Phrase: "pPS-2"

Phrase: "(222aa"

Phrase: ")"

Phrase: "+Myc"

Phrase: "all"

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "more rapid changes than pPS-2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "(166aa"

Phrase: ")"

Phrase: "+Myc-transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.218: This time-dependent change in nuclear morphology correlated with an increase in floating dead cells in the medium. 

Phrase: "This time-dependent change in nuclear morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]
   738   C1260954:Morphologic change [Anatomical Abnormality]

Phrase: "correlated with an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1707520:Correlated [Qualitative Concept]

Phrase: "in floating dead cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in the medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]
Processing 00000000.tx.219: Quantification of the rate of cell death induced by the different PS-2 constructs 20and 44h after transfection revealed that pPS-2+Myc, pPS-2(268aa)+Myc, and pPS-2(222aa)+Myc kill cells at similar rates (Fig. 5 A). 

Phrase: "Quantification of the rate of cell death"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709793:Quantification [Quantitative Concept]

Phrase: "induced by the different PS-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205263:Induced [Functional Concept]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   753   C1705242:Different [Qualitative Concept]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "20and 44h after transfection"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that pPS-2+Myc,"

Phrase: "pPS-2"

Phrase: "(268aa"

Phrase: ")"

Phrase: "+Myc,"

Phrase: "and"

Phrase: "pPS-2"

Phrase: "(222aa"

Phrase: ")"

Phrase: "+Myc kill cells at similar rates"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0599733:cells kill [Cell Function]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5 A"

Phrase: ")."
Processing 00000000.tx.220: In contrast, in cells transfected with PS-2(166aa)+Myc this rate was reduced ~70% 20h after transfection, but by 44h it had accelerated and approached that of the other constructs (Fig. 5 A). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418867:Ps [Gene or Genome]
   770   C1518860:PS [Geographic Area]
   770   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(166aa"

Phrase: ")"

Phrase: "+Myc"

Phrase: "this rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "~70% 20h after transfection,"

Phrase: "but by 44h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0233535:but [Mental or Behavioral Dysfunction]

Phrase: "it"

Phrase: "had"

Phrase: "accelerated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:Accelerated [Functional Concept]

Phrase: "and"

Phrase: "approached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0449445:Approach [Spatial Concept]

Phrase: "that of the"

Phrase: "other constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "(Fig. 5 A"

Phrase: ")."
Processing 00000000.tx.221: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.222: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.223: Quantitation of cell survival upon transfection of PS-2 constructs. 

Phrase: "Quantitation of cell survival"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "upon transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of PS-2 constructs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C2827421:Construct [Classification]
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.224: (A) HeLa cells were transfected with 20g equivalents of pPS-2+Myc, pPS-2(268aa)+Myc, pPS-2(222aa)+Myc, or pPS-2(166aa)+Myc DNAs or were mock transfected, and the number of floating cells that accumulated in the media were counted 20and 44h after transfection. 

Phrase: "(A) HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0018873:HeLa Cells [Cell]
           HeLa
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 20g equivalents of pPS-2+Myc,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0439185:Equivalents [Quantitative Concept]
   711 E C0205163:Equivalent [Qualitative Concept]

Phrase: "pPS-2"

Phrase: "(268aa"

Phrase: ")"

Phrase: "+Myc,"

Phrase: "pPS-2"

Phrase: "(222aa"

Phrase: ")"

Phrase: "+Myc,"

Phrase: "or"

Phrase: "pPS-2"

Phrase: "(166aa"

Phrase: ")"

Phrase: "+Myc DNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "were"

Phrase: "mock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: "transfected"

Phrase: ","

Phrase: "and"

Phrase: "the number of floating cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "accumulated in the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "20and 44h after transfection."
Processing 00000000.tx.225: The line graph shows the number of floating cells (dead cells) in four separate experiments relative to that seen in control mock-transfected cells. 

Phrase: "The line graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681493:Graph [Intellectual Product]
   861   C2698021:Graph [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the number of floating cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(dead cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "in four separate experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "relative to that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "seen in control mock-transfected cells."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   753   C0007634:Cells [Cell]
   753   C0205397:Seen [Qualitative Concept]
   753   C0243148:control [Qualitative Concept]
   753   C0562577:mock [Finding]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C0042789:see [Organism Function]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1947903:See [Activity]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.226: The average error for four experiments was ~10-15% and is not included for clarity of presentation. 

Phrase: "The average error for four experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0743559:error [Qualitative Concept]
   753   C1608199:Error [Functional Concept]

Phrase: "was ~"

Phrase: "10-15%"

Phrase: "and"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "included for clarity of presentation."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0332257:included [Functional Concept]
   760   C0449450:Presentation [Idea or Concept]
   760   C0486588:Clarity [Clinical Attribute]
   760   C3272888:Clarity [Laboratory Procedure]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]
Processing 00000000.tx.227: Note, cells transfected with pPS-2(166aa)+Myc DNA displayed delayed cell death at 20h. 

Phrase: "Note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with pPS-2"

Phrase: "(166aa"

Phrase: ")"

Phrase: "+Myc DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "delayed cell death at 20h."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.228: (B) HeLa cells were transfected with either pGFP, pGFP-PS-2, or pGFP-PS-2(N141I), and fluorescent images of the same coverslip areas were captured and counted 17,41,and 65h after transfection. 

Phrase: "(B) HeLa cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0004561:B-Cells [Cell]
   901   C0018873:HeLa Cells [Cell]
           HeLa
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with either pGFP,"

Phrase: "pGFP-PS-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "pGFP-PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(N141I"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "fluorescent images of the same coverslip areas"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured"

Phrase: "and"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "17,"

Phrase: "41,"

Phrase: "and"

Phrase: "65h after transfection."
Processing 00000000.tx.229: The number of fluorescent cells seen at 41and 65h were normalized to the numbers seen at 17h as a means of measuring the effects of expression of the GFP constructs on cell viability. 

Phrase: "The number of fluorescent cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "seen at 41and 65h"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "were"

Phrase: "normalized to the numbers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]
   770   C1882115:Normalized [Research Activity]

Phrase: "seen at 17h"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "as a means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "of measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the effects of expression of the GFP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "constructs on cell viability."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0007620:Cell Viability [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0443348:viability [Qualitative Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C2827421:Construct [Classification]
Processing 00000000.tx.230: The histograms show the average percentage of cell viability in six independent transfections with the GFP-PS-2 and GFP-PS-2(Ans141Ile) constructs, and the corresponding average for three transfections with the GFP construct. 

Phrase: "The histograms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348974:Histogram [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the average percentage of cell viability"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "in six independent transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "with the GFP-PS-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "GFP-PS-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(Ans141Ile"

Phrase: ")"

Phrase: "constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "the corresponding average for three transfections"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1510992:Average [Quantitative Concept]
   753   C2825518:AVERAGE [Quantitative Concept]

Phrase: "with the GFP construct."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]
Processing 00000000.tx.231: (C) HeLa cells were transfected with equivalent amounts plasmid DNA expressing either wild-type PS-2 or PS-2 containing the AD-associated mutation (N141I). 

Phrase: "(C) HeLa cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0018873:HeLa Cells [Cell]
           HeLa
   896   C0229579:C-Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with equivalent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205163:Equivalent [Qualitative Concept]
   790   C0439185:equivalent [Quantitative Concept]

Phrase: "amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "plasmid DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "expressing"

Phrase: "either wild-type PS-2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0441730:Type 2 [Classification]
   840   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1883559:Wild Type [Organism Attribute]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1418867:Ps [Gene or Genome]
   804   C1518860:PS [Geographic Area]
   804   C1547052:*Type [Quantitative Concept]
   804   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the AD-associated mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(N141I"

Phrase: ")."
Processing 00000000.tx.232: The number of dead cells was counted 40h after transfection. 

Phrase: "The number of dead cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "40h after transfection."
Processing 00000000.tx.233: The histogram shows the rates of cell death in three separate experiments using 15g of plasmid DNA relative to the number of dead cells found in the mock-transfected controls. 

Phrase: "The histogram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348974:Histogram [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the rates of cell death"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C0205848:Rates, Death [Quantitative Concept]
   781 E C0026565:Death rate [Quantitative Concept]
   781 E C1108678:death rate [Quantitative Concept]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "in three separate experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "15g of plasmid DNA"

Phrase: "relative to the number of dead cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "found in the mock-transfected controls."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0150312:Found [Quantitative Concept]
   753   C0562577:mock [Finding]
   719 E C0243095:Find [Finding]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.234: [View Larger Versions of these Images (20 + 22 + 41K GIF file)] Abnormal Nuclear Morphology as a Consequence of PS-2 Expression Correlates with Death of HeLa Cells by Apoptosis The striking changes seen in PS-2-transfected cells were reminiscent of the nuclear and morphological changes that occur during programmed cell death, or apoptosis (Wyllie, 1980; Earnshaw, 1995). 

Phrase: "[View Larger Versions of these Images"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0333052:versions [Functional Concept]
   719 E C2607870:Version [Spatial Concept]

Phrase: "(20 + 22 + 41K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0016094:File [Occupational Activity]
   804   C0180853:File [Medical Device]
   804   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Abnormal Nuclear Morphology as a Consequence of PS-2 Expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   782   C1849376:Abnormal nuclear morphology [Finding]
   760   C1749565:nuclear morphology [Cell Function]
   739   C0332437:Morphology [Qualitative Concept]
   739   C0543482:morphology [Spatial Concept]
   739   C0700329:Morphology, NOS [Finding]
   739   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "Correlates with Death of HeLa Cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0018873:HeLa Cells [Cell]
           HeLa
   783   C0007587:cells death [Cell Function]
   753   C0007634:Cells [Cell]
   753   C0011065:Death [Organism Function]
   753   C1306577:Death, NOS [Finding]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "by Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "The striking changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "seen in PS-2-transfected cells"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007634:Cells [Cell]
   753   C0205397:Seen [Qualitative Concept]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   753   C3282337:Cells [Cell]
   719 E C0042789:see [Organism Function]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1947903:See [Activity]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "reminiscent of the nuclear"

Phrase: "and"

Phrase: "morphological changes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   933   C1260954:Morphologic change [Anatomical Abnormality]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   861   C0543482:morphological [Spatial Concept]
   827 E C1705241:Change [Quantitative Concept]
   789 E C0332437:Morphology [Qualitative Concept]
   789 E C0700329:Morphology, NOS [Finding]
   789 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "that"

Phrase: "occur during programmed cell death,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0162638:Programmed Cell Death [Cell Function]
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1709305:Occur [Activity]
   760   C1948049:Cell [Spatial Concept]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "or"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(Wyllie,"

Phrase: "1980"

Phrase: "; Earnshaw,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.235: To investigate if the cells were indeed dying by apoptosis, we used the terminal deoxynucleotide transferase nick end labeling (TUNEL) assay to identify apoptotic cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "if"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "indeed"

Phrase: "dying by apoptosis,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C0184532:dying [Organism Function]
   718 E C0011065:Expired [Organism Function]
   718 E C0231800:Expired [Organ or Tissue Function]
   718 E C1516044:Apoptotic [Qualitative Concept]
   718 E C1704631:Expire [Idea or Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the terminal deoxynucleotide transferase nick end labeling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   919   C0600528:terminal nick end labeling [Molecular Biology Research Technique]
   799   C1167624:Labeling [Mental Process]
   799   C1947902:Labeling [Manufactured Object]
   799   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "(TUNEL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1167624:Labeling [Mental Process]
   812   C1947902:Labeling [Manufactured Object]
   812   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: ")"

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "apoptotic cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.236: HeLa cells transfected with pPS-2 (166aa)+Myc offered an unusual opportunity to determine if the putative dying cells could be TUNEL labeled since they manifested and displayed the morphological features of apoptosis over a prolonged time period and the expressed cells adhered to the coverslips up until 40h after transfection. 

Phrase: "HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with pPS-2"

Phrase: "(166aa"

Phrase: ")"

Phrase: "+Myc"

Phrase: "offered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444648:Offered [Finding]

Phrase: "an unusual opportunity to"

Phrase: "determine"

Phrase: "if"

Phrase: "the putative dying cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "be"

Phrase: "TUNEL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1167624:Labeling [Mental Process]
   812   C1947902:Labeling [Manufactured Object]
   812   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "since"

Phrase: "they"

Phrase: "manifested"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205319:manifested [Functional Concept]
  1000   C1280444:manifested [Qualitative Concept]

Phrase: "and"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "the morphological features of apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "over a prolonged time period"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   901   C0439582:Time period [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   743 E C1632851:Times [Quantitative Concept]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "and"

Phrase: "the expressed cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "adhered to the coverslips"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0231441:Adhered [Finding]

Phrase: "up"

Phrase: "until"

Phrase: "40h after transfection."
Processing 00000000.tx.237: In contrast, we were unable to TUNEL label cells transfected with full-length PS-2 since most of the transfected cells had lifted off of the coverslips by 18-24 h after transfection, probably as a consequence of a faster death rate and the multiple washing steps used in the TUNEL assay. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "we"

Phrase: "were"

Phrase: "unable to TUNEL label cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1299582:Unable [Finding]

Phrase: "transfected with full-length PS-2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0806636:Length 2 [Quantitative Concept]
   753   C0443225:Full [Qualitative Concept]
   753   C1418867:Ps [Gene or Genome]
   753   C1444754:Length [Quantitative Concept]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   753   C1706316:LENGTH [Research Activity]

Phrase: "since"

Phrase: "most of the transfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0205393:Most [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "lifted off of the coverslips"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0206244:Lifted [Activity]
   726 E C0181620:Lift [Medical Device]

Phrase: "by 18-24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "after transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "probably as a consequence of a faster death rate"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0026565:Death rate [Quantitative Concept]
   764   C0205848:Death Rate [Quantitative Concept]
   764   C0686907:Consequence of [Functional Concept]
           Consequence
   764   C1108678:death rate [Quantitative Concept]
   742   C0011065:Death [Organism Function]
   742   C0750492:Probably [Idea or Concept]
   742   C0871208:Rate [Activity]
   742   C1306577:Death, NOS [Finding]
   742   C1521828:Rate [Quantitative Concept]
   708   C0015663:Fast [Finding]
   708   C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "the multiple washing steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1261552:steps [Conceptual Entity]
   793 E C1704379:Step [Functional Concept]
   793 E C1705117:Step [Quantitative Concept]
   793 E C2825408:Step [Manufactured Object]

Phrase: "used in the TUNEL assay."
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   744   C0005507:Assay [Laboratory Procedure]
   744   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0243073:assay [Qualitative Concept]
   744   C0444930:End [Spatial Concept]
   744   C1167624:Labeling [Mental Process]
   744   C1273517:used [Finding]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1947902:Labeling [Manufactured Object]
   744   C2746065:End [Temporal Concept]
   744   C2827499:Labeling [Governmental or Regulatory Activity]
   739   C0012881:Terminal Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1333243:TERMINAL TRANSFERASE [Gene or Genome]
   711 E C0042153:use [Functional Concept]
   711 E C0181496:Label [Manufactured Object]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.238: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.239: 6, A-D, shows a typical example of PS-2(166aa)+ Myc-transfected cells in which TUNEL-positive labeling (Fig. 6 B) correlated with PS-2 expression (Fig. 6 A). 

Phrase: "6,"

Phrase: "A-D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a typical example of PS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707959:Example [Conceptual Entity]

Phrase: "(166aa"

Phrase: ")"

Phrase: "+ Myc-transfected cells in which TUNEL-positive labeling"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   754   C0439178:% positive cells [Quantitative Concept]
   738   C0007634:Cells [Cell]
   738   C3282337:Cells [Cell]
   737   C1656978:cell end [Cell Component]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6 B)"

Phrase: "correlated with PS-2 expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]
   760   C1707520:Correlated [Qualitative Concept]

Phrase: "(Fig. 6 A"

Phrase: ")."
Processing 00000000.tx.240: Interestingly, only the highly condensed nuclei of the rounded-up shrunken cells that appear about to detach from the coverslip (seen by the phase contrast image; Fig. 6 D, arrowheads) were prominently labeled. 

Phrase: "Interestingly,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the highly condensed nuclei of the rounded-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0007610:Nucleus [Cell Component]

Phrase: "up shrunken cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "about to"

Phrase: "detach from the coverslip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0687118:detach [Functional Concept]

Phrase: "("

Phrase: "seen by the phase contrast image"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0444701:Phase contrast [Laboratory Procedure]
   753   C0205390:Phase [Temporal Concept]
   753   C0205397:Seen [Qualitative Concept]
   753   C1704254:Image [Intellectual Product]
   753   C1704922:Image [Entity]
   753   C1979874:Contrast [Qualitative Concept]
   753   C3542466:Image [Intellectual Product]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "; Fig. 6 D,"

Phrase: "arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")"

Phrase: "were"

Phrase: "prominently"

Phrase: "labeled."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.241: Even the PS-2-positive cell with the multiple compacted DNA aggregates, seen by DAPI staining (Fig. 6 C), was not TUNEL labeled, suggesting that it is an earlier stage of apoptosis during which few free DNA 3 ends have been generated or are accessible for labeling. 

Phrase: "Even"

Phrase: "the PS-2-positive cell with the multiple compacted DNA aggregates,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0439178:positive cell [Quantitative Concept]
   754   C0007634:THE CELL [Cell]
           Cell
   738   C1269647:Cell [Cell]
   738   C1704653:Cell [Medical Device]
   738   C1948049:Cell [Spatial Concept]

Phrase: "seen by DAPI staining"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0205397:Seen [Qualitative Concept]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "(Fig. 6 C),"

Phrase: "was"

Phrase: "not TUNEL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1167624:Labeling [Mental Process]
   804   C1947902:Labeling [Manufactured Object]
   804   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "labeled,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "an earlier stage of apoptosis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1517886:Early Stage [Classification]
   790   C2363430:Early stage [Temporal Concept]
   760   C0205390:Stage [Temporal Concept]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]

Phrase: "during which"

Phrase: "few free DNA 3 ends"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   812   C0444930:ends [Spatial Concept]
   779 E C2746065:End [Temporal Concept]
   741 E C0205088:Terminal [Temporal Concept]
   741 E C1705314:Terminal [Manufactured Object]
   741 E C1705315:Terminal [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "or"

Phrase: "are"

Phrase: "accessible for labeling."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0814423:accessibility [Qualitative Concept]
Processing 00000000.tx.242: In addition to DNA cleavage, another feature of cells undergoing apoptosis is the collapse of the nuclear envelope and cleavage of lamin proteins (Kaufmann, 1989; Ucker et al., 1992; Oberhammer et al., 1994; Lazebnik et al., 1995; Rao et al., 1996). 

Phrase: "In addition to DNA cleavage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1721094:DNA Cleavage [Molecular Function]
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "another feature of cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C1562749:Cell feature [Organism Attribute]
   770   C1521970:Feature [Qualitative Concept]
   770   C1706388:Feature [Conceptual Entity]
   770   C2346469:Feature [Qualitative Concept]
   770   C2348519:Feature [Qualitative Concept]

Phrase: "undergoing"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "the collapse of the nuclear envelope"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0036974:collapse [Pathologic Function]
   753   C0332521:Collapse [Phenomenon or Process]
   753   C0344329:Collapse [Finding]
   753   C1880118:COLLAPSE [Phenomenon or Process]

Phrase: "and"

Phrase: "cleavage of lamin proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   909   C1159830:cleavage of lamin [Cell Function]
   802   C0597304:Protein Cleavage [Molecular Function]
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "(Kaufmann,"

Phrase: "1989"

Phrase: "; Ucker et al.,"

Phrase: "1992"

Phrase: "; Oberhammer et al.,"

Phrase: "1994"

Phrase: "; Lazebnik et al.,"

Phrase: "1995"

Phrase: "; Rao et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.243: We therefore examined the integrity of the nuclear lamina in pPS-2 (166aa+Myc- transfected cells using an antibody specific for lamins A/C (Fig. 6, E-H). 

Phrase: "We therefore"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the integrity of the nuclear lamina"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205266:integrity [Qualitative Concept]
   753   C0872403:integrity [Individual Behavior]
   753   C1947912:Integrity [Qualitative Concept]

Phrase: "in pPS-2"

Phrase: "(166aa+Myc- transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody specific for lamins A/C (Fig. 6,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   745   C2599300:Lamin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0205369:Specific [Qualitative Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "E-H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.244: In PS-2-expressing cells, the nuclear lamina had indeed collapsed but was round and apparently normal in PS-2-negative cells. 

Phrase: "In PS-2-expressing cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "the nuclear lamina"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1136039:Nuclear Lamina [Cell Component]
   861   C0521447:Nuclear [Spatial Concept]
   861   C0920995:Lamina [Body Part, Organ, or Organ Component]
   861   C2330124:Lamina [Body Part, Organ, or Organ Component]
   861   C2700402:Lamina [Plant]
   789 E C0205274:Laminar [Spatial Concept]

Phrase: "had"

Phrase: "indeed"

Phrase: "collapsed"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0344329:collapsed [Finding]
  1000   C0392748:Collapsed [Functional Concept]
   966 E C0036974:collapse [Pathologic Function]
   966 E C0332521:Collapse [Phenomenon or Process]
   966 E C1880118:COLLAPSE [Phenomenon or Process]

Phrase: "but"

Phrase: "was"

Phrase: "round"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332490:Round [Spatial Concept]

Phrase: "and"

Phrase: "apparently normal in PS-2-negative cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0007634:Normal cell [Cell]
   757   C1268443:Normal cell [Cell]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.245: In some PS-expressing cells, the nuclear lamina was diffuse, suggesting cleavage of the nuclear lamins during apoptosis. 

Phrase: "In some PS-expressing cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "the nuclear lamina"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1136039:Nuclear Lamina [Cell Component]
   861   C0521447:Nuclear [Spatial Concept]
   861   C0920995:Lamina [Body Part, Organ, or Organ Component]
   861   C2330124:Lamina [Body Part, Organ, or Organ Component]
   861   C2700402:Lamina [Plant]
   789 E C0205274:Laminar [Spatial Concept]

Phrase: "was"

Phrase: "diffuse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "cleavage of the nuclear lamins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1159830:cleavage of lamin [Cell Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "during apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.246: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.247: 6. 

Phrase: "6."
Processing 00000000.tx.248: Correlation of apoptotic events in HeLa cells expressing PS-2. 

Phrase: "Correlation of apoptotic events"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "in HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "PS-2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]
Processing 00000000.tx.249: HeLa cells were transfected with the pPS-2(166aa)+Myc construct and were examined for apoptotic or morphological changes 48h after transfection. 

Phrase: "HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with the pPS-2"

Phrase: "(166aa"

Phrase: ")"

Phrase: "+Myc construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "were"

Phrase: "examined for apoptotic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332128:Examined [Finding]
   790   C1516044:Apoptotic [Qualitative Concept]
   718 E C0162638:Apoptosis [Cell Function]

Phrase: "or"

Phrase: "morphological changes 48h after transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1442464:48H [Temporal Concept]
Processing 00000000.tx.250: The rows of panels are the same cells stained for PS-2 protein (A and E), TUNEL labeling (B), or lamin staining (F); 

Phrase: "The rows of panels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1552840:rows [Idea or Concept]
   737 E C1552846:Row [Idea or Concept]

Phrase: "are"

Phrase: "the same cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "stained for PS-2 protein (A"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "E"

Phrase: ")"

Phrase: ","

Phrase: "TUNEL labeling"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "lamin staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "(F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.251: DAPI staining of DNA (C and D) and phase contrast images (D and H). 

Phrase: "DAPI staining of DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "(C"

Phrase: "and"

Phrase: "D)"

Phrase: "and"

Phrase: "phase contrast images"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]
   734   C0444701:Phase contrast [Laboratory Procedure]

Phrase: "(D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.252: Cells that labeled positive for TUNEL appeared rounded-up and shrunken by phase contrast microscopy (arrowheads). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that labeled positive for TUNEL appeared rounded-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0439178:% Positive [Quantitative Concept]
   739   C1446409:Positive [Qualitative Concept]
   739   C1514241:Positive [Finding]
   739   C2825490:Positive [Qualitative Concept]

Phrase: "up"

Phrase: "and"

Phrase: "shrunken by phase contrast microscopy"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0026024:Microscopy, Phase-Contrast [Laboratory Procedure]
   806   C0444701:Phase contrast [Laboratory Procedure]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0332513:Shrunken [Functional Concept]
   760   C1979874:Contrast [Qualitative Concept]
   726 E C0205230:shrink [Spatial Concept]

Phrase: "(arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.253: [View Larger Version of this Image (57K GIF file)] Direct Demonstration that Overexpression of PS-2 Causes Cell Death Using GFP as a Reporter To directly watch temporally the pathway of apoptosis, we generated GFP fusion proteins in which PS-2 was fused in frame to the COOH terminus of the GFP. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(57K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "]"

Phrase: "Direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "Demonstration"

Phrase: "that Overexpression of PS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "Causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Cell Death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GFP as a Reporter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "To directly watch temporally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   727   C0699864:Watchfulness [Mental Process]

Phrase: "the pathway of apoptosis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0162638:Apoptosis Pathway [Cell Function]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "GFP fusion proteins in which PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332466:Fusion [Functional Concept]
   748   C1293131:Fusion [Therapeutic or Preventive Procedure]
   745   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "was"

Phrase: "fused"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0699952:Fused [Functional Concept]
   966 E C1414861:FUSE [Gene or Genome]
   966 E C1708111:Fuse [Manufactured Object]

Phrase: "in frame to the COOH terminus of the GFP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0080089:Frame [Nucleotide Sequence]
   742   C0180979:Frame [Medical Device]
   742   C1705858:Frame [Manufactured Object]
Processing 00000000.tx.254: Two different constructs were studied. 

Phrase: "Two different constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.255: The first was pGFP-PS-2, in which wild-type PS-2 was linked to GFP. 

Phrase: "The first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "was"

Phrase: "pGFP-PS-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "in which wild-type PS-2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   875   C0441730:Type 2 [Classification]
   861   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1883559:Wild Type [Organism Attribute]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1418867:Ps [Gene or Genome]
   812   C1518860:PS [Geographic Area]
   812   C1547052:*Type [Quantitative Concept]
   812   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "linked to GFP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]
Processing 00000000.tx.256: The second was pGFP- PS-2(N141I), containing the AD-associated PS-2 mutation at codon 141,converting asparagine to isoleucine (Levy-Lahad et al., 1995a; Rogaev et al., 1995). 

Phrase: "The second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "was"

Phrase: "pGFP- PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(N141I"

Phrase: ")"

Phrase: ","

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the AD-associated PS-2 mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0026882:Mutation [Genetic Function]
   795   C1705285:Mutation [Cell or Molecular Dysfunction]
   713   C1863051:ALZHEIMER DISEASE 2 [Disease or Syndrome]

Phrase: "at codon 141,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "converting"

Phrase: "asparagine to isoleucine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "(Levy-Lahad et al.,"

Phrase: "1995a"

Phrase: "; Rogaev et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.257: Immunoblot analysis of transfected HeLa cell lysates indicated both GFP- PS-2 fusion proteins to migrate on SDS-PAGE as ~80-kD polypeptides (Fig. 2 E), consistent with fusion of 27kD of GFP sequences with 50-55 kD of PS-2. 

Phrase: "Immunoblot analysis of transfected HeLa cell lysates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "both GFP- PS-2 fusion proteins to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332466:Fusion [Functional Concept]
   799   C1293131:Fusion [Therapeutic or Preventive Procedure]
   793   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "migrate on SDS-PAGE as ~80-kD polypeptides"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   744   C0026691:KD [Disease or Syndrome]
   744   C0232902:migrate [Functional Concept]
   744   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]
   744   C1704732:Page [Intellectual Product]
   744   C1705240:KD [Gene or Genome]
   744   C1839259:KD [Disease or Syndrome]

Phrase: "(Fig. 2 E"

Phrase: ")"

Phrase: ","

Phrase: "consistent with fusion of 27kD of GFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "sequences with 50-55 kD of PS-2."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0026691:KD [Disease or Syndrome]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0450382:55 [Intellectual Product]
   744   C1418867:Ps [Gene or Genome]
   744   C1518860:PS [Geographic Area]
   744   C1519249:Sequence [Functional Concept]
   744   C1552158:Ps [Body Part, Organ, or Organ Component]
   744   C1705240:KD [Gene or Genome]
   744   C1839259:KD [Disease or Syndrome]
Processing 00000000.tx.258: There was no evidence for any proteolytic cleavage of the fusion proteins. 

Phrase: "There"

Phrase: "was"

Phrase: "no evidence for any proteolytic cleavage of the fusion proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.259: Furthermore, both GFP-PS-2 fusion proteins displayed classical ER and nuclear envelope localization when examined by direct fluorescence microscopy (Fig. 7, A and B), indicating that fusion of GFP with PS-2 did not noticeably alter the normal ER localization pattern of PS-2. 

Phrase: "Furthermore,"

Phrase: "both GFP-PS-2 fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "classical ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "nuclear envelope localization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]
   734   C0028584:Nuclear Envelope [Cell Component]

Phrase: "when"

Phrase: "examined by direct fluorescence microscopy"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   797   C0600070:Direct microscopy [Laboratory Procedure]
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0332128:Examined [Finding]
   760   C0439851:Direct [Qualitative Concept]
   760   C1947931:Direct [Qualitative Concept]

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that fusion of GFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332466:Fusion [Functional Concept]
   770   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "with PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "did"

Phrase: "not noticeably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the normal ER localization pattern of PS-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.260: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.261: 7. 

Phrase: "7."
Processing 00000000.tx.262: Fluorescent studies of PS-2 expression in HeLa cells using GFP as a reporter. 

Phrase: "Fluorescent studies of PS-2 expression"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "in HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GFP as a reporter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.263: (A) Fluorescent and phase contrast images of living HeLa cells transfected with pGFP-PS-2, showing the GFP- PS-2 fusion protein is localized to the ER. 

Phrase: "(A) Fluorescent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "phase contrast images of living HeLa cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "transfected with pGFP-PS-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the GFP- PS-2 fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "localized to the ER."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0392752:Localized [Spatial Concept]
Processing 00000000.tx.264: A presumably untransfected cell is indicated by the arrowhead. 

Phrase: "A presumably untransfected cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "indicated by the arrowhead."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0453107:Arrowhead [Food]
   770   C1080898:Arrowhead [Plant]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.265: (B) HeLa cells were transfected with either GFP alone (top row), GFP fused with wild-type PS-2 (second row), or GFP fused with the AD PS-2(N141I) mutant (bottom row). 

Phrase: "(B) HeLa cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0004561:B-Cells [Cell]
   901   C0018873:HeLa Cells [Cell]
           HeLa
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with either GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(top row"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552846:Row [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "fused with wild-type PS-2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1883559:Wild Type [Organism Attribute]
   783   C0441730:Type 2 [Classification]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C0699952:Fused [Functional Concept]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1547052:*Type [Quantitative Concept]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   719 E C1414861:FUSE [Gene or Genome]
   719 E C1708111:Fuse [Manufactured Object]

Phrase: "(second row"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552846:Row [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "fused with the AD PS-2"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   789   C1863051:ALZHEIMER DISEASE 2 [Disease or Syndrome]
   770   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0002395:Alzheimer's Disease [Disease or Syndrome]
   767   C1521724:Alzheimer's Disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0699952:Fused [Functional Concept]
   744   C1418867:Ps [Gene or Genome]
   744   C1518860:PS [Geographic Area]
   744   C1552158:Ps [Body Part, Organ, or Organ Component]
   739   C1425076:MALS-2 [Gene or Genome]
   711 E C1414861:FUSE [Gene or Genome]
   711 E C1708111:Fuse [Manufactured Object]

Phrase: "(N141I"

Phrase: ")"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(bottom row"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552846:Row [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.266: The fluorescent images of cells expressing GFP proteins on the same area of the gridded coverslip were captured 17and 65h after transfection. 

Phrase: "The fluorescent images of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "expressing"

Phrase: "GFP proteins on the same area of the gridded coverslip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "captured"

Phrase: "17and 65h after transfection."
Processing 00000000.tx.267: Please note, the number of fluorescing cells 65h after transfection increases in cells expressing GFP alone, whereas cells expressing the two GFP-PS-2 fusion constructs show a dramatic decrease in fluorescence. 

Phrase: "Please"

Phrase: "note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the number of fluorescing cells 65h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "increases in cells"
Meta Candidates (Total=13; Excluded=10; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0442805:Increase [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "expressing"

Phrase: "GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "whereas"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the two GFP-PS-2 fusion constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C2827421:Construct [Classification]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a dramatic decrease in fluorescence."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.268: [View Larger Version of this Image (93K GIF file)] HeLa cells grown on gridded coverslips were transfected with the GFP vector lacking any insert or with the GFP- PS-2 fusion constructs, and the effects on cell viability were studied over time. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(93K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "grown on gridded coverslips"

Phrase: "were"

Phrase: "transfected with the GFP vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "any insert"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441587:Insert [Health Care Activity]
  1000   C1743766:Insert [Medical Device]
  1000   C1883719:Insert [Functional Concept]

Phrase: "or with the GFP- PS-2 fusion constructs,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   744   C0332466:Fusion [Functional Concept]
   744   C1293131:Fusion [Therapeutic or Preventive Procedure]
   744   C1418867:Ps [Gene or Genome]
   744   C1518860:PS [Geographic Area]
   744   C1552158:Ps [Body Part, Organ, or Organ Component]
   711   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "the effects on cell viability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "studied over time."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   841   C0040227:Time Study [Intellectual Product]
   841   C2349982:Study Time [Temporal Concept]
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.269: Images of cells on different coverslip areas were recorded 17h after transfection, and the same areas (identified by grid markings on the coverslips) were reexamined 41and 65h after transfection (examples of such fields are shown in Fig. 7 B). 

Phrase: "Images of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1704254:Image [Intellectual Product]
   756   C1704922:Image [Entity]
   756   C3542466:Image [Intellectual Product]

Phrase: "on different coverslip areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0205146:areas [Spatial Concept]
   793 E C0017446:Area [Geographic Area]

Phrase: "were"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "17h after transfection,"

Phrase: "and"

Phrase: "the same areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "("

Phrase: "identified by grid markings"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205396:Identified [Qualitative Concept]
   770   C0522501:markings [Qualitative Concept]
   770   C1415284:GRID [Gene or Genome]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C2348395:Grid [Medical Device]
   770   C2825313:Grid [Manufactured Object]

Phrase: "on the coverslips"

Phrase: ")"

Phrase: "were"

Phrase: "reexamined"

Phrase: "41and 65h after transfection"

Phrase: "(examples of such fields"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707959:Example [Conceptual Entity]

Phrase: "are"

Phrase: "shown in Fig. 7 B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0349966:Fig [Food]
   760   C1337208:FIG [Food]
   726   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.270: The number of fluorescing cells seen 41and 65h after transfection were normalized to the cell counts at 17h. 

Phrase: "The number of fluorescing cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "41and 65h after transfection"

Phrase: "were"

Phrase: "normalized to the cell counts"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0007584:Counts, Cell [Laboratory Procedure]
   760   C0007634:Cell [Cell]
   760   C0439157:counts [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1882115:Normalized [Research Activity]
   760   C1948049:Cell [Spatial Concept]
   726 E C0750480:Count [Activity]
   726 E C1705566:Count [Quantitative Concept]

Phrase: "at 17h."
Processing 00000000.tx.271: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.272: 5 B, the number of cells expressing GFP increased ~155% after 41 h and to 158% at 65h. 

Phrase: "5 B,"

Phrase: "the number of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "expressing"

Phrase: "GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "~155% after 41 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and to 158%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "at 65h."
Processing 00000000.tx.273: The initial increase at 41h probably resulted from either cell division of the transfected cells (the HeLa cell cycle is ~23 h; Monteiro and Mical, 1996) and/or an increase in GFP expression in cells previously scored as nonexpressors. 

Phrase: "The initial increase at 41h probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "resulted from either cell division of the transfected cells"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0007590:Cell division [Cell Function]
           cells division
   742   C0007634:Cell [Cell]
           Cells
   742   C1269647:Cell [Cell]
   742   C1293097:Division [Therapeutic or Preventive Procedure]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2919030:Division [Organization]
   742   C2919031:Division [Activity]
   742   C3282337:Cells [Cell]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "("

Phrase: "the HeLa cell cycle is ~23 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0033727:H+ [Element, Ion, or Isotope]
   799   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0441932:H+ [Classification]
   799   C0564385:/h [Quantitative Concept]

Phrase: "; Monteiro"

Phrase: "and"

Phrase: "Mical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537694:MICAL [Gene or Genome]

Phrase: "1996"

Phrase: ")"

Phrase: "and/or"

Phrase: "an increase in GFP expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "in cells previously"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "scored as nonexpressors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0449820:scored [Quantitative Concept]
Processing 00000000.tx.274: The smaller increase at 65h is probably due to loss of transient GFP expression during prolonged growth. 

Phrase: "The smaller increase at 65h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "probably due to loss of transient GFP expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0040704:Transient [Population Group]
   744   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205374:Transient [Temporal Concept]
   744   C0750492:Probably [Idea or Concept]
   744   C1517945:Loss [Quantitative Concept]
   744   C3146286:Due [Idea or Concept]

Phrase: "during prolonged growth."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
Processing 00000000.tx.275: In sharp contrast, cell viability dramatically decreased in cells expressing GFP-PS-2 fusion proteins. 

Phrase: "In sharp contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]

Phrase: "cell viability dramatically"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0007620:Cell Viability [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0443348:viability [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "decreased in cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0007634:Cells [Cell]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C3282337:Cells [Cell]
   756 E C0547047:Decrease [Quantitative Concept]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "GFP-PS-2 fusion proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.276: 41h after transfection, cell viability decreased to ~76% in cells expressing wild-type PS-2 fusion proteins and decreased further to 33% by 65h. 

Phrase: "41h after transfection,"

Phrase: "cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "to ~76% in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1883351:To [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild-type PS-2 fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332466:Fusion [Functional Concept]
   799   C1293131:Fusion [Therapeutic or Preventive Procedure]
   793   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "further to 33%"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1517331:Further [Spatial Concept]
   756 E C0205108:far [Spatial Concept]

Phrase: "by 65h."
Processing 00000000.tx.277: A similar dramatic decrease in cell viability was seen in cells expressing the PS-2(N141I) mutation with viability decreasing to 74% at 41h and 38% after 65h. 

Phrase: "A similar dramatic decrease in cell viability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007620:Cell Viability [Cell Function]
   799   C0443348:viability [Qualitative Concept]

Phrase: "was"

Phrase: "seen in cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0205397:Seen [Qualitative Concept]
   790   C3282337:Cells [Cell]
   756 E C0042789:see [Organism Function]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1947903:See [Activity]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(N141I"

Phrase: ")"

Phrase: "mutation with viability decreasing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to 74%"

Phrase: "at 41h"

Phrase: "and"

Phrase: "38% after 65h."
Processing 00000000.tx.278: In both cases, decrease in cell viability correlated with the appearance of numerous rounded-up shrunken cells at the later time points, consistent with cell death by apoptosis. 

Phrase: "In both cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "decrease in cell viability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007620:Cell Viability [Cell Function]
   812   C0443348:viability [Qualitative Concept]

Phrase: "correlated with the appearance of numerous rounded-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0233426:Appearance [Organism Attribute]
   748   C0332490:Rounded [Spatial Concept]
   748   C0439064:Numerous [Quantitative Concept]
   748   C0700364:Appearance [Qualitative Concept]
   748   C1707520:Correlated [Qualitative Concept]

Phrase: "up shrunken cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "at the later time points,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "consistent with cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "by apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.279: However, a careful comparison of cell viability in six sets of independent experiments and analysis of greater than 2,000cells indicated no significant difference in the rate of cell survival between wild-type and mutant PS-2 GFP fusion proteins in HeLa cells (Fig. 5 B). 

Phrase: "However,"

Phrase: "a careful comparison of cell viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "in six"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "sets of independent experiments"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   819   C0332291:Independent of [Functional Concept]
   770   C0036849:Set [Mental Process]
   770   C0085862:Independent [Idea or Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1299583:Independent [Finding]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "analysis of greater"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "than 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "000cells"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "no significant difference in the rate of cell survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1705241:*Difference [Quantitative Concept]
   742   C1705242:Difference [Qualitative Concept]

Phrase: "between wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant PS-2 GFP fusion proteins in HeLa cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   745   C0007594:Cell Fusion [Laboratory Procedure]
   745   C1261468:Cell fusion [Cell Function]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332466:Fusion [Functional Concept]
   742   C1293131:Fusion [Therapeutic or Preventive Procedure]
   731   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(Fig. 5 B"

Phrase: ")."
Processing 00000000.tx.280: The time-dependent loss of GFP fluorescence could have resulted from the loss of transient expression or the loss of cells from the coverslips due to death. 

Phrase: "The time-dependent loss of GFP fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]

Phrase: "could"

Phrase: "have"

Phrase: "resulted from the loss of transient expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0040704:Transient [Population Group]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205374:Transient [Temporal Concept]
   748   C1517945:Loss [Quantitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "or"

Phrase: "the loss of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "from the coverslips"

Phrase: "due to death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]
Processing 00000000.tx.281: To test these and other possibilities, we followed individual GFP-expressing cells over a period of time. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "these"

Phrase: "and"

Phrase: "other possibilities,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   916   C0332149:Possible [Qualitative Concept]
   916   C1705910:Possible [Qualitative Concept]
   916   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "individual GFP-expressing cells over a period of time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.282: A typical example of this analysis is shown in Fig. 

Phrase: "A typical example of this analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707959:Example [Conceptual Entity]

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.283: 8, where at least three of a group of cells attached on the No. 

Phrase: "8,"

Phrase: "where at least three of a group of cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   762   C0441835:Group A [Classification]
   742   C0007634:Cells [Cell]
   742   C0205449:Three [Quantitative Concept]
   742   C0441833:Group [Idea or Concept]
   742   C0687744:group [Population Group]
   742   C1257890:Group [Population Group]
   742   C1552516:Group [Health Care Related Organization]
   742   C1705428:Group [Conceptual Entity]
   742   C1705429:Group [Population Group]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "attached on the"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0231441:Attached [Finding]
   756 E C1314972:ATTACH [Intellectual Product]

Phrase: "No."
Processing 00000000.tx.284: 2grid mark of the coverslip are clearly seen to express the GFP-PS-2 fusion protein by fluorescence at 22h. 

Phrase: "2grid mark of the coverslip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522501:mark [Qualitative Concept]

Phrase: "are"

Phrase: "clearly"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "the GFP-PS-2 fusion protein by fluorescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332466:Fusion [Functional Concept]
   744   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "at 22h."
Processing 00000000.tx.285: After 50h, these same cells, which had retained some residual fluorescence, had rounded-up and had shrunken cytoplasms typical of dying cells. 

Phrase: "After 50h,"

Phrase: "these same cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "had"

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "some residual fluorescence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "had"

Phrase: "rounded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332490:Rounded [Spatial Concept]

Phrase: "-"

Phrase: "up"

Phrase: "and"

Phrase: "had"

Phrase: "shrunken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332513:Shrunken [Functional Concept]
   966 E C0205230:shrink [Spatial Concept]

Phrase: "cytoplasms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasms [Cell Component]
   916 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "typical of dying cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538928:Typical [Qualitative Concept]
Processing 00000000.tx.286: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.287: 8. 

Phrase: "8."
Processing 00000000.tx.288: Direct demonstration that PS-2 overexpression in HeLa cells causes cell death. 

Phrase: "Direct demonstration"

Phrase: "that PS-2 overexpression in HeLa cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.289: HeLa cells were transfected with a GFP-PS-2 fusion construct, and images of an individual group of transfected cells on the No. 

Phrase: "HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with a GFP-PS-2 fusion construct,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   744   C0332466:Fusion [Functional Concept]
   744   C1293131:Fusion [Therapeutic or Preventive Procedure]
   744   C1418867:Ps [Gene or Genome]
   744   C1518860:PS [Geographic Area]
   744   C1552158:Ps [Body Part, Organ, or Organ Component]
   744   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "images of an individual group of transfected cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1704254:Image [Intellectual Product]
   711   C1704922:Image [Entity]
   711   C3542466:Image [Intellectual Product]

Phrase: "on the"

Phrase: "No."
Processing 00000000.tx.290: 2region of the gridded coverslip were recorded at various times after transfection. 

Phrase: "2region of the gridded coverslip"

Phrase: "were"

Phrase: "recorded at various times"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0040223:times [Temporal Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1632851:Times [Quantitative Concept]
   737   C0034869:Record [Intellectual Product]
   737 E C3541383:Time [Temporal Concept]

Phrase: "after transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.291: The GFP fluorescent (left) and phase contrast images (right) of the same coverslip region 22and 50h after transfection are shown. 

Phrase: "The GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "fluorescent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "phase contrast images"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]
   734   C0444701:Phase contrast [Laboratory Procedure]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "of the same coverslip region 22and 50h"

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.292: By following this group of cells it was possible to conclude that the same three cells expressing the GFP fusion protein at 22h had rounded-up and died by 50h. 

Phrase: "By"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "this group of cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "it"

Phrase: "was"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the same three cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the GFP fusion protein at 22h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332466:Fusion [Functional Concept]
   753   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "had"

Phrase: "rounded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332490:Rounded [Spatial Concept]

Phrase: "-"

Phrase: "up"

Phrase: "and"

Phrase: "died by 50h."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0011065:Died [Organism Function]
   790   C1546956:Died [Finding]
   718 E C0231800:Expired [Organ or Tissue Function]
   718 E C1704631:Expire [Idea or Concept]
Processing 00000000.tx.293: [View Larger Version of this Image (94K GIF file)] A Comparison of Nonfusion PS-2 Proteins Indicates the AD-associated (Asn141Ile) Mutation Increases Cell Death The lack of a noticeable difference in the rate of cell survival between wild-type PS-2 and the AD-associated mutation when studied as GFP fusion proteins could have resulted from the GFP moiety masking or interfering with PS-2 properties. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(94K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "]"

Phrase: "A Comparison of Nonfusion PS-2 Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707455:Comparison [Activity]

Phrase: "Indicates"

Phrase: "the AD-associated"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0332281:Associated [Qualitative Concept]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]
   708   C0002395:Alzheimer's Disease [Disease or Syndrome]
   708   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "(Asn141Ile"

Phrase: ")"

Phrase: "Mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "Increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Cell Death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "The lack of a noticeable difference"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "in the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "between wild-type PS-2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   875   C0441730:Type 2 [Classification]
   861   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1883559:Wild Type [Organism Attribute]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1418867:Ps [Gene or Genome]
   812   C1518860:PS [Geographic Area]
   812   C1547052:*Type [Quantitative Concept]
   812   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the AD-associated mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "when"

Phrase: "studied as GFP fusion proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   773   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0332466:Fusion [Functional Concept]
   760   C1293131:Fusion [Therapeutic or Preventive Procedure]
   726   C0557651:Study [Manufactured Object]
   726   C2603343:Study [Research Activity]

Phrase: "could"

Phrase: "have"

Phrase: "resulted from the GFP moiety masking"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   753   C0150112:masking [Functional Concept]
   719 E C0024861:Mask [Medical Device]
   719   C1274040:Result [Functional Concept]
   719 E C1538279:MASK [Gene or Genome]
   719   C1546471:Result [Idea or Concept]
   719 E C1845191:MASK [Gene or Genome]
   719   C2825142:Result [Finding]

Phrase: "or"

Phrase: "interfering with PS-2 properties."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0521102:interfering [Qualitative Concept]
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]
Processing 00000000.tx.294: Therefore, wild-type and the AD PS-2 mutant were expressed and studied as nonfusion proteins in HeLa cells by transient transfection of equivalent amounts of DNA. 

Phrase: "Therefore,"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "the AD PS-2 mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0596988:Mutant [Cell or Molecular Dysfunction]
   712   C1863051:ALZHEIMER DISEASE 2 [Disease or Syndrome]

Phrase: "were"

Phrase: "expressed"

Phrase: "and"

Phrase: "studied as nonfusion proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]

Phrase: "in HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "by transient transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of equivalent amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "of DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.295: Measurement of dead floating cells 40h after transfection indicated the mutant kills cells 1.84-fold faster than does wild-type PS-2 (Fig. 5 C). 

Phrase: "Measurement of dead floating cells 40h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0242485:Measurement [Functional Concept]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "the mutant kills cells 1.84-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332462:Fold [Spatial Concept]
   799   C1880834:FOLD [Phenomenon or Process]

Phrase: "faster than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0015663:Fast [Finding]
   799   C0456962:Fast [Qualitative Concept]

Phrase: "does"

Phrase: "wild-type PS-2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   875   C0441730:Type 2 [Classification]
   861   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1883559:Wild Type [Organism Attribute]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1418867:Ps [Gene or Genome]
   812   C1518860:PS [Geographic Area]
   812   C1547052:*Type [Quantitative Concept]
   812   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 5 C)."
Processing 00000000.tx.296: Since the cells were dying at different rates it was difficult to normalize transfection efficiencies using unlinked reporters. 

Phrase: "Since"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "dying at different rates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0184532:dying [Organism Function]

Phrase: "it"

Phrase: "was"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "transfection efficiencies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:efficiencies [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   777 E C0442799:Efficient [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "unlinked reporters."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0335038:reporters [Professional or Occupational Group]
   827 E C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   827 E C1705915:Reporter [Conceptual Entity]
   827 E C1709908:Reporter [Group]
Processing 00000000.tx.297: However, the mutant may be considerably more toxic than was estimated by our experiments if less mutant DNA was transfected since immunoblotting of equivalent protein lysates, prepared from parallel sets of transfections 20h after transfection, indicated the mutant to be expressed ~25% that of wild-type protein levels (Fig. 1 F). 

Phrase: "However,"

Phrase: "the mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "be"

Phrase: "considerably more toxic than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600688:toxic [Injury or Poisoning]
   770   C1407029:Toxic [Qualitative Concept]

Phrase: "was"

Phrase: "estimated by our experiments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C0750572:Estimated [Quantitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "if"

Phrase: "less mutant DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "transfected"

Phrase: "since immunoblotting of equivalent protein lysates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "prepared from parallel sets of transfections 20h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0036849:Set [Mental Process]
   748   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]
   748   C2348042:Parallel [Qualitative Concept]
   748   C2826345:PARALLEL [Research Activity]
   714   C1521827:Prepare [Functional Concept]

Phrase: "after transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "the mutant to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "be"

Phrase: "expressed ~25%"

Phrase: "that of wild-type protein levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C1883559:Wild Type [Organism Attribute]
   756   C0428479:Protein level [Laboratory or Test Result]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332307:Type [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 1 F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.298: Discussion The evidence presented here demonstrates that forced expression of PS-2 in HeLa cells, by itself, is sufficient to induce apoptosis and that the AD-associated mutation N141I induces an increase in cell death. 

Phrase: "Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "The evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "demonstrates"

Phrase: "that forced expression of PS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in HeLa cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "by itself,"

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the AD-associated mutation N141I"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "an increase in cell death."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007587:Cell Death [Cell Function]
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]
Processing 00000000.tx.299: Initially, it was thought that PS-2 may inhibit apoptosis because a COOH-terminal fragment of mouse PS-2, termed ALG-3, rescued T cells from receptor-induced programmed cell death (Vito et al., 1996a). 

Phrase: "Initially,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "that PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "because"

Phrase: "a COOH-terminal fragment of mouse PS-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "termed ALG-3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0003372:ALG [Immunologic Factor,Pharmacologic Substance]
   793   C1515273:Term [Temporal Concept]
   793   C1705313:Term [Idea or Concept]
   793   C2826302:TERM [Intellectual Product]

Phrase: "rescued T cells from receptor-"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0034790:T-Cell Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   806   C0039194:T-Cells [Cell]
   781   C1514760:Receptor Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "programmed cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:Programmed Cell Death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(Vito et al.,"

Phrase: "1996a"

Phrase: ")."
Processing 00000000.tx.300: More recently, the cause of this rescue has been shown to be an artifactual consequence of expressing a PS-2 fragment such that it acts in a dominant negative fashion (Vito et al., 1996b). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "the cause of this rescue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015127:cause [Functional Concept]
   760   C1524003:Cause [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an artifactual consequence of expressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "a PS-2 fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "such"

Phrase: "that"

Phrase: "it"

Phrase: "acts in a dominant negative fashion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0205160:Negative [Qualitative Concept]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "(Vito et al.,"

Phrase: "1996b"

Phrase: ")."
Processing 00000000.tx.301: Further evidence supporting the participation of PS-2 in apoptosis was obtained upon expression of either wild-type or mutant PS-2(N141I) in PC12 cells that had been triggered by external stimuli to undergo apoptosis (Deng et al., 1996; Wolozin et al., 1996). 

Phrase: "Further evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the participation of PS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679823:Participation [Functional Concept]

Phrase: "in apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "obtained upon expression of either wild-type"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1301820:Obtained [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   714 E C1706701:Obtain [Activity]

Phrase: "or"

Phrase: "mutant PS-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0596988:Mutant [Cell or Molecular Dysfunction]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(N141I"

Phrase: ")"

Phrase: "in PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "triggered by external stimuli to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1444748:Triggered by [Qualitative Concept]
           Trigger
   760   C0205101:External [Spatial Concept]
   760   C0234402:Stimuli [Phenomenon or Process]
   726   C0032930:Trigger [Clinical Attribute]

Phrase: "undergo"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(Deng et al.,"

Phrase: "1996"

Phrase: "; Wolozin et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.302: PS-2 expression accelerated death in these cells, with the PS-2(N141I) mutant increasing apoptosis but only in cells grown under certain culture conditions (Wolozin et al., 1996). 

Phrase: "PS-2 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "accelerated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:Accelerated [Functional Concept]

Phrase: "death in these cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0007587:cells death [Cell Function]
   770   C0011065:Death [Organism Function]
   770   C1306577:Death, NOS [Finding]

Phrase: "with the PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(N141I"

Phrase: ")"

Phrase: "mutant increasing apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "but"

Phrase: "only in cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "grown under certain culture conditions"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C2242979:Culture [Laboratory Procedure]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "(Wolozin et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.303: The PC12 studies offered only weak evidence for the apoptotic property of PS-2 since the cells had been primed to undergo apoptosis by external agents. 

Phrase: "The PC12 studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "offered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444648:Offered [Finding]

Phrase: "only weak evidence for the apoptotic property of PS-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "since"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "been"

Phrase: "primed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:primed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undergo"

Phrase: "apoptosis by external agents."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.304: Moreover, PC12 cells are balanced at a suicidal decision and are particularly susceptible to induction of apoptosis by a wide variety of stimuli. 

Phrase: "Moreover,"

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "balanced at a suicidal decision"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205415:Balanced [Functional Concept]
   760   C0438696:Suicidal [Finding]
   760   C0679006:Decision [Mental Process]
   726 E C0014653:Balance [Organism Function]
   726 E C0560184:Balance [Finding]

Phrase: "and"

Phrase: "are"

Phrase: "particularly susceptible to induction of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231204:Susceptible [Functional Concept]
   753   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "by a wide variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883525:Variety [Conceptual Entity]
   861   C2346866:Variety [Conceptual Entity]

Phrase: "of stimuli."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234402:Stimuli [Phenomenon or Process]
Processing 00000000.tx.305: Our results showing apoptotic induction in HeLa cells provide strong and independent evidence for the PS-2 apoptotic property since HeLa cells are typically highly resistant to apoptosis. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "apoptotic induction in HeLa cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C3266896:Apoptosis Induction [Cell Function]
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "strong"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442821:Strong [Qualitative Concept]
   928 E C0237897:Strength [Quantitative Concept]
   928 E C0808080:Strength [Idea or Concept]
   928 E C1705922:Strength [Qualitative Concept]

Phrase: "and"

Phrase: "independent evidence for the PS-2 apoptotic property"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332120:Evidence [Functional Concept]

Phrase: "since"

Phrase: "HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "typically highly resistant to apoptosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.306: The mechanisms by which PS-2 overexpression leads to cell death by apoptosis are not revealed by our studies. 

Phrase: "The mechanisms by which PS-2 overexpression"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "leads to cell death"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0007587:Cell Death [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0011065:Death [Organism Function]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C1269647:Cell [Cell]
   770   C1306577:Death, NOS [Finding]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "by apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "revealed by our studies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0443289:Revealed [Qualitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.307: Although the presenilins are ubiquitously expressed, PS-2 is expressed at considerably lower levels than PS-1 (Rogaev et al., 1995; Sherrington et al., 1995; Li et al., 1995; Lee et al., 1996). 

Phrase: "Although"

Phrase: "the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "ubiquitously"

Phrase: "expressed"

Phrase: ","

Phrase: "PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "expressed at considerably lower levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0441889:Levels [Qualitative Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "than PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(Rogaev et al.,"

Phrase: "1995"

Phrase: "; Sherrington et al.,"

Phrase: "1995"

Phrase: "; Li et al.,"

Phrase: "1995"

Phrase: "; Lee et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.308: Perhaps in normal cells, expression of one or both of the presenilins is modulated by other factors that regulate the commitment to the cell death pathway. 

Phrase: "Perhaps in normal cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   799   C0007634:Normal cell [Cell]
           Cells
   799   C1268443:Normal cell [Cell]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expression of one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "both of the presenilins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0238767:Both [Spatial Concept]
   770   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]
   770   C1706086:Both [Qualitative Concept]

Phrase: "is"

Phrase: "modulated by other factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443264:Modulated [Spatial Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "regulate"

Phrase: "the commitment to the cell death pathway."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0870312:commitment [Mental Process]
Processing 00000000.tx.309: Presumably, in the transient transfections increases in expression of PS-2 leads to the perturbation of this regulation in favor of the apoptotic pathway. 

Phrase: "Presumably,"

Phrase: "in the transient transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "increases in expression of PS-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0442805:Increase [Functional Concept]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "leads to the perturbation of this regulation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0181586:leads [Medical Device]
   748   C0332453:perturbation [Functional Concept]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in favor of the apoptotic pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C0162638:Apoptosis Pathway [Cell Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.310: Although PS-1 is highly homologous to PS-2, no increased apoptosis has been documented in cell lines and transgenic mice overexpressing PS-1 (Duff et al., 1996; Kovacs et al., 1996; Thinakaran et al., 1996). 

Phrase: "Although"

Phrase: "PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "highly homologous to PS-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1334043:Homologous [Gene or Genome]

Phrase: "no increased apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "in cell lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0007600:Cell lines [Cell]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(Duff et al.,"

Phrase: "1996"

Phrase: "; Kovacs et al.,"

Phrase: "1996"

Phrase: "; Thinakaran et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.311: While the simplest explanation is that PS-1 may function differently from PS-2, another possibility is that transgenic lines overexpressing PS-1 may induce compensatory changes in the expression of antiapoptotic genes. 

Phrase: "While"

Phrase: "the simplest explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "differently from PS-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418867:Ps [Gene or Genome]
   770   C1518860:PS [Geographic Area]
   770   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that transgenic lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0003069:Transgenic [Animal]
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "compensatory changes in the expression of antiapoptotic genes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.312: Another likely possibility is that proteolytic cleavage of PS proteins alter their properties significantly. 

Phrase: "Another likely possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that proteolytic cleavage of PS proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "their properties significantly."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]
Processing 00000000.tx.313: Most prior reports have shown overexpression of PS proteins in cell lines and transgenic mice to yield primarily proteolytic products. 

Phrase: "Most prior reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0684224:Reports [Intellectual Product]
   827   C0700287:reports [Health Care Activity]
   793 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "overexpression of PS proteins in cell lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "and"

Phrase: "transgenic mice to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "yield"

Phrase: "primarily proteolytic products."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.314: However, in our experiments we failed to observe significant cleavage (<5-10%) of the expressed PS-2 proteins, including those containing full-length PS-2 sequences. 

Phrase: "However,"

Phrase: "in our experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "observe"

Phrase: "significant cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "("

Phrase: "<5-10%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "of the expressed PS-2 proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those containing full-length PS-2 sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   799   C0162326:Sequences [Nucleotide Sequence]
   766 E C0004793:Sequence [Nucleotide Sequence]
   766 E C0162327:Sequence [Nucleotide Sequence]
   766 E C1519249:Sequence [Functional Concept]
   716 E C1548958:Sequential [Idea or Concept]
   716 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.315: Based on these observations, we propose that proteolytic cleavage of the presenilins diminishes the apoptotic effects of the full-length proteins. 

Phrase: "Based on these observations,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0302523:observations [Research Activity]
   770   C0700325:observations [Health Care Activity]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3244290:observations [Functional Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C1964257:Observation [Diagnostic Procedure]

Phrase: "we"

Phrase: "propose"

Phrase: "that proteolytic cleavage of the presenilins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "diminishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminish [Quantitative Concept]

Phrase: "the apoptotic effects of the full-length proteins."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.316: That PS truncations are less toxic than full-length proteins is supported by higher levels of truncated proteins that accumulated with increasing length of COOH-terminal truncations (see Fig. 2, C and D). 

Phrase: "That PS truncations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706395:Truncation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "less toxic than full-length proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0815048:toxic proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0600688:toxic [Injury or Poisoning]
   753   C1407029:Toxic [Qualitative Concept]

Phrase: "is"

Phrase: "supported by higher levels of truncated proteins"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C1521721:Supported [Conceptual Entity]
   741   C0428479:Protein level [Laboratory or Test Result]
   714 E C0183683:Support [Medical Device]
   714   C0205250:High [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714   C1299351:High [Qualitative Concept]
   714 E C1547707:Level [Geographic Area]
   714   C2700149:HIGH [Intellectual Product]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "accumulated with increasing length of COOH-terminal truncations"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0205088:Terminal [Temporal Concept]
   744   C0442808:Increasing [Functional Concept]
   744   C1444754:Length [Quantitative Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C1706316:LENGTH [Research Activity]
   711   C1706395:Truncation [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.317: The AD-associated PS-2 mutation converting arginine to isoleucine at codon 141caused an increase in apoptosis in cells overexpressing the mutant protein. 

Phrase: "The AD-associated PS-2 mutation converting arginine to isoleucine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   788   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "at codon 141caused"

Phrase: "an increase in apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "the mutant protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.318: Despite accumulating to lower protein levels than the wild-type protein, the mutant is more toxic. 

Phrase: "Despite accumulating to"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "protein levels than the wild-type protein,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0441889:Levels [Qualitative Concept]
   745   C0428479:Protein level [Laboratory or Test Result]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "the mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "more toxic."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0600688:toxic [Injury or Poisoning]
   861   C1407029:Toxic [Qualitative Concept]
Processing 00000000.tx.319: The deletion studies presented here have indicated that retention of NH2-terminal PS-2 sequences are necessary for apoptosis. 

Phrase: "The deletion studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "have"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that retention of NH2-terminal PS-2 sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0035280:Retention [Mental Process]
   744   C0333117:Retention [Functional Concept]
   744   C1753315:retention [Cell Function]

Phrase: "are"

Phrase: "necessary for apoptosis."
Processing 00000000.tx.320: Not surprisingly, fusion of GFP to the NH2 terminus of PS-2 masks these differences. 

Phrase: "Not surprisingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "fusion of GFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332466:Fusion [Functional Concept]
   790   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "to the NH2 terminus"

Phrase: "of PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "masks"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024861:Mask [Medical Device]
  1000   C1538279:MASK [Gene or Genome]
  1000   C1845191:MASK [Gene or Genome]

Phrase: "these differences."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.321: Clearly, if the differential killing effect of full-length wild-type and mutant PS-2 is relevant to disease, then it must manifest in neurons that are at risk in AD. 

Phrase: "Clearly,"

Phrase: "if"

Phrase: "the differential"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443199:Differential [Qualitative Concept]
  1000   C1705242:Differential [Qualitative Concept]

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "effect of full-length wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "mutant PS-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0596988:Mutant [Cell or Molecular Dysfunction]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "relevant to disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347946:Relevant [Qualitative Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "it"

Phrase: "must"

Phrase: "manifest in neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C0205319:Manifest [Functional Concept]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "that"

Phrase: "are"

Phrase: "at risk in AD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1444641:At risk [Qualitative Concept]
   783   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]
   753   C1516077:At [Spatial Concept]
Processing 00000000.tx.322: Suggestive evidence that apoptosis may be involved in AD is supported by increased accumulation of the death-promoting protein, Bax, as well as increased evidence for nuclear DNA fragmentation, in AD cases but not in controls (Su et al., 1997). 

Phrase: "Suggestive evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "involved in AD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C0002395:Alzheimer's Disease [Disease or Syndrome]
   797   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C1314939:Involved [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "supported by increased accumulation of the death-promoting protein,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0011065:Death [Organism Function]
   742   C0033414:Promoting [Activity]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205217:Increased [Quantitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C1306577:Death, NOS [Finding]
   742   C1521721:Supported [Conceptual Entity]
   708 E C0183683:Support [Medical Device]

Phrase: "Bax,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "as well as"

Phrase: "increased evidence for nuclear DNA fragmentation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "in AD cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]
   708   C0002395:Alzheimer's Disease [Disease or Syndrome]
   708   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "but"

Phrase: "not in controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1518422:Not [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(Su et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.323: Additionally, recent reports suggest that AD mutations in APP may also induce apoptosis when expressed in neuronal cells and that death is mediated by heterotrimeric guanosine triphosphate-binding proteins (G proteins; Yamatsuji et al., 1996). 

Phrase: "Additionally,"

Phrase: "recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that AD mutations in APP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C0596611:gene mutations [Genetic Function]
   739   C0026882:Mutations [Genetic Function]
   706 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "also"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "when"

Phrase: "expressed in neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "is"

Phrase: "mediated by heterotrimeric guanosine triphosphate-binding proteins"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0018353:Guanosine Triphosphate [Nucleic Acid, Nucleoside, or Nucleotide]
   778   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0033618:Protein Binding [Molecular Function]
   748   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0146894:triphosphate [Inorganic Chemical]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "(G proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "; Yamatsuji et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.324: Interestingly, FAD patients with mutations in presenilin genes and transgenic mice expressing mutant human PS genes have elevated levels of A42-43 peptides (Duff et al., 1996; Scheuner et al., 1996; Borchelt et al., 1996; Tomita et al., 1997), which have been documented to induce apoptosis (LaFerla et al., 1995). 

Phrase: "Interestingly,"

Phrase: "FAD patients with mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "in presenilin genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "mutant human PS genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   886   C0678941:mutant gene [Gene or Genome]
   858   C0314604:Human gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "elevated levels of A42-43 peptides"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Duff et al.,"

Phrase: "1996"

Phrase: "; Scheuner et al.,"

Phrase: "1996"

Phrase: "; Borchelt et al.,"

Phrase: "1996"

Phrase: "; Tomita et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "have"

Phrase: "been"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(LaFerla et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.325: The obvious implications of all of this is that missense mutations in presenilins produce subtle effects that increase apoptosis over the course of the neuronal life span. 

Phrase: "The obvious implications of all of this"

Phrase: "is"

Phrase: "that missense mutations in presenilins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0599155:Mutations, Missense [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "produce"

Phrase: "subtle effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "apoptosis over the course of the neuronal life span."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   758   C1660771:Apoptosis of neurons [Cell Function]
           neuron apoptosis
   742   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.326: Footnotes Received for publication 28 April 1997 and in revised form 19 August 1997.  

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "Received for publication 28 April 1997"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and in revised form 19 August 1997."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1515981:And [Idea or Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
Processing 00000000.tx.327: Address all correspondence to Mervyn J.

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence to Mervyn J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0282413:Correspondence [Intellectual Product]
Processing 00000000.tx.328: Monteiro, Ph.D., University of Maryland Biotechnology Institute, Room N352, 725West Lombard Street, Baltimore, MD 21201.Tel.: 

Phrase: "Monteiro,"

Phrase: "Ph.D.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1512022:Ph.D. [Intellectual Product]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "University of Maryland Biotechnology Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0021622:institute [Organization]
   804   C1272753:Institute [Idea or Concept]

Phrase: "Room N352,"

Phrase: "725West Lombard Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD 21201.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.329: (410) 706-8132.Fax: (410) 706-1732. 

Phrase: "(410"

Phrase: ")"

Phrase: "706-8132.Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085205:Fax [Manufactured Object]
   827   C1549619:FAX [Conceptual Entity]
   827   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "(410"

Phrase: ")"

Phrase: "706-1732."
Processing 00000000.tx.330: We gratefully acknowledge the help of Weihong Zha and Meredith Hopkins in constructing the PS-2 Bluescript and pGFP-PS-2(86aa) constructs, respectively. 

Phrase: "We gratefully"

Phrase: "acknowledge"

Phrase: "the"

Phrase: "help of Weihong Zha"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0018896:Help [Social Behavior]
   770   C1552861:help [Idea or Concept]

Phrase: "and"

Phrase: "Meredith Hopkins in constructing"

Phrase: "the PS-2 Bluescript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "pGFP-PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418867:Ps [Gene or Genome]
   827   C1518860:PS [Geographic Area]
   827   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(86aa"

Phrase: ")"

Phrase: "constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "respectively."
Processing 00000000.tx.331: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.332: Ann Pluta and a benevolent reviewer for The Journal of Cell Biology for insightful comments on the manuscript. 

Phrase: "Ann Pluta"

Phrase: "and"

Phrase: "a benevolent reviewer for The Journal of Cell Biology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1709941:Reviewer [Qualitative Concept]
   742   C1882950:Reviewer [Population Group]

Phrase: "for insightful comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0282411:Comments [Intellectual Product]
   861   C0947611:comments [Intellectual Product]
   861   C1705247:Comments [Conceptual Entity]

Phrase: "on the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.333: This work was supported in part by a grant from the National Institute on Aging to M.J. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by a grant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "from the National Institute on Aging"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1955974:National Institute on Aging [Health Care Related Organization]
   812   C0001811:Ageing [Organism Function]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]
   812   C3245503:national [Intellectual Product]
   779 E C0001779:Age [Organism Attribute]

Phrase: "to"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.334: Monteiro. 

Phrase: "Monteiro."
Processing 00000000.tx.335: Abbreviations used in this paper aa, amino acid(s); 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used in this paper aa,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0030351:Paper [Manufactured Object]
   760   C1235746:Aa [Plant]
   760   C1273517:used [Finding]
   760   C1547566:Paper [Idea or Concept]
   760   C1882141:aa [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "("

Phrase: "s)"

Phrase: ";"
Processing 00000000.tx.336: AD, Alzheimer's disease; 

Phrase: "AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0002395:Alzheimer's Disease [Disease or Syndrome]
   913   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.337: APP, -amyloid precursor protein gene; 

Phrase: "APP, -"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "amyloid precursor protein gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.338: CMV, cytomegalovirus; 

Phrase: "CMV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010825:Cytomegalovirus [Virus]

Phrase: "cytomegalovirus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010825:Cytomegalovirus [Virus]

Phrase: ";"
Processing 00000000.tx.339: DAPI, 46-diamidino-2-phenylindole; 

Phrase: "DAPI,"

Phrase: "46-diamidino-2-phenylindole"

Phrase: ";"
Processing 00000000.tx.340: GST, glutathione-S-transferase; 

Phrase: "GST,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glutathione-S-transferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.341: PS-1 and -2, presenilin 1and 2; 

Phrase: "PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and -"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "presenilin 1and 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1418986:PRESENILIN 2 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.342: TMD, transmembrane domain. 

Phrase: "TMD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538714:TMD [Gene or Genome]

Phrase: "transmembrane domain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C2752508:transmembrane [Cell Component]
   861   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.343: References 1. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.344: Alzheimer's Disease Collaborative Group. 

Phrase: "Alzheimer's Disease Collaborative Group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]
Processing 00000000.tx.345: 1995. 

Phrase: "1995."
Processing 00000000.tx.346: The structure of the presenilin 1(S182) gene and identification of six novel mutations in early onset AD families. 

Phrase: "The structure of the presenilin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "(S182"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418985:S182 [Gene or Genome]
  1000   C2986918:S182 [Gene or Genome]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "identification of six novel mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in early onset AD families."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0344339:disease family [Finding]
   799   C0015576:Families [Family Group]
   799   C1704727:Family [Conceptual Entity]
   734   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   716 E C0241888:Familial [Functional Concept]
   709   C0679245:early disease [Temporal Concept]
Processing 00000000.tx.347: Nat. 

Phrase: "Nat."
Processing 00000000.tx.348: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.349: 11: 219-222 2. 

Phrase: "11"

Phrase: ":"

Phrase: "219-222 2."
Processing 00000000.tx.350: Borchelt, D.R., G. 

Phrase: "Borchelt,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.351: Thinakaran, C.B. 

Phrase: "Thinakaran,"

Phrase: "C.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.352: Eckman, M.K. 

Phrase: "Eckman,"

Phrase: "M."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.353: Lee, F. 

Phrase: "Lee,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.354: Davenport, T. 

Phrase: "Davenport,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.355: Ratovitsky, C.-M. 

Phrase: "Ratovitsky,"

Phrase: "C.-M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.356: Prada, G. 

Phrase: "Prada,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.357: Kim, S. 

Phrase: "Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.358: Seekins, D. 

Phrase: "Seekins,"

Phrase: "D."
Processing 00000000.tx.359: Yager, et al . 1996. 

Phrase: "Yager,"

Phrase: "et al . 1996."
Processing 00000000.tx.360: Familial Alzheimer's disease-linked presenilin 1variants elevate A1-42/1-40 ratio in vitro and in vivo. 

Phrase: "Familial Alzheimer's disease-linked presenilin 1variants"

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "A1-42/1-40 ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.361: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.362: 17: 1005-1013 3. 

Phrase: "17"

Phrase: ":"

Phrase: "1005-1013 3."
Processing 00000000.tx.363: Boteva, K., M. 

Phrase: "Boteva,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.364: Vitek, H. 

Phrase: "Vitek,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553145:Vitek [Laboratory Procedure]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.365: Mitsudade, H. 

Phrase: "Mitsudade,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.366: Silva, P.-T. 

Phrase: "Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   928   C0144237:Silvan [Organic Chemical]
   907 E C0043217:Wood [Substance]
   907 E C0442548:Woods [Geographic Area]

Phrase: "P.-T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.367: Xu, G. 

Phrase: "Xu,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.368: Small, and J.R. 

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "and"

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.369: Gilbert. 

Phrase: "Gilbert."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]
Processing 00000000.tx.370: 1996. 

Phrase: "1996."
Processing 00000000.tx.371: Mutation analysis of presenilin 1gene in Alzheimer's disease. 

Phrase: "Mutation analysis of presenilin 1gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0796357:mutation analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.372: Lancet. 

Phrase: "Lancet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]
Processing 00000000.tx.373: 347: 130-131 4. 

Phrase: "347"

Phrase: ":"

Phrase: "130-131 4."
Processing 00000000.tx.374: Campion, D., J.M. 

Phrase: "Campion,"

Phrase: "D."

Phrase: ","

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.375: Flaman, A. 

Phrase: "Flaman,"

Phrase: "A."
Processing 00000000.tx.376: Brice, D. 

Phrase: "Brice,"

Phrase: "D."
Processing 00000000.tx.377: Hannequin, B. 

Phrase: "Hannequin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.378: Dubois, C. 

Phrase: "Dubois,"

Phrase: "C."
Processing 00000000.tx.379: Martin, V. 

Phrase: "Martin,"

Phrase: "V."
Processing 00000000.tx.380: Moreau, F. 

Phrase: "Moreau,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.381: Charbonnier, O. 

Phrase: "Charbonnier,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.382: Didierjean, S. 

Phrase: "Didierjean,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.383: Tardieu, et al . 1995. 

Phrase: "Tardieu,"

Phrase: "et al . 1995."
Processing 00000000.tx.384: Mutations in the presenilin 1gene in families with early-onset Alzheimer's disease. 

Phrase: "Mutations in the presenilin 1gene"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with early-onset Alzheimer's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.385: Hum. 

Phrase: "Hum."
Processing 00000000.tx.386: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.387: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.388: 4: 2373-2377 [Abstract]. 

Phrase: "4"

Phrase: ":"

Phrase: "2373-2377"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.389: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.390: Chapman, J., A. 

Phrase: "Chapman,"

Phrase: "J.,"

Phrase: "A."
Processing 00000000.tx.391: Asherova, N. 

Phrase: "Asherova,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.392: Wang, T.A. 

Phrase: "Wang,"

Phrase: "T.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0193959:t a [Therapeutic or Preventive Procedure]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.393: Treves, A.D. 

Phrase: "Treves,"

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.394: Korczyn, and L.G. 

Phrase: "Korczyn,"

Phrase: "and"

Phrase: "L.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439294:l g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.395: Goldfarb. 

Phrase: "Goldfarb."
Processing 00000000.tx.396: 1995. 

Phrase: "1995."
Processing 00000000.tx.397: Familial Alzheimer's disease associated with S182 codon 286mutation. 

Phrase: "Familial Alzheimer's disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "associated with S182 codon 286mutation."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0009221:Codon [Nucleotide Sequence]
   760   C1095825:Codon [Plant]
   760   C1418985:S182 [Gene or Genome]
   760   C2986918:S182 [Gene or Genome]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.398: Lancet. 

Phrase: "Lancet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]
Processing 00000000.tx.399: 346: 1040 6. 

Phrase: "346"

Phrase: ":"

Phrase: "1040 6."
Processing 00000000.tx.400: Cook, D.B., J.C. 

Phrase: "Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "D."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "J.C."
Processing 00000000.tx.401: Sung, T.E. 

Phrase: "Sung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0037173:SING [Geographic Area]
   966   C0234857:sing [Individual Behavior]

Phrase: "T.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.402: Golde, K.M. 

Phrase: "Golde,"

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.403: Felsenstein, B.S. 

Phrase: "Felsenstein,"

Phrase: "B.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.404: Wojczyk, R.E. 

Phrase: "Wojczyk,"

Phrase: "R.E."
Processing 00000000.tx.405: Tanzi, J.Q. 

Phrase: "Tanzi,"

Phrase: "J.Q."
Processing 00000000.tx.406: Trojanowski, V.M.Y. 

Phrase: "Trojanowski,"

Phrase: "V.M.Y."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2349138:V/m [Quantitative Concept]
Processing 00000000.tx.407: Lee, and R.M. 

Phrase: "Lee,"

Phrase: "and"

Phrase: "R.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0694746:r m [Immunologic Factor,Pharmacologic Substance]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.408: Doms. 

Phrase: "Doms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3539821:DOM [Gene or Genome]
Processing 00000000.tx.409: 1996. 

Phrase: "1996."
Processing 00000000.tx.410: Expression and analysis of presenilin-1 in a human neuronal system: localization in cell bodies and dendrites. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "analysis of presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in a human neuronal system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: ":"

Phrase: "localization in cell bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0599444:Cell body [Cell Component]
   827   C2752549:cell body [Cell Component]
   812   C0242821:bodies [Human]
   812   C1995017:Bodies [Cell Component]
   779 E C0460148:Body [Anatomical Structure]
   779 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "dendrites."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011305:Dendrites [Cell Component]
Processing 00000000.tx.411: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.412: Natl. 

Phrase: "Natl."
Processing 00000000.tx.413: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.414: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.415: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.416: 93: 9223-9228 [Abstract/Free FullText]. 

Phrase: "93"

Phrase: ":"

Phrase: "9223-9228"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.417: 7. 

Phrase: "7."
Processing 00000000.tx.418: Corder, E.H., A.M. 

Phrase: "Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.419: Saunders, W.J. 

Phrase: "Saunders,"

Phrase: "W.J."
Processing 00000000.tx.420: Strittmatter, D.E. 

Phrase: "Strittmatter,"

Phrase: "D."

Phrase: "E."
Processing 00000000.tx.421: Schmechel, P.C. 

Phrase: "Schmechel,"

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.422: Gaskell, G.W. 

Phrase: "Gaskell,"

Phrase: "G.W."
Processing 00000000.tx.423: Small, A.D. 

Phrase: "Small, A.D."
Processing 00000000.tx.424: Roses, J.L. 

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "J.L."
Processing 00000000.tx.425: Haines, and M.A. 

Phrase: "Haines,"

Phrase: "and"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.426: Pericak-Vance. 

Phrase: "Pericak-Vance."
Processing 00000000.tx.427: 1993. 

Phrase: "1993."
Processing 00000000.tx.428: Gene dose apolipoprotein E type 4allele and the risk of Alzheimer's disease in late onset families. 

Phrase: "Gene dose apolipoprotein E type 4allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   709   C0314611:Gene type [Genetic Function]

Phrase: "and"

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in late onset families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.429: Science (Wash. DC). 

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "(Wash. DC"

Phrase: ")."
Processing 00000000.tx.430: 261: 921-923 8. 

Phrase: "261"

Phrase: ":"

Phrase: "921-923 8."
Processing 00000000.tx.431: Cruts, M., H. 

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.432: Backhovens, S.Y. 

Phrase: "Backhovens,"

Phrase: "S."

Phrase: "Y."
Processing 00000000.tx.433: Wang, G. 

Phrase: "Wang,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.434: Vangassen, J. 

Phrase: "Vangassen,"

Phrase: "J."
Processing 00000000.tx.435: Theurns, C. 

Phrase: "Theurns,"

Phrase: "C."
Processing 00000000.tx.436: Dejonghe, A. 

Phrase: "Dejonghe,"

Phrase: "A."
Processing 00000000.tx.437: Wehnert, J. 

Phrase: "Wehnert,"

Phrase: "J."
Processing 00000000.tx.438: Devoecht, G. 

Phrase: "Devoecht,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.439: deWinter, P. 

Phrase: "deWinter,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.440: Cras, et al . 1995. 

Phrase: "Cras,"

Phrase: "et al . 1995."
Processing 00000000.tx.441: Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14Q24.3. 

Phrase: "Molecular genetic analysis of familial early-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1513380:Molecular Genetic Analysis [Molecular Biology Research Technique]
           Molecular Analysis
   764   C0679560:genetic analysis [Laboratory Procedure]
   764   C0796344:Genetic Analysis [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "linked to chromosome 14Q24.3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1520594:14q24.3 [Cell Component]
   797   C0008666:Chromosome 3 [Cell Component]
   760   C0008633:Chromosome [Cell Component]
   760   C1520591:14q24 [Cell Component]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.442: Hum. 

Phrase: "Hum."
Processing 00000000.tx.443: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.444: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.445: 4: 2363-2371 [Abstract]. 

Phrase: "4"

Phrase: ":"

Phrase: "2363-2371"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.446: 9. 

Phrase: "9."
Processing 00000000.tx.447: Cruts, M., L. 

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.448: Hendriks, and C. 

Phrase: "Hendriks,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.449: Van Broeckhoven. 

Phrase: "Van Broeckhoven."
Processing 00000000.tx.450: 1996. 

Phrase: "1996."
Processing 00000000.tx.451: The presenilin genes: a new gene family involved in Alzheimer's disease pathology. 

Phrase: "The presenilin genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: ":"

Phrase: "a new gene family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1517488:Gene Family [Gene or Genome]
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "involved in Alzheimer's disease pathology."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
   760   C1314939:Involved [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.452: Hum. 

Phrase: "Hum."
Processing 00000000.tx.453: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.454: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.455: 5: 1449-1455 [Abstract]. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "1449-1455"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.456: 10. 

Phrase: "10."
Processing 00000000.tx.457: Deng, G., C.J. 

Phrase: "Deng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549988:DEng [Intellectual Product]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "C.J."
Processing 00000000.tx.458: Pike, and C.W. 

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "and"

Phrase: "C.W."
Processing 00000000.tx.459: Cotman. 

Phrase: "Cotman."
Processing 00000000.tx.460: 1996. 

Phrase: "1996."
Processing 00000000.tx.461: Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cell. 

Phrase: "Alzheimer-associated presenilin-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418986:PRESENILIN 2 [Gene or Genome]
   812   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "confers"

Phrase: "increased sensitivity to apoptosis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1881189:INCREASED SENSITIVITY [Phenomenon or Process]
   833   C2346484:INCREASED SENSITIVITY [Phenomenon or Process]
           SENSITIVITY
   797   C0332324:Sensitive to [Functional Concept]
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "in PC12 cell."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085262:PC12 Cell [Cell]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.462: FEBS Lett. 

Phrase: "FEBS Lett."
Processing 00000000.tx.463: 397: 50-54 11. 

Phrase: "397"

Phrase: ":"

Phrase: "50-54 11."
Processing 00000000.tx.464: Doan, A., G. 

Phrase: "Doan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0591397:Doan's [Organic Chemical,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.465: Thinakaran, D.R. 

Phrase: "Thinakaran,"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.466: Borchelt, H.H. 

Phrase: "Borchelt,"

Phrase: "H.H."
Processing 00000000.tx.467: Slunt, T. 

Phrase: "Slunt,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.468: Rativitsky, M. 

Phrase: "Rativitsky,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.469: Podlisny, D.J. 

Phrase: "Podlisny,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.470: Selkoe, M. 

Phrase: "Selkoe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.471: Seeger, S.E. 

Phrase: "Seeger,"

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.472: Gandy, D.L. 

Phrase: "Gandy,"

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.473: Price, and S.S. 

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "and S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.474: Sisodia. 

Phrase: "Sisodia."
Processing 00000000.tx.475: 1996. 

Phrase: "1996."
Processing 00000000.tx.476: Protein topology of presenilin 1. 

Phrase: "Protein topology of presenilin 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002812:Topology [Biomedical Occupation or Discipline]
Processing 00000000.tx.477: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.478: 17: 1023-1030 12. 

Phrase: "17"

Phrase: ":"

Phrase: "1023-1030 12."
Processing 00000000.tx.479: Duff, K., C. 

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.480: Eckman, C. 

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.481: Zehr, X. 

Phrase: "Zehr,"

Phrase: "X."
Processing 00000000.tx.482: Yu, C.-M. 

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.-M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.483: Prada, J. 

Phrase: "Prada,"

Phrase: "J."
Processing 00000000.tx.484: Perez-tur, M. 

Phrase: "Perez-tur,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: Hutton, L. 

Phrase: "Hutton,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.486: Buee, Y. 

Phrase: "Buee,"

Phrase: "Y."
Processing 00000000.tx.487: Harigaya, D. 

Phrase: "Harigaya,"

Phrase: "D."
Processing 00000000.tx.488: Yager, et al . 1996. 

Phrase: "Yager,"

Phrase: "et al . 1996."
Processing 00000000.tx.489: Increased amyloid-42(43) in brains of mice expressing mutant presenilin 1. 

Phrase: "Increased amyloid-42"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0205217:Increased [Quantitative Concept]
   827   C0442805:Increased [Functional Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(43"

Phrase: ")"

Phrase: "in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "mutant presenilin 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418985:PRESENILIN 1 [Gene or Genome]
   827   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.490: Nature (Lond.). 

Phrase: "Nature"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "(Lond."

Phrase: ")."
Processing 00000000.tx.491: 383: 710-713 13. 

Phrase: "383"

Phrase: ":"

Phrase: "710-713 13."
Processing 00000000.tx.492: Earnshaw, W.C.. 

Phrase: "Earnshaw,"

Phrase: "W.C.."
Processing 00000000.tx.493: 1995. 

Phrase: "1995."
Processing 00000000.tx.494: Nuclear changes in apoptosis. 

Phrase: "Nuclear changes in apoptosis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   858   C1159823:apoptotic nuclear changes [Cell Function]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.495: Curr. 

Phrase: "Curr."
Processing 00000000.tx.496: Opin. 

Phrase: "Opin."
Processing 00000000.tx.497: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.498: 7: 337-343 14. 

Phrase: "7"

Phrase: ":"

Phrase: "337-343 14."
Processing 00000000.tx.499: Graham, R., and A.J. van der Eb. 

Phrase: "Graham, R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "A.J. van der Eb."
Processing 00000000.tx.500: 1973. 

Phrase: "1973."
Processing 00000000.tx.501: A new technique for the assay of infectivity of human adenovirus 5DNA. 

Phrase: "A new technique for the assay of infectivity of human adenovirus 5DNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C1510438:Assay technique [Laboratory Procedure]
   736   C0449851:Technique [Functional Concept]
Processing 00000000.tx.502: Virology. 

Phrase: "Virology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042762:Virology [Biomedical Occupation or Discipline]
  1000   C0205466:virology [Functional Concept]
Processing 00000000.tx.503: 52: 456-467 15. 

Phrase: "52"

Phrase: ":"

Phrase: "456-467 15."
Processing 00000000.tx.504: Haass, C.. 

Phrase: "Haass,"

Phrase: "C.."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.505: 1997. 

Phrase: "1997."
Processing 00000000.tx.506: Presenilins: genes for life and death. 

Phrase: "Presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ":"

Phrase: "genes for life and death."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.507: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.508: 18: 687-690 16. 

Phrase: "18"

Phrase: ":"

Phrase: "687-690 16."
Processing 00000000.tx.509: Haass, C., Y. 

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Y."
Processing 00000000.tx.510: Hung, M. 

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.511: Citron, D.B. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.512: Teplow, and D.J. 

Phrase: "Teplow,"

Phrase: "and"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.513: Selkoe. 

Phrase: "Selkoe."
Processing 00000000.tx.514: 1995. 

Phrase: "1995."
Processing 00000000.tx.515: -Amyloid, protein processing and Alzheimer's disease. 

Phrase: "-Amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033666:protein processing [Molecular Function]
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.516: Drug Res. 

Phrase: "Drug Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.517: 45: 398-402 . 17. 

Phrase: "45"

Phrase: ":"

Phrase: "398-402 . 17."
Processing 00000000.tx.518: Kaufmann, S.H.. 

Phrase: "Kaufmann,"

Phrase: "S."

Phrase: "H.."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.519: 1989. 

Phrase: "1989."
Processing 00000000.tx.520: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. 

Phrase: "Induction of endonucleolytic DNA cleavage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in human acute myelogenous leukemia cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   897   C0427861:Human cells [Laboratory or Test Result]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   787   C1517806:Leukemic Cell [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0023467:Acute myelogenous leukaemia [Neoplastic Process]

Phrase: "by etoposide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015133:Etoposide [Carbohydrate,Pharmacologic Substance]

Phrase: "camptothecin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006812:Camptothecin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "other cytotoxic anticancer drugs"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   913   C0304497:cytotoxic drugs [Pharmacologic Substance]
   901   C1548818:Anticancer Drugs [Health Care Activity]
   827   C0013227:Drugs [Pharmacologic Substance]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]

Phrase: ":"

Phrase: "a cautionary note."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1316572:Note [Clinical Attribute]
   861   C1317574:Note [Intellectual Product]
   861   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.521: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.522: 49: 5870-5878 [Abstract]. 

Phrase: "49"

Phrase: ":"

Phrase: "5870-5878"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.523: 18. 

Phrase: "18."
Processing 00000000.tx.524: Kim, T.W., W.H. 

Phrase: "Kim,"

Phrase: "T.W., W.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.525: Pettingell, O.G. 

Phrase: "Pettingell,"

Phrase: "O.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.526: Hallmark, R.D. 

Phrase: "Hallmark,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.527: Moir, W. 

Phrase: "Moir,"

Phrase: "W."
Processing 00000000.tx.528: Wasco, and R.E. 

Phrase: "Wasco,"

Phrase: "and"

Phrase: "R.E."
Processing 00000000.tx.529: Tanzi. 

Phrase: "Tanzi."
Processing 00000000.tx.530: 1997. 

Phrase: "1997."
Processing 00000000.tx.531: Endoproteolytic cleavage and proteosomal degradation of presenilin 2transfected cells. 

Phrase: "Endoproteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "proteosomal degradation of presenilin 2transfected cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
Processing 00000000.tx.532: J. 

Phrase: "J."
Processing 00000000.tx.533: Biol. 

Phrase: "Biol."
Processing 00000000.tx.534: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.535: 272: 11006-11010 [Abstract/Free FullText]. 

Phrase: "272"

Phrase: ":"

Phrase: "11006-11010"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.536: 19. 

Phrase: "19."
Processing 00000000.tx.537: Kovacs, D.M., H.J. 

Phrase: "Kovacs,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "H.J."
Processing 00000000.tx.538: Fausett, K.J. 

Phrase: "Fausett,"

Phrase: "K.J."
Processing 00000000.tx.539: Page, T.-W. 

Phrase: "Page,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "T.-W."
Processing 00000000.tx.540: Kim, R.D. 

Phrase: "Kim,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.541: Moir, D.E. 

Phrase: "Moir,"

Phrase: "D."

Phrase: "E."
Processing 00000000.tx.542: Merriam, R.D. 

Phrase: "Merriam,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.543: Hollister, O.G. 

Phrase: "Hollister,"

Phrase: "O.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.544: Hallmark, R. 

Phrase: "Hallmark,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.545: Mancini, K.M. 

Phrase: "Mancini,"

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.546: Felsenstein, et al . 1996. 

Phrase: "Felsenstein,"

Phrase: "et al . 1996."
Processing 00000000.tx.547: Alzheimer-associated presenilins 1and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. 

Phrase: "Alzheimer-associated presenilins 1and 2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   836   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   836   C1418986:PRESENILIN 2 [Gene or Genome]
   804   C0332281:Associated [Qualitative Concept]
   804   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: ":"

Phrase: "neuronal expression in brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "localization to intracellular membranes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   870   C1658979:localization to membrane [Cell Function]
   819   C1660749:intracellular localization [Cell Function]
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "in mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.548: Nat. 

Phrase: "Nat."
Processing 00000000.tx.549: Med. 

Phrase: "Med."
Processing 00000000.tx.550: 2: 224-229 20. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "224-229 20."
Processing 00000000.tx.551: LaFerla, F.M., B.T. 

Phrase: "LaFerla,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]
Processing 00000000.tx.552: Tinkle, C.J. 

Phrase: "Tinkle,"

Phrase: "C.J."
Processing 00000000.tx.553: Bieberich, C. 

Phrase: "Bieberich,"

Phrase: "C."
Processing 00000000.tx.554: Haudenschild, and G. 

Phrase: "Haudenschild,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.555: Jay. 

Phrase: "Jay."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326402:Jay [Bird]
Processing 00000000.tx.556: 1995. 

Phrase: "1995."
Processing 00000000.tx.557: The Alzheimer's A peptide induces neurodegeneration and apoptotic cell death in transgenic mice. 

Phrase: "The Alzheimer's"

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "apoptotic cell death in transgenic mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0162638:apoptotic cell death [Cell Function]
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.558: Nat. 

Phrase: "Nat."
Processing 00000000.tx.559: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.560: 9: 21-30 21. 

Phrase: "9"

Phrase: ":"

Phrase: "21-30 21."
Processing 00000000.tx.561: Laemmli, U.K.. 

Phrase: "Laemmli,"

Phrase: "U.K.."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.562: 1970. 

Phrase: "1970."
Processing 00000000.tx.563: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. 

Phrase: "Cleavage of structural proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0597304:Protein Cleavage [Molecular Function]
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "during the assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706853:Assembly [Activity]
  1000   C1879748:Assembly [Manufactured Object]

Phrase: "of the head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018670:Head [Body Location or Region]
  1000   C1281590:Head [Body Part, Organ, or Organ Component]
  1000   C1706305:Head [Manufactured Object]
   944 E C0205096:Cephalic [Spatial Concept]

Phrase: "of bacteriophage T4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162570:Bacteriophage T4 [Virus]
Processing 00000000.tx.564: Nature (Lond.). 

Phrase: "Nature"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "(Lond."

Phrase: ")."
Processing 00000000.tx.565: 227: 680-685 22. 

Phrase: "227"

Phrase: ":"

Phrase: "680-685 22."
Processing 00000000.tx.566: Lazebnik, Y.A., R. 

Phrase: "Lazebnik,"

Phrase: "Y."

Phrase: "A.,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.567: Takahashi, R. 

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.568: Moir, R. 

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.569: Goldman, G. 

Phrase: "Goldman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.570: Poirier, S. 

Phrase: "Poirier,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.571: Kaufmann, and W. 

Phrase: "Kaufmann,"

Phrase: "and"

Phrase: "W."
Processing 00000000.tx.572: Earnshaw. 

Phrase: "Earnshaw."
Processing 00000000.tx.573: 1995. 

Phrase: "1995."
Processing 00000000.tx.574: Studies of lamin proteinase reveal multiple parallel pathways during apoptotic execution. 

Phrase: "Studies of lamin proteinase"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "multiple parallel pathways during apoptotic execution."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]
   731   C0162638:Apoptosis Pathway [Cell Function]
Processing 00000000.tx.575: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.576: Natl. 

Phrase: "Natl."
Processing 00000000.tx.577: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.578: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.579: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.580: 92: 9042-9046 [Abstract]. 

Phrase: "92"

Phrase: ":"

Phrase: "9042-9046"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.581: 23. 

Phrase: "23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.582: Lee, M.K., Z. 

Phrase: "Lee,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Z."
Processing 00000000.tx.583: Xu, P.C. 

Phrase: "Xu,"

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.584: Wong, and D.W. 

Phrase: "Wong,"

Phrase: "and"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.585: Cleveland. 

Phrase: "Cleveland."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]
Processing 00000000.tx.586: 1993. 

Phrase: "1993."
Processing 00000000.tx.587: Neurofilaments are obligate heteropolymers in vivo. 

Phrase: "Neurofilaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027834:neurofilaments [Cell Component]

Phrase: "are"

Phrase: "obligate heteropolymers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596383:Heteropolymer [Chemical Viewed Structurally]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.588: J. 

Phrase: "J."
Processing 00000000.tx.589: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.590: 122: 1337-1350 [Abstract]. 

Phrase: "122"

Phrase: ":"

Phrase: "1337-1350"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.591: 24. 

Phrase: "24."
Processing 00000000.tx.592: Lee, M.K., H.H. 

Phrase: "Lee,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "H.H."
Processing 00000000.tx.593: Slunt, L.J. 

Phrase: "Slunt,"

Phrase: "L.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.594: Martin, G. 

Phrase: "Martin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.595: Thinakaran, G. 

Phrase: "Thinakaran,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.596: Kim, S.E. 

Phrase: "Kim,"

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.597: Gandy, M. 

Phrase: "Gandy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.598: Seeger, E. 

Phrase: "Seeger,"

Phrase: "E."
Processing 00000000.tx.599: Koo, D.L. 

Phrase: "Koo,"

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.600: Price, and S.S. 

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "and S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.601: Sisodia. 

Phrase: "Sisodia."
Processing 00000000.tx.602: 1996. 

Phrase: "1996."
Processing 00000000.tx.603: Expression of presenilin 1and 2(PS1 and PS2) in human and murine tissues. 

Phrase: "Expression of presenilin 1and 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: ")"

Phrase: "in human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "murine tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.604: J. 

Phrase: "J."
Processing 00000000.tx.605: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.606: 16: 7513-7525 [Abstract/Free FullText]. 

Phrase: "16"

Phrase: ":"

Phrase: "7513-7525"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.607: 25. 

Phrase: "25."
Processing 00000000.tx.608: Lehmann, S., R. 

Phrase: "Lehmann,"

Phrase: "S."

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.609: Chiesa, and D.A. 

Phrase: "Chiesa,"

Phrase: "and"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.610: Harris. 

Phrase: "Harris."
Processing 00000000.tx.611: 1997. 

Phrase: "1997."
Processing 00000000.tx.612: Evidence for a six-transmembrane domain structure of presenilin 1. 

Phrase: "Evidence for a six-transmembrane domain structure of presenilin 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.613: J. 

Phrase: "J."
Processing 00000000.tx.614: Biol Chem. 

Phrase: "Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.615: 272: 12047-12051 [Abstract/Free FullText]. 

Phrase: "272"

Phrase: ":"

Phrase: "12047-12051"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.616: 26. 

Phrase: "26."
Processing 00000000.tx.617: Levitan, D., and I. 

Phrase: "Levitan,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.618: Greenwald. 

Phrase: "Greenwald."
Processing 00000000.tx.619: 1995. 

Phrase: "1995."
Processing 00000000.tx.620: Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. 

Phrase: "Facilitation of lin-12-mediated signalling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "by sel-12,"

Phrase: "a Caenorhabditis elegans S182 Alzheimer's disease gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0017337:Gene [Gene or Genome]
   799   C1416989:MAL gene [Gene or Genome]
Processing 00000000.tx.621: Nature (Lond.). 

Phrase: "Nature"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "(Lond."

Phrase: ")."
Processing 00000000.tx.622: 377: 351-354 27. 

Phrase: "377"

Phrase: ":"

Phrase: "351-354 27."
Processing 00000000.tx.623: Levitan, D., T.G. 

Phrase: "Levitan,"

Phrase: "D."

Phrase: ","

Phrase: "T.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.624: Doyle, D. 

Phrase: "Doyle,"

Phrase: "D."
Processing 00000000.tx.625: Brousseau, M.K. 

Phrase: "Brousseau,"

Phrase: "M."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.626: Lee, G. 

Phrase: "Lee,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.627: Thinakaran, H.H. 

Phrase: "Thinakaran,"

Phrase: "H.H."
Processing 00000000.tx.628: Slunt, S.S. 

Phrase: "Slunt,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.629: Sisodia, and I. 

Phrase: "Sisodia,"

Phrase: "and"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.630: Greenwald. 

Phrase: "Greenwald."
Processing 00000000.tx.631: 1996. 

Phrase: "1996."
Processing 00000000.tx.632: Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. 

Phrase: "Assessment of normal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1261322:Assessment [Health Care Activity]
   790   C1516048:Assessment [Activity]

Phrase: "and"

Phrase: "mutant human presenilin function in Caenorhabditis elegans."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
Processing 00000000.tx.633: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.634: Natl. 

Phrase: "Natl."
Processing 00000000.tx.635: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.636: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.637: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.638: 93: 14940-14944 [Abstract/Free FullText]. 

Phrase: "93"

Phrase: ":"

Phrase: "14940-14944"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.639: 28. 

Phrase: "28."
Processing 00000000.tx.640: Levy-Lahad, E., W. 

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "W."
Processing 00000000.tx.641: Wasco, P. 

Phrase: "Wasco,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.642: Poorkaj, D.M. 

Phrase: "Poorkaj,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.643: Romano, J. 

Phrase: "Romano,"

Phrase: "J."
Processing 00000000.tx.644: Oshima, W.H. 

Phrase: "Oshima,"

Phrase: "W.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.645: Pettingell, C. 

Phrase: "Pettingell,"

Phrase: "C."
Processing 00000000.tx.646: Yu, P.D. 

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "P.D."
Processing 00000000.tx.647: Jondro, S.D. 

Phrase: "Jondro,"

Phrase: "S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.648: Schmidt, K. 

Phrase: "Schmidt,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.649: Wang, et al . 1995a. 

Phrase: "Wang,"

Phrase: "et al . 1995a."
Processing 00000000.tx.650: Candidate gene for the chromosome 1familial Alzheimer's disease locus. 

Phrase: "Candidate gene for the chromosome 1familial Alzheimer's disease locus."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C1332838:Candidate Disease Gene [Gene or Genome]
           Candidate Gene
   762   C1708726:Gene Locus [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   734   C1416989:MAL gene [Gene or Genome]
Processing 00000000.tx.651: Science (Wash. DC). 

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "(Wash. DC"

Phrase: ")."
Processing 00000000.tx.652: 269: 973-977 29. 

Phrase: "269"

Phrase: ":"

Phrase: "973-977 29."
Processing 00000000.tx.653: Levy-Lahad, E., E.M. 

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.654: Wijsman, E. 

Phrase: "Wijsman,"

Phrase: "E."
Processing 00000000.tx.655: Nemens, L. 

Phrase: "Nemens,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.656: Anderson, K.A.B. 

Phrase: "Anderson,"

Phrase: "K.A.B."
Processing 00000000.tx.657: Goddard, J.L. 

Phrase: "Goddard,"

Phrase: "J.L."
Processing 00000000.tx.658: Weber, T.D. 

Phrase: "Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "T.D."
Processing 00000000.tx.659: Bird, and G.D. 

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "and"

Phrase: "G.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439417:g d [Quantitative Concept]
Processing 00000000.tx.660: Schellenberg. 

Phrase: "Schellenberg."
Processing 00000000.tx.661: 1995b. 

Phrase: "1995b."
Processing 00000000.tx.662: A familial Alzheimer's disease locus on chromosome 1. 

Phrase: "A familial Alzheimer's disease locus on chromosome 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.663: Science (Wash. DC). 

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "(Wash. DC"

Phrase: ")."
Processing 00000000.tx.664: 269: 970-973 30. 

Phrase: "269"

Phrase: ":"

Phrase: "970-973 30."
Processing 00000000.tx.665: Li, X., and I. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "X.,"

Phrase: "and"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.666: Greenwald. 

Phrase: "Greenwald."
Processing 00000000.tx.667: 1996. 

Phrase: "1996."
Processing 00000000.tx.668: Membrane topology of the C.elegans SEL-12 presenilin. 

Phrase: "Membrane topology of the C.elegans SEL-12 presenilin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0002812:Topology [Biomedical Occupation or Discipline]
Processing 00000000.tx.669: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.670: 17: 1015-1021 31. 

Phrase: "17"

Phrase: ":"

Phrase: "1015-1021 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450355:31 [Intellectual Product]
Processing 00000000.tx.671: Li, J., J. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "J."
Processing 00000000.tx.672: Ma, and H. 

Phrase: "Ma,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.673: Potter. 

Phrase: "Potter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]
Processing 00000000.tx.674: 1995. 

Phrase: "1995."
Processing 00000000.tx.675: Identification and expression analysis of a potentially familial Alzheimer disease gene on chromosome 1related to AD3. 

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "expression analysis of a potentially familial Alzheimer disease gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   784   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "on chromosome 1related"

Phrase: "to AD3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986918:AD3 [Gene or Genome]
Processing 00000000.tx.676: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.677: Natl. 

Phrase: "Natl."
Processing 00000000.tx.678: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.679: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.680: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.681: 92: 12180-12184 [Abstract]. 

Phrase: "92"

Phrase: ":"

Phrase: "12180-12184"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.682: 32. 

Phrase: "32."
Processing 00000000.tx.683: Mercy, M.R., J.C. 

Phrase: "Mercy,"

Phrase: "M."

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "J.C."
Processing 00000000.tx.684: Troncoso, and M.J. 

Phrase: "Troncoso,"

Phrase: "and"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.685: Monteiro. 

Phrase: "Monteiro."
Processing 00000000.tx.686: 1992. 

Phrase: "1992."
Processing 00000000.tx.687: A new series of trpE vectors that enable high expression of nonfusion proteins in bacteria. 

Phrase: "A new series of trpE vectors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "that"

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "high expression of nonfusion proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in bacteria."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0004611:Bacteria [Bacterium]
  1000   C1510439:bacteria [Functional Concept]
  1000   C2347473:% Bacteria [Quantitative Concept]
   928 E C0521009:Bacterial [Qualitative Concept]
Processing 00000000.tx.688: Protein Expr. 

Phrase: "Protein Expr."
Processing 00000000.tx.689: Purif. 

Phrase: "Purif."
Processing 00000000.tx.690: 3: 57-64 33. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "57-64 33."
Processing 00000000.tx.691: Monteiro, M.J., and T. 

Phrase: "Monteiro,"

Phrase: "M."

Phrase: "J.,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.692: Mical. 

Phrase: "Mical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537694:MICAL [Gene or Genome]
Processing 00000000.tx.693: 1996. 

Phrase: "1996."
Processing 00000000.tx.694: Resolution of kinase activities during the HeLa cell cycle: identification of kinases with cyclic activities. 

Phrase: "Resolution of kinase activities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514893:Resolution [Idea or Concept]
   770   C1706463:Resolution [Quantitative Concept]
   770   C2699488:Resolution [Conceptual Entity]

Phrase: "during the HeLa cell cycle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007586:Cell Cycle [Cell Function]
   901   C1155839:Cell Cycle [Cell Function]
   827   C1511572:Cycle [Temporal Concept]
   734   C0018873:HeLa cell [Cell]

Phrase: ":"

Phrase: "identification of kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "with cyclic activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.695: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.696: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.697: 223: 443-451 34. 

Phrase: "223"

Phrase: ":"

Phrase: "443-451 34."
Processing 00000000.tx.698: Monteiro, M.J., C. 

Phrase: "Monteiro,"

Phrase: "M."

Phrase: "J.,"

Phrase: "C."
Processing 00000000.tx.699: Hicks, L. 

Phrase: "Hicks,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.700: Gu, and S. 

Phrase: "Gu,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.701: Janicki. 

Phrase: "Janicki."
Processing 00000000.tx.702: 1994. 

Phrase: "1994."
Processing 00000000.tx.703: Determinants for intracellular sorting of cytoplasmic and nuclear intermediate filaments. 

Phrase: "Determinants for intracellular sorting of cytoplasmic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1521761:Determinant [Functional Concept]

Phrase: "and"

Phrase: "nuclear intermediate filaments."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0021770:Intermediate Filaments [Cell Component]
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]
Processing 00000000.tx.704: J. 

Phrase: "J."
Processing 00000000.tx.705: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.706: 127: 1327-1343 [Abstract]. 

Phrase: "127"

Phrase: ":"

Phrase: "1327-1343"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.707: 35. 

Phrase: "35."
Processing 00000000.tx.708: Mullan, M., and F. 

Phrase: "Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.709: Crawford. 

Phrase: "Crawford."
Processing 00000000.tx.710: 1993. 

Phrase: "1993."
Processing 00000000.tx.711: Genetic and molecular advances in Alzheimer's disease. 

Phrase: "Genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "molecular advances in Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0725066:Advance [Medical Device]
Processing 00000000.tx.712: Trends Neurosci. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.713: 16: 398-403 36. 

Phrase: "16"

Phrase: ":"

Phrase: "398-403 36."
Processing 00000000.tx.714: Oberhammer, F.A., K. 

Phrase: "Oberhammer,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "A.,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.715: Hochegger, G. 

Phrase: "Hochegger,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.716: Froschl, R. 

Phrase: "Froschl,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.717: Tiefenbacher, and M. 

Phrase: "Tiefenbacher,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.718: Pavelka. 

Phrase: "Pavelka."
Processing 00000000.tx.719: 1994. 

Phrase: "1994."
Processing 00000000.tx.720: Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase. 

Phrase: "Chromatin condensation during apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233656:Condensation [Mental or Behavioral Dysfunction]
   770   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "accompanied by degradation of lamin A+B,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0125258:Lamin A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1416877:LAMIN A [Gene or Genome]
   774   C0125259:Lamin B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0064635:Lamin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "without enhanced activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of cdc2 kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.721: J. 

Phrase: "J."
Processing 00000000.tx.722: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.723: 126: 827-837 [Abstract]. 

Phrase: "126"

Phrase: ":"

Phrase: "827-837"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.724: 37. 

Phrase: "37."
Processing 00000000.tx.725: Opas, M., E. 

Phrase: "Opas,"

Phrase: "M."

Phrase: ","

Phrase: "E."
Processing 00000000.tx.726: Dziak, L. 

Phrase: "Dziak,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.727: Fliegel, and M. 

Phrase: "Fliegel,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.728: Michalak. 

Phrase: "Michalak."
Processing 00000000.tx.729: 1991. 

Phrase: "1991."
Processing 00000000.tx.730: Regulation of expression and intracellular distribution of calreticulin, a major calcium binding protein of nonmuscle cells. 

Phrase: "Regulation of expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "intracellular distribution of calreticulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "a major calcium binding protein of nonmuscle cells."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C0006732:Calcium-binding protein [Amino Acid, Peptide, or Protein,Receptor]
   800   C1822659:calcium binding protein [Gene or Genome]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1516144:Calcium Binding [Molecular Function]
   767 E C0033618:Protein Binding [Molecular Function]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C0805431:Calcium/Protein [Quantitative Concept]
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.731: J. 

Phrase: "J."
Processing 00000000.tx.732: Cell Physiol. 

Phrase: "Cell Physiol."
Processing 00000000.tx.733: 149: 160-171 38. 

Phrase: "149"

Phrase: ":"

Phrase: "160-171 38."
Processing 00000000.tx.734: Perez-Tur, J., S. 

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.735: Froelich, G. 

Phrase: "Froelich,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.736: Prihar, R. 

Phrase: "Prihar,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.737: Crook, M. 

Phrase: "Crook,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.738: Baker, K. 

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.739: Duff, M. 

Phrase: "Duff,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.740: Wragg, F. 

Phrase: "Wragg,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.741: Busfield, C. 

Phrase: "Busfield,"

Phrase: "C."
Processing 00000000.tx.742: Lendon, R.F. 

Phrase: "Lendon,"

Phrase: "R.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.743: Clark, et al . 1995. 

Phrase: "Clark,"

Phrase: "et al . 1995."
Processing 00000000.tx.744: A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. 

Phrase: "A mutation in Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "destroying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Destroy [Idea or Concept]

Phrase: "a splice acceptor site in the presenilin-1 gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0887918:Splice Acceptor Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0000901:acceptor [Population Group]
   742   C0205145:Site [Spatial Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]
Processing 00000000.tx.745: Neuroreport. 

Phrase: "Neuroreport."
Processing 00000000.tx.746: 7: 297-301 39. 

Phrase: "7"

Phrase: ":"

Phrase: "297-301 39."
Processing 00000000.tx.747: Rao, L., D. 

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.748: Perez, and E. 

Phrase: "Perez,"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.749: White. 

Phrase: "White."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]
Processing 00000000.tx.750: 1996. 

Phrase: "1996."
Processing 00000000.tx.751: Lamin proteolysis facilitates nuclear events during apoptosis. 

Phrase: "Lamin proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0597304:Proteolysis [Molecular Function]
   789 E C1947941:proteolytic [Enzyme]

Phrase: "facilitates"

Phrase: "nuclear events during apoptosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441471:Events [Event]
   770   C3541888:Events [Classification]
Processing 00000000.tx.752: J. 

Phrase: "J."
Processing 00000000.tx.753: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.754: 135: 1441-1455 [Abstract]. 

Phrase: "135"

Phrase: ":"

Phrase: "1441-1455"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.755: 40. 

Phrase: "40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.756: Rogaev, E.I., R. 

Phrase: "Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.757: Sherrington, E.A. 

Phrase: "Sherrington,"

Phrase: "E.A."
Processing 00000000.tx.758: Rogaeva, G. 

Phrase: "Rogaeva,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.759: Levesque, M. 

Phrase: "Levesque,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.760: Ikeda, Y. 

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "Y."
Processing 00000000.tx.761: Liang, H. 

Phrase: "Liang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.762: Chi, C. 

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.763: Lin, K. 

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.764: Holman, T. 

Phrase: "Holman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.765: Tsuda, et al . 1995. 

Phrase: "Tsuda,"

Phrase: "et al . 1995."
Processing 00000000.tx.766: Familial Alzheimer's disease in kindereds with missense mutations in the gene on chromosome 1related to the Alzheimer's disease type 3gene. 

Phrase: "Familial Alzheimer's disease in kindereds"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "with missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 1related"

Phrase: "to the Alzheimer's disease type 3gene."
Processing 00000000.tx.767: Nature (Lond.). 

Phrase: "Nature"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "(Lond."

Phrase: ")."
Processing 00000000.tx.768: 376: 775-778 41. 

Phrase: "376"

Phrase: ":"

Phrase: "775-778 41."
Processing 00000000.tx.769: Scheuner, D., C. 

Phrase: "Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "C."
Processing 00000000.tx.770: Eckman, X. 

Phrase: "Eckman,"

Phrase: "X."
Processing 00000000.tx.771: Song, M. 

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.772: Citron, N. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.773: Suzuki, T.D. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T.D."
Processing 00000000.tx.774: Bird, J. 

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "J."
Processing 00000000.tx.775: Hardy, M. 

Phrase: "Hardy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.776: Hutton, W. 

Phrase: "Hutton,"

Phrase: "W."
Processing 00000000.tx.777: Kukull, E. 

Phrase: "Kukull,"

Phrase: "E."
Processing 00000000.tx.778: Larson, et al . 1996. 

Phrase: "Larson,"

Phrase: "et al . 1996."
Processing 00000000.tx.779: Secreted amyloid -protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin and 2and APP mutations linked to familial Alzheimer's disease. 

Phrase: "Secreted amyloid -protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in the senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "in vivo by the presenilin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "2and APP mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0596611:gene mutations [Genetic Function]
   827   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0017337:Gene [Gene or Genome]
   799   C0026882:Mutations [Genetic Function]
   766 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "linked to familial Alzheimer's disease."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.780: Nat. 

Phrase: "Nat."
Processing 00000000.tx.781: Med. 

Phrase: "Med."
Processing 00000000.tx.782: 2: 864-870 42. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "864-870 42."
Processing 00000000.tx.783: Shen, J., R.T. 

Phrase: "Shen,"

Phrase: "J.,"

Phrase: "R.T."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.784: Bronson, D.F. 

Phrase: "Bronson,"

Phrase: "D."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.785: Chen, W. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "W."
Processing 00000000.tx.786: Xia, D.J. 

Phrase: "Xia,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.787: Selkoe, and S. 

Phrase: "Selkoe,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.788: Tonegawa. 

Phrase: "Tonegawa."
Processing 00000000.tx.789: 1997. 

Phrase: "1997."
Processing 00000000.tx.790: Skeletal and CNS defects in presenilin-1-deficient mice. 

Phrase: "Skeletal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037253:skeletal [Body System]
  1000   C0521324:Skeletal [Spatial Concept]

Phrase: "and"

Phrase: "CNS defects in presenilin-1-deficient mice."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0243067:defects [Functional Concept]
   714 E C1457869:Defect [Functional Concept]
   714 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.791: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.792: 89: 629-639 43. 

Phrase: "89"

Phrase: ":"

Phrase: "629-639 43."
Processing 00000000.tx.793: Sherrington, R., E.I. 

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "E.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.794: Rogaev, Y. 

Phrase: "Rogaev,"

Phrase: "Y."
Processing 00000000.tx.795: Liang, E.A. 

Phrase: "Liang,"

Phrase: "E.A."
Processing 00000000.tx.796: Rogaeva, G. 

Phrase: "Rogaeva,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.797: Levesque, M. 

Phrase: "Levesque,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.798: Ikeda, H. 

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.799: Chi, C. 

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.800: Lin, G. 

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.801: Li, K. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.802: Holman, et al . 1995. 

Phrase: "Holman,"

Phrase: "et al . 1995."
Processing 00000000.tx.803: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. 

Phrase: "Cloning of a gene bearing missense mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0009015:Cloning [Research Activity]

Phrase: "in early-onset familial Alzheimer's disease."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   924   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   897   C0679245:early disease [Temporal Concept]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.804: Nature (Lond.). 

Phrase: "Nature"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "(Lond."

Phrase: ")."
Processing 00000000.tx.805: 375: 754-760 44. 

Phrase: "375"

Phrase: ":"

Phrase: "754-760 44."
Processing 00000000.tx.806: Sherrington, R., S. 

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.807: Froelich, S. 

Phrase: "Froelich,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.808: Sorbi, D. 

Phrase: "Sorbi,"

Phrase: "D."
Processing 00000000.tx.809: Campion, H. 

Phrase: "Campion,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.810: Chi, E.A. 

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "E.A."
Processing 00000000.tx.811: Rogaeva, G. 

Phrase: "Rogaeva,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.812: Levesque, E.I. 

Phrase: "Levesque,"

Phrase: "E.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.813: Rogaev, C. 

Phrase: "Rogaev,"

Phrase: "C."
Processing 00000000.tx.814: Lin, Y. 

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "Y."
Processing 00000000.tx.815: Liang, et al . 1996. 

Phrase: "Liang,"

Phrase: "et al . 1996."
Processing 00000000.tx.816: Alzheimer's disease associated with mutations in presenilin 2is rare and variably penetrant. 

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "associated with mutations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026882:Mutations [Genetic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in presenilin 2is"

Phrase: "rare"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]

Phrase: "and"

Phrase: "variably penetrant."
Processing 00000000.tx.817: Hum. 

Phrase: "Hum."
Processing 00000000.tx.818: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.819: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.820: 5: 985-988 [Abstract/Free FullText]. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "985-988"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.821: 45. 

Phrase: "45."
Processing 00000000.tx.822: Strittmatter, W.J., and A.D Roses. 

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "and"

Phrase: "A.D Roses."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0035853:Roses [Plant]
   793 E C0995005:ROSE [Pharmacologic Substance]
   734   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.823: 1995. 

Phrase: "1995."
Processing 00000000.tx.824: Apolipoprotein E and Alzheimer disease. 

Phrase: "Apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.825: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.826: Natl. 

Phrase: "Natl."
Processing 00000000.tx.827: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.828: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.829: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.830: 92: 4725-4727 [Abstract]. 

Phrase: "92"

Phrase: ":"

Phrase: "4725-4727"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.831: 46. 

Phrase: "46."
Processing 00000000.tx.832: Su, J.H., G. 

Phrase: "Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.833: Deng, and C.W. 

Phrase: "Deng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549988:DEng [Intellectual Product]

Phrase: "and"

Phrase: "C.W."
Processing 00000000.tx.834: Cotman. 

Phrase: "Cotman."
Processing 00000000.tx.835: 1997. 

Phrase: "1997."
Processing 00000000.tx.836: Bax protein expression is increased in Alzheimer's brain: correlation with DNA damage, Bcl-2 expression, and brain pathology. 

Phrase: "Bax protein expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0219474:Bax protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "increased in Alzheimer's brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "correlation with DNA damage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "Bcl-2 expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0376515:Bcl-2 [Gene or Genome]

Phrase: "and"

Phrase: "brain pathology."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0006119:Brain Pathology [Pathologic Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   789 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.837: J. 

Phrase: "J."
Processing 00000000.tx.838: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.839: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.840: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.841: 56: 86-93 47. 

Phrase: "56"

Phrase: ":"

Phrase: "86-93 47."
Processing 00000000.tx.842: Tamkun, M.M., K.M. 

Phrase: "Tamkun,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.843: Knoth, J.A. 

Phrase: "Knoth,"

Phrase: "J."

Phrase: "A."
Processing 00000000.tx.844: Wabridge, H. 

Phrase: "Wabridge,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.845: Kroemer, D.M. 

Phrase: "Kroemer,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.846: Roden, and K.M. 

Phrase: "Roden,"

Phrase: "and"

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.847: Glover. 

Phrase: "Glover."
Processing 00000000.tx.848: 1991. 

Phrase: "1991."
Processing 00000000.tx.849: Molecular cloning and characterization of two voltage-gated K channel cDNAs from human ventricle. 

Phrase: "Molecular cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "characterization of two voltage-gated K channel cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "from human ventricle."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0018827:Ventricle [Body Part, Organ, or Organ Component]
   861   C2355627:Ventricle [Body Part, Organ, or Organ Component]
   789 E C1522565:Ventricular [Spatial Concept]
   761 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.850: FASEB (Fed. Am. Soc. Exp. Biol.) 

Phrase: "FASEB"

Phrase: "("

Phrase: "Fed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "Am. Soc. Exp. Biol."

Phrase: ")"
Processing 00000000.tx.851: J. 

Phrase: "J."
Processing 00000000.tx.852: 5: 331-337 [Abstract/Free FullText]. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "331-337"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.853: 48. 

Phrase: "48."
Processing 00000000.tx.854: Thinakaran, G., D.R. 

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.855: Borchelt, M.K. 

Phrase: "Borchelt,"

Phrase: "M."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.856: Lee, H.H. 

Phrase: "Lee,"

Phrase: "H.H."
Processing 00000000.tx.857: Slunt, L. 

Phrase: "Slunt,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.858: Spitzer, G. 

Phrase: "Spitzer,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.859: Kim, T. 

Phrase: "Kim,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.860: Ratovitsky, F. 

Phrase: "Ratovitsky,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.861: Davenport, C. 

Phrase: "Davenport,"

Phrase: "C."
Processing 00000000.tx.862: Nordstedt, M. 

Phrase: "Nordstedt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.863: Seeger, et al . 1996. 

Phrase: "Seeger,"

Phrase: "et al . 1996."
Processing 00000000.tx.864: Endoproteolysis of presenilin 1and accumulation of processed derivatives in vivo. 

Phrase: "Endoproteolysis of presenilin 1and accumulation of processed derivatives"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.865: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.866: 17: 181-190 49. 

Phrase: "17"

Phrase: ":"

Phrase: "181-190 49."
Processing 00000000.tx.867: Tomita, T., K. 

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.868: Maruyama, T.C. 

Phrase: "Maruyama,"

Phrase: "T.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.869: Saido, H. 

Phrase: "Saido,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.870: Kume, K. 

Phrase: "Kume,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.871: Shinozaki, S. 

Phrase: "Shinozaki,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.872: Tokuhiro, A. 

Phrase: "Tokuhiro,"

Phrase: "A."
Processing 00000000.tx.873: Capell, J. 

Phrase: "Capell,"

Phrase: "J."
Processing 00000000.tx.874: Walter, H. 

Phrase: "Walter,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.875: Grunberg, C. 

Phrase: "Grunberg,"

Phrase: "C."
Processing 00000000.tx.876: Hass, et al . 1997. 

Phrase: "Hass,"

Phrase: "et al . 1997."
Processing 00000000.tx.877: The presenilin 2mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid protein ending at the 42nd (or 43rd) residue. 

Phrase: "The presenilin 2mutation"

Phrase: "(N141I"

Phrase: ")"

Phrase: "linked to familial Alzheimer disease"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(Volga German families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: ")"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the secretion of amyloid protein ending"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "at the 42nd"

Phrase: "("

Phrase: "or"

Phrase: "43rd"

Phrase: ")"

Phrase: "residue."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.878: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.879: Natl. 

Phrase: "Natl."
Processing 00000000.tx.880: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.881: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.882: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.883: 94: 2025-2030 [Abstract/Free FullText]. 

Phrase: "94"

Phrase: ":"

Phrase: "2025-2030"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.884: 50. 

Phrase: "50."
Processing 00000000.tx.885: Ucker, D.S., J. 

Phrase: "Ucker,"

Phrase: "D.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "J."
Processing 00000000.tx.886: Myers, and P.S. 

Phrase: "Myers,"

Phrase: "and"

Phrase: "P.S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.887: Obermiller. 

Phrase: "Obermiller."
Processing 00000000.tx.888: 1992. 

Phrase: "1992."
Processing 00000000.tx.889: Activation driven cell death: quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death. 

Phrase: "Activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "quantitative differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "distinguish"

Phrase: "stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234402:Stimuli [Phenomenon or Process]

Phrase: "triggering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "nontransformed T cell proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1155046:T-Cell Proliferation [Cell Function]
   861   C0596290:Cell Proliferation [Cell Function]
   812   C0334094:Proliferation [Pathologic Function]
   812   C1514485:Proliferation [Functional Concept]

Phrase: "or"

Phrase: "death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]
Processing 00000000.tx.890: J. 

Phrase: "J."
Processing 00000000.tx.891: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.892: 149: 1583-1592 [Abstract/Free FullText]. 

Phrase: "149"

Phrase: ":"

Phrase: "1583-1592"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.893: 51. 

Phrase: "51."
Processing 00000000.tx.894: Van Broeckhoven, C.. 

Phrase: "Van Broeckhoven,"

Phrase: "C.."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.895: 1995. 

Phrase: "1995."
Processing 00000000.tx.896: Molecular genetics of Alzheimer's disease: identification of genes and gene mutations. 

Phrase: "Molecular genetics of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   797   C0019247:Molecular Disease [Disease or Syndrome]
           genetics disease
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]
   760   C1521991:Molecular [Qualitative Concept]

Phrase: ":"

Phrase: "identification of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "gene mutations."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0596611:gene mutations [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.897: Eur. 

Phrase: "Eur."
Processing 00000000.tx.898: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.899: 35: 8-19 52. 

Phrase: "35"

Phrase: ":"

Phrase: "8-19 52."
Processing 00000000.tx.900: Vito, P., E. 

Phrase: "Vito,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "E."
Processing 00000000.tx.901: Lacana, and L.D. 

Phrase: "Lacana,"

Phrase: "and"

Phrase: "L.D."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0475219:L/d [Quantitative Concept]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.902: D'Adamio. 

Phrase: "D'"

Phrase: "Adamio."
Processing 00000000.tx.903: 1996a. 

Phrase: "1996a."
Processing 00000000.tx.904: Interfering with apoptosis: Ca2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. 

Phrase: "Interfering with apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C0521102:interfering [Qualitative Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ":"

Phrase: "Ca2+-binding protein ALG-2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0251337:Ca2+-binding protein- [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1418406:ALG-2 [Gene or Genome]
   804   C0003372:ALG [Immunologic Factor,Pharmacologic Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "Alzheimer's disease gene ALG-3."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   911   C1843013:Alzheimer disease 3 [Disease or Syndrome]
   847   C0067430:MAL-3 [Organic Chemical]
   847   C1425077:MALS-3 [Gene or Genome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C1416989:MAL gene [Gene or Genome]
   804   C0003372:ALG [Immunologic Factor,Pharmacologic Substance]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0017337:Gene [Gene or Genome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.905: Science (Wash. DC). 

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "(Wash. DC"

Phrase: ")."
Processing 00000000.tx.906: 271: 521-525 [Abstract]. 

Phrase: "271"

Phrase: ":"

Phrase: "521-525"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.907: 53. 

Phrase: "53."
Processing 00000000.tx.908: Vito, P., B. 

Phrase: "Vito,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.909: Wolozin, J.K. 

Phrase: "Wolozin,"

Phrase: "J.K."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.910: Ganjei, K. 

Phrase: "Ganjei,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.911: Iwasaki, E. 

Phrase: "Iwasaki,"

Phrase: "E."
Processing 00000000.tx.912: Lacana, and L.D. 

Phrase: "Lacana,"

Phrase: "and"

Phrase: "L.D."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0475219:L/d [Quantitative Concept]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.913: D'Adamio. 

Phrase: "D'"

Phrase: "Adamio."
Processing 00000000.tx.914: 1996b. 

Phrase: "1996b."
Processing 00000000.tx.915: Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. 

Phrase: "Requirement of the familial Alzheimer's disease gene PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1514873:Requirement [Functional Concept]

Phrase: "for apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.916: J. 

Phrase: "J."
Processing 00000000.tx.917: Biol. 

Phrase: "Biol."
Processing 00000000.tx.918: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.919: 271: 31025-31028 [Abstract/Free FullText]. 

Phrase: "271"

Phrase: ":"

Phrase: "31025-31028"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.920: 54. 

Phrase: "54."
Processing 00000000.tx.921: Yamatsuji, T., T. 

Phrase: "Yamatsuji,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.922: Matsui, T. 

Phrase: "Matsui,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.923: Okamoto, K. 

Phrase: "Okamoto,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.924: Komatsuzaki, S. 

Phrase: "Komatsuzaki,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.925: Takeda, H. 

Phrase: "Takeda,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.926: Fukumoto, T. 

Phrase: "Fukumoto,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.927: Iwatsubo, N. 

Phrase: "Iwatsubo,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.928: Suziki, A. 

Phrase: "Suziki,"

Phrase: "A."
Processing 00000000.tx.929: Asami-Odaka, S. 

Phrase: "Asami-Odaka,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.930: Ireland, et al . 1996. 

Phrase: "Ireland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022067:Ireland [Geographic Area]

Phrase: "et al . 1996."
Processing 00000000.tx.931: G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. 

Phrase: "G protein-mediated neuronal DNA fragmentation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0376669:DNA Fragmentation [Molecular Function]
   799   C0332472:Fragmentation [Anatomical Abnormality]
   799   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "induced by familial Alzheimer's disease-associated mutants of APP."
Meta Candidates (Total=34; Excluded=3; Pruned=0; Remaining=31)
   782   C0611285:Alzheimer's Disease Amyloid Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   770   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   770   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   770   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   767   C1955168:Alzheimer precursor protein [Amino Acid, Peptide, or Protein]
   766   C0368670:Amyloid associated protein [Amino Acid, Peptide, or Protein]
   753   C0002395:Alzheimer's Disease [Disease or Syndrome]
   753   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1521724:Alzheimer's Disease [Pathologic Function]
   751   C0002726:amyloid disease [Disease or Syndrome]
   751   C0243083:associated disease [Pathologic Function]
   751   C0277558:Familial disease [Disease or Syndrome]
   751   C0678941:gene mutants [Gene or Genome]
   751   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0012634:Disease [Disease or Syndrome]
   736   C0015576:familial [Family Group]
   736   C0017337:Gene [Gene or Genome]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0205263:Induced [Functional Concept]
   736   C0241888:Familial [Functional Concept]
   736   C0332281:Associated [Qualitative Concept]
   736   C0596988:mutants [Cell or Molecular Dysfunction]
   736   C1709634:Precursor [Idea or Concept]
   734   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   723   C1416989:MAL gene [Gene or Genome]
   715 E C0344339:disease family [Finding]
   715   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   715   C1517488:Gene Family [Gene or Genome]
   703 E C0750490:Associate [Idea or Concept]
   703 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.932: Science (Wash. DC). 

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "(Wash. DC"

Phrase: ")."
Processing 00000000.tx.933: 272: 1349-1352 [Abstract]. 

Phrase: "272"

Phrase: ":"

Phrase: "1349-1352"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.934: 55. 

Phrase: "55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.935: Walter, J., A. 

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "A."
Processing 00000000.tx.936: Capell, J. 

Phrase: "Capell,"

Phrase: "J."
Processing 00000000.tx.937: Grunberg, B. 

Phrase: "Grunberg,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.938: Presold, A. 

Phrase: "Presold,"

Phrase: "A."
Processing 00000000.tx.939: Schindzielorz, R. 

Phrase: "Schindzielorz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.940: Prior, M.B. 

Phrase: "Prior, M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.941: Podlisny, P. 

Phrase: "Podlisny,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.942: Fraser, P.H. 

Phrase: "Fraser,"

Phrase: "P.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.943: St. 

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.944: George-Hyslop, D.J. 

Phrase: "George-Hyslop,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.945: Selkoe, and C. 

Phrase: "Selkoe,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.946: Hass. 

Phrase: "Hass."
Processing 00000000.tx.947: 1996. 

Phrase: "1996."
Processing 00000000.tx.948: The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. 

Phrase: "The Alzheimer's disease-associated presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "differentially phosphorylated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "located"

Phrase: "predominantly within the endoplasmic reticulum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
Processing 00000000.tx.949: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.950: Med. 

Phrase: "Med."
Processing 00000000.tx.951: 2: 673-691 56. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "673-691 56."
Processing 00000000.tx.952: Wasco, W., W.P. 

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "W.P."
Processing 00000000.tx.953: Pettingell, P.D. 

Phrase: "Pettingell,"

Phrase: "P.D."
Processing 00000000.tx.954: Jondro, S.D. 

Phrase: "Jondro,"

Phrase: "S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.955: Schmidt, S. 

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.956: Gurubhagavatula, L. 

Phrase: "Gurubhagavatula,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.957: Rodes, T. 

Phrase: "Rodes,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.958: DiBlasi, D.M. 

Phrase: "DiBlasi,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.959: Romano, S.Y. 

Phrase: "Romano,"

Phrase: "S."

Phrase: "Y."
Processing 00000000.tx.960: Guenette, D.M. 

Phrase: "Guenette,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.961: Kovacs, et al . 1995. 

Phrase: "Kovacs,"

Phrase: "et al . 1995."
Processing 00000000.tx.962: Familial Alzheimer's chromosome 14mutations. 

Phrase: "Familial Alzheimer's chromosome 14mutations."
Processing 00000000.tx.963: Nat. 

Phrase: "Nat."
Processing 00000000.tx.964: Med. 

Phrase: "Med."
Processing 00000000.tx.965: 1: 848 57. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "848 57."
Processing 00000000.tx.966: Wyllie, A.H.. 

Phrase: "Wyllie,"

Phrase: "A.H.."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.967: 1980. 

Phrase: "1980."
Processing 00000000.tx.968: Cell death: significance of apoptosis. 

Phrase: "Cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "significance of apoptosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0237881:Significance [Quantitative Concept]
   790   C0750502:Significance [Idea or Concept]
   718 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.969: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.970: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.971: Cytol. 

Phrase: "Cytol."
Processing 00000000.tx.972: 68: 251-306 58. 

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "251-306 58."
Processing 00000000.tx.973: Wolozin, B., K. 

Phrase: "Wolozin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.974: Iwasaki, P. 

Phrase: "Iwasaki,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.975: Vito, J.K. 

Phrase: "Vito,"

Phrase: "J.K."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.976: Ganjei, E. 

Phrase: "Ganjei,"

Phrase: "E."
Processing 00000000.tx.977: Lacana, T. 

Phrase: "Lacana,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.978: Sunderland, B. 

Phrase: "Sunderland,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.979: Zhao, J.W. 

Phrase: "Zhao,"

Phrase: "J.W."
Processing 00000000.tx.980: Kusiak, W. 

Phrase: "Kusiak,"

Phrase: "W."
Processing 00000000.tx.981: Wasco, and L. 

Phrase: "Wasco,"

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.982: D'Adamio. 

Phrase: "D'"

Phrase: "Adamio."
Processing 00000000.tx.983: 1996. 

Phrase: "1996."
Processing 00000000.tx.984: Participation of presenilin 2in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. 

Phrase: "Participation of presenilin 2in apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679823:Participation [Functional Concept]

Phrase: ":"

Phrase: "enhanced basal activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1707919:Enhanced Activity [Quantitative Concept]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "conferred by an Alzheimer mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.985: Science (Wash. DC). 

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "(Wash. DC"

Phrase: ")."
Processing 00000000.tx.986: 274: 1710-1713 [Abstract/Free FullText]. 

Phrase: "274"

Phrase: ":"

Phrase: "1710-1713"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.987: 59. 

Phrase: "59."
Processing 00000000.tx.988: Wong, P.C., H. 

Phrase: "Wong,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.989: Zeng, H. 

Phrase: "Zeng,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.990: Chen, M.W. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "M."

Phrase: "W."
Processing 00000000.tx.991: Becher, D.J.S. 

Phrase: "Becher,"

Phrase: "D.J.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.992: Sirinathsinghji, M.E. 

Phrase: "Sirinathsinghji,"

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.993: Trumbauer, H.Y. 

Phrase: "Trumbauer,"

Phrase: "H.Y."
Processing 00000000.tx.994: Chen, D.L. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.995: Price, L.H.T. 

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "L.H.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346686:L/h [Quantitative Concept]
Processing 00000000.tx.996: Van der Ploeg, and S.S. 

Phrase: "Van der Ploeg,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "and S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.997: Sisodia. 

Phrase: "Sisodia."
Processing 00000000.tx.998: 1997. 

Phrase: "1997."
Processing 00000000.tx.999: Presenilin 1is required for Notch1 and Dll1 expression in the paraxial mesoderm. 

Phrase: "Presenilin 1is"

Phrase: "required for Notch1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "Dll1 expression in the paraxial mesoderm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.1000: Nature (Lond.). 

Phrase: "Nature"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "(Lond."

Phrase: ")."
Processing 00000000.tx.1001: 387: 288-292 60. 

Phrase: "387"

Phrase: ":"

Phrase: "288-292 60."
Processing 00000000.tx.1002: Xiao, J., and M.J. 

Phrase: "Xiao,"

Phrase: "J.,"

Phrase: "and"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.1003: Monteiro. 

Phrase: "Monteiro."
Processing 00000000.tx.1004: 1994. 

Phrase: "1994."
Processing 00000000.tx.1005: Identification and characterization of a novel (115kDa) neurofilament-associated kinase. 

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "characterization of a novel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "(115kDa"

Phrase: ")"

Phrase: "neurofilament-associated kinase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249073:neurofilament-associated kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.1006: J. 

Phrase: "J."
Processing 00000000.tx.1007: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.1008: 14: 1820-1833 [Abstract]. 

Phrase: "14"

Phrase: ":"

Phrase: "1820-1833"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.1009: Copyright  1997 by The Rockefeller University Press.

Phrase: "Copyright  1997 by The Rockefeller University Press."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0009993:Copyright [Intellectual Product]
   748   C0041740:University [Manufactured Object,Organization]
   748   C1552856:copyright [Idea or Concept]

